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INTRODUCTION TO THE PORTFOLLIO - VOLUME 1
This portfolio contains a selection of work completed as part of the PsychD in Clinical 
Psychology, 2000-2003. Volume 1 comprises the academic dossier, which contains four core 
essays; the clinical dossier which comprises descriptions and summaries of all placements 
undertaken and summaries of five clinical case reports; and the research dossier, which 
consists of a research log book, the service related research project completed in year 1 and 
the major research project completed in year 3.
Volume II comprises the Clinical Dossier of work completed during the PsychD in Clinical 
Psychology. This volume contains five case reports covering the four core placements, and a 
specialist placement. Placement summaries, contracts and relevant documentation; such as 
log books of clinical experience and placement evaluation forms are incorporated. This 
volume will be kept in the Psychology Department within the University of Surrey due to the 
confidential nature if the material.
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ACADEMIC DOSSIER
OVERVIEW
This section contains four essays from the core client groups worked with and studied 
throughout the first two years of training. These essays critically examine the theory 
and practice of a range of psychological approaches with regard various issues across 
the life span.
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ADULT MENTAL HEALTH ESSAY
Compare and Contrast Cognitive Behavioural and Psychoanalytic Concepts of 
Depression in Adults and Evidence Underlying Each of these Models.
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Compare and Contrast Cognitive Behavioural and Psychoanalytic Concepts of 
Depression in Adults and Evidence Underlying Each of these Models.
Depression will initially be operationalised. Cognitive-Behavioural and Psychoanalytic 
models will then be described in turn examining their development and more specifically 
their understanding of depression. Evidence will be provided for the rationales they give. 
These will be confined to an adult population. Comparisons will then attempt to be drawn 
between the models. The main ideas will then be summarised.
Depression:
Before any understanding surrounding depression can be achieved, it must be made clear 
what is meant when talking of depression in a clinical context. The word ‘depression’ is 
frequently used in everyday language such as ‘I feel depressed today,' or ‘Isn’t the weather 
depressing?’. Therefore depression is used in lay terms to describe a transient fluctuation in 
mood often mild, yet can also describe an extremely impairing disorder.
For the purpose of this work, the focus shall be conditions that can be diagnosed as a 
syndrome of depression using the Diagnostic and Statistical Manual (DSM-IV; American 
Psychiatric Association, 1994). Our interest will be on those meeting criteria for Major 
Depressive Episode, see table 1. Other aspects include: symptoms not meeting criteria for a 
mixed episode; symptoms not being due directly to physiological effects or a general medical 
condition and the symptoms not being better accounted for by bereavement. The symptoms 
should also cause significant impairment or distress in functioning.
Table 1: Diagnostic Criteria for M ajor Depressive Episode.
Diagnostic and Statistical Manual (DSM-IV; American Psychiatric Association, 1994).
M ajor depressive episode 
A Five or more o f the following symptoms during the same 2-week period; at least one of the 
symptoms is depressed mood or loss of interest or pleasure.
a) depressed mood most of the day, nearly every day (as indicated by subjective report or observation 
by others).
b) markedly diminished interest or pleasure in all or almost all activities most of the day, nearly every 
day (as indicated by subjective account or observation by others).
c) significant weight loss when not dieting or weight gain (e.g. a change of more then 5% body weight 
in a month), or decrease in appetite nearly every day.
d) insomnia or hypersomnia nearly every day.
e) psychomotor agitation or retardation nearly every day (observable by others).
f) fatigue or loss of energy nearly every day.
g) feelings of worthlessness or excessive or inappropriate guilt nearly every day.
h) diminished ability to think or concentrate, or indecisiveness, nearly every day (either subjective or 
observed by others).
i) recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific 
plan, or a suicide attempt or a specific plan for committing suicide.
Other types of mood disorders that shall not be included for our purposes are identified as 
‘dysthymic disorder’ and ‘depression not otherwise specified.' The former comprises 
depressed mood of insufficient severity to meet the criteria for major depressive episode. It is 
characterised by low mood most of the day, for more days than not for at least two years. The 
latter includes pre-menstrual dysphoric disorder, minor depressive disorder and recurrent 
brief depression.
Major Depressive Episode is most widespread of all mood disorders. It is estimated that six 
to eighteen percent of the general population will experience at least one episode during their 
lifetime (Kessler, McGonagle, Swartz & Blazer, 1993). Over 80 percent of depressed patients 
have more than one depressive episode (Belsher & Costello, 1988). Women are said to be 
more prone to depression than men, with a ratio of two to one (Brown & Harris, 1978). As 
the ‘common cold of psychiatry’ (Seligman 1975), depression has been investigated from 
many perspectives and now two of these shall be examined in some detail.
Cognitive Behavioural Theory
Cognitive Behavioural theory stems back to the early part of the century with the work 
surrounding classical conditioning. This highlighted that responses can be learned. This was 
then extended to conditioned fear, relating this to humans. The prime example being ‘Little 
Albert’ (Watson & Raynor, 1920). Here a small child was conditioned to fear a white rat as it 
was paired with a loud noise. As fear is an aversive reaction, avoidance is sought to reduce it. 
This maintains the cycle, as the reality of the situation is never tested and confidence reduced. 
Therefore the therapy emerged focusing on exposure. By the 1970’s there was full emergence 
of behaviour therapy. The turning point came as psychological problems began to not only be 
conceptualised in terms of behavioural and physiological aspects but cognitive processes too.
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This led to the development of perhaps the most dominant theory and subsequent therapy 
today, by Aaron Beck (1987, 1991). Beck trained psychoanalytically but was struck by 
patients negative thinking patterns, which he observed to be distortions of reality and highly 
dysfunctional. Thus he formulated the Cognitive Model to describe depression. Beck 
postulated that throughout childhood, attitudes and assumptions are formed and that these 
leave individuals vulnerable to certain events. If  such an event occurs this will lead to the 
production of negative automatic thoughts. These thoughts will in turn effect and lower 
mood, which will increase the production of negative thoughts. A viscous cycle begins. This 
manifests itself in the cognitive triad comprising negative thoughts about the self, world and 
future. Cognitive distortions then extend over the person’s daily functioning. Other cognitive 
changes may subsequently occur such as faulty information processing whereby the person 
selectively attends to information and events that confirm their negative views. The treatment 
rationale therefore is to help the person recognise such patterns of distorted thinking and any 
dysfunctional behaviour. Through collaborative systematic patient-therapist discussion and 
structured behavioural assignments, the patient will try to evaluate and modify them.
Other Cognitive models have emerged such as Seligman’s learned helplessness model 
(1975). Proposing that when an individual believes no control is possible, (s)he will 
subsequently fail to take action and depressive symptoms will in turn be experienced. Thus 
the salient cognition as defined in 1989 by Abramson, Metalsky & Alloy is ‘hopelessness.1 
Other models include Rehm’s 1977 Self-Control Theory, depression occurring when one has 
deficits in aspects of self-regulation. Nezu (1987) focuses on problem solving deficits. 
Depression occurring and perpetuated by ineffective problem solving skills to cope with the 
stressful life event that is occurring.
For the purposes of this work the emphasis will be on Beck’s Cognitive Theory. The main 
concepts being that negative thoughts effect mood. For the therapy to be effective evidence is 
needed that working on the thoughts will effect the depressed mood and therefore is an 
appropriate point of intersection in the cycle. More specifically, it is important to know 
whether there are thoughts specific to depression. Beck postulated that these surround loss 
and failure. Beck also proposed faulty information processing, so attention and memory in 
depression need investigation. Beck more recently elaborated on more causal interpretations 
and vulnerability to depression. These explanations include maladaptive beliefs/dysfunctional
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attitudes that are latent until activated by a precipitating life event and vulnerable personality 
characteristics.
The following work will aim to look at research conducted to test these concepts and in effect 
aim to provide evidence for the Cognitive-Behavioural model of depression in adults.
Evidence for the Cognitive-Behavioural Model
Each of the components above will be investigated in turn with research pertaining to each 
concept discussed. The first and perhaps central theme within Beck’s model o f depression is 
the reciprocal relationship between thoughts and mood. Thus the centrality of thoughts is 
perhaps at the crux of the cognitive behavioural model. The therapy, which stems from the 
theory, recognises and attempts to modify these thoughts. Therefore the descriptive claims of 
Beck surrounding thinking patterns in the depressed are central to Cognitive Behavioural 
Therapy (CBT). Evidence supporting these concepts is therefore imperative.
Thoughts and mood
There has been considerable empirical support for the relationship between thoughts and 
mood in clinical and non clinical populations and some of these will be now be elaborated 
upon.
Blackburn, Jones & Lewin (1986) extended Wilkinson & Blackburn’s (1981) research. This 
had measured the negative interpretation for both pleasant and unpleasant situations. These 
situations related to the core components of Beck’s negative triad: the self, world and future. 
The depressed group had significantly more negative cognition’s surrounding these 
components that the non-depressed controls and recovered depressed group. The latter study 
extended this using five groups: depressed, anxious, normal controls, recovered depressed 
and recovered anxious. None had previously had Cognitive Therapy and all assessments were 
completed before start of treatment. Well validated and reliable measures were used to 
measure depression, anxiety and cognitive functioning. Findings differentiated the groups on 
all three of the severity measures. The depressed group were more depressed and more 
anxious than the other groups including the anxious group. The depressed scored the highest 
and therefore the most poorly on all measures. They were more hopeless and had more 
negative automatic thoughts and more dysfunctional attitudes than all other groups. Self-rated 
depressed mood was significantly associated with depressed thinking. Therefore this study
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highlights a strong association between thinking and mood providing support for the 
Cognitive Behavioural Model in the understanding of depression.
On the whole evidence assuming a relationship between thoughts and mood appears to be 
consistent. However it is important to note, that evidence for negative thinking does not mean 
it occurs in the absence of positive cognitions. Kendall, Howard & Hays (1989) found that in 
a week, for every two positive thoughts, a depressed person had three negative ones. One also 
cannot assume causation or even vulnerability for negative thinking or dysfunctional attitudes 
from this information; this must be taken at purely a descriptive level. These studies also rely 
heavily on self-report questionnaires and this may lower their reliability. For the purposes of 
this work, evidence supporting one of the main concepts from Beck’s Cognitive model 
explaining depression in adults has been highlighted.
Depression specific cognition’s
The second main inference from Beck’s theory was that within depression the thoughts are 
characterised by loss and failure. In a study by Clark, Steer, Beck & Snow (1996), psychiatric 
patients, chronically ill patients and normal controls were investigated for loss and threat 
cognitions and anxiety and depressive symptoms. A strong relationship emerged between 
cognition and symptom, with loss being associated with depression and threat with anxiety. 
Content specificity also varied with level of symptom severity.
Westra & Kuiper (1997) used the information processing dot probe technique, which 
involves pairs of words appearing on a screen and then disappearing. On a third of the trials, 
a small dot will appear. The participant is required to press the button when they see it. It will 
be in the spatial location of one of the words presented. This then assumed that the reaction 
time would be quicker if the dot is presented where attention had been directed. There were 
four groups covering different domains of maladjustment (depression, anxiety, bulimia and 
Type A personality). Support for the content specificity was gained, with depressed patients 
allocating their attention more towards stimuli related to themes of loss and hopelessness. 
Watkins, Mathews, Williamson & Fuller (1992) also showed depressed people had increased 
recall for material that was depression relevant and not for information that was irrelevant 
such as physical threat. The evidence therefore is consistent with thoughts of loss being 
associated with depressive symptomatology, but the level of specificity may vary with 
severity of psychopathology, as noted in Clark et al. (1996). Therefore Beck’s claims have
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been supported. However also Seligmans hopelessness cognition’s in the depressed have 
received strong empirical support.
So far evidence for the role of cognition’s and content specificity in depression has been 
illustrated. The final descriptive concept of interest is that of faulty information processing.
Faulty Information Processing
According to Cognitive theorists when depressed one attends to or remembers negative 
information that serves to maintain and exacerbate the depressed mood and subsequent 
thoughts. More recently and with the adaptation and development of research methodologies 
from experimental psychology, some good empirical studies have emerged testing these 
concepts in depression.
McCabe & Gotlib (1993) and McCabe & Gotlib (1995) found evidence for these notions. In 
the first study using a dichotic listening task, the person was asked to shadow words in the 
attended ear whilst distracter words (positive, negative or neutral) played in the unattended 
ear. A button was to be pressed when a light in front of them was illuminated. Results 
indicated depressed people took longer to press the button when the light appeared during 
presentation of the negative distracter word. This was not found in the non-depressed 
controls. It would seem they had fewer attentional resources to devote to this kind of 
secondary task. Their second study showed that it was perhaps not an emphasis on negative 
stimuli that characterises depressed persons, but a potential loss of a positive bias that non 
depressed persons have. This conclusion was drawn from clinically depressed people 
showing even handed attention to both positive and negative stimuli, but non-depressed 
demonstrating an attentional bias away from the negative stimuli. Denny & Hunt (1992), 
found depressed patients recalled significantly more negatively valenced items than positive 
ones. This was the opposite for the non-depressed controls. Therefore better memory for 
negative rather than positive stimuli, plus attentional biases appear to have been 
demonstrated. These again highlight empirical evidence for the concepts outlined by the 
Cognitive Behavioural Model in conceptualising depression.
However all these concepts, such as cognition’s and moods, content specificity and 
information processing may all be concomitants of the depressed state. Beck however in his 
theory postulated vulnerability factors in depression. These are harder to investigate, because
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if  the dysfunctional attitudes/schemata are supposed to be latent and below conscious 
awareness, they will be extremely difficult to research, as are not in the person’s awareness. 
This could partly explain some of the earlier work that has failed to find evidence for 
vulnerability factors as proposed by Beck’s model. Examples are Blackburn & Smyth (1985) 
who found no significant differences in scores for dysfunctional attitudes between recovered 
and never depressed controls after mood induction.
Studies implementing more experimental procedures as opposed to self-ratings and ones that 
include previously depressed and/or longitudinal components would seemingly be more 
reliable. One such longitudinal study by Britlebank, Scott, Williams & Ferrier (1993) 
involved pregnant women rating positive, negative and self-esteem threatening words. Later 
those who recalled more of the latter were classed as ‘vulnerable to depression.’ There were 
no differences with regard's depression levels at this point in time. Three months after 
delivery those who were in this category and who had experienced a negative life event had 
elevated levels of depression. All the other groups showed a decrease.
Ingram, Bernet & McLaughlan (1994), using a dichotic listening task with never depressed 
and previously depressed showed that when negative mood was induced, some of the 
attentional bias’s found in depressed patients might be reinstated. This did not happen to the 
never depressed group. This provides some evidence for a latent cognitive bias. Therefore 
implementation of these newer methods has begun to see more evidence underlying the 
vulnerability hypothesis presented by the Cognitive Behavioural model.
Beck also differentiated personality characteristics. Sociotropic individuals he proposed place 
emphasis towards positive interactions with others. They show a high need for intimacy and 
dependency. They are characterised as sensitive and afraid of rejection. The autonomous 
individual places emphasis on independence and goal attainment. They are particularly 
sensitive to demands and restrictions especially if these interfere with achievement of their 
goals. Therefore sociotropic depression is characterised by seeking support and reassurance 
plus a preoccupation with loss of gratification and sense of social undesirability. Autonomous 
depression is characterised by withdrawing from others and aiming to maintain autonomy. 
They are highly self critical and their cognition’s centre around personal incompetence and 
subsequent defeat. These have been investigated and evidence pertaining to the sociotropic 
personality has had more consistent support than that of the autonomous classification.
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Nunn, Mathews & Trower (1997) tested 24 depressed patients and equal matched controls 
using two selective processing tasks. Performance was related to self-reported autonomous 
and sociotropic related concerns. Results showed depressed patients with a negative bias 
favouring all negative self-related information. This bias did not seem proportional to the 
match between material and self-reported autonomous or sociotropic concerns. Whilst the 
match between material and personality type did not produce a link with depression, there 
was an increase in sociotropy concerns with severity of depression. This argues that it is not 
only when distracting words match the active concerns that interference will be elicited. 
People with depression appear to be able to elaborate on any word with negative meaning and 
then relate it to themselves. This did not have to match sociotropic or autonomous concerns. 
Although sociotropy scores did distinguish the depressed group from the controls.
With depression defined by the DSM criteria for major depressive episode and using an adult 
population, these studies have so far provided evidence for some of the main concepts of 
depression as understood by Beck’s Cognitive Model. These include a relationship between 
thought and mood and thoughts specific to depression, such as loss and hopelessness. Also 
evidence for negative biases in attention and memory. It also tentatively appears that there 
may be some support for vulnerability factors such as the latent cognitive bias and perhaps 
personality characteristics. These findings are less consistent.
With the Cognitive Behavioural model able to be operationally defined and empirically 
tested, it is of great interest to move on to the Psychoanalytic model of depression, 
investigating its concepts and evidence base for depression.
Psychoanalytic Theory
It is important to highlight before presentation of psychoanalytic theory that depression may 
not always be assumed as Major Depressive Episode. Many Psychoanalysts would not 
emphasise the DSM-IV criteria and diagnostic labels. Therefore it is important to note that 
the Psychoanalytic concepts and subsequent evidence pertaining to depression may be with a 
slightly different population than those in the Cognitive Behavioural literature.
Psychoanalytic theories have developed through the years giving rise to a number of schools 
of thought. Freud (1917) compared depression to bereavement, describing the depressed 
person as responding to a loss much in the same way as a bereaved person. However unlike
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the bereaved person whereby nothing about the loss is unconscious, in depression the loss 
object is withdrawn from consciousness. In melancholia (depression) the relationship to the 
object is complex mainly due to ambivalence. Therefore the person is experiencing a loss of 
someone/thing that was not only loved, but hated as well. Identification with the lost object 
enables the loss to be dealt with. The consequence of this is that the anger toward the lost 
object as defined through the ambivalence is then turned against the self.
Kleinian thinking developed from this line of reasoning. With a more fluid than phasical 
approach, it looks at development from birth with the emphasis on object relations. Melanie 
Klein (1934) explains depression as resulting from the negotiation of the depressive position. 
She suggests that from birth an infant sees the world as part objects. The infant splits off 
good from bad, keeping them apart, idealising with the good object and internalising it. The 
depressive position is reached whereby the infant comes to perceive whole objects. For 
example there is no longer a separate good and bad breast, but a mother, an individual 
incorporating both the good and bad aspects. At this point the individual will realise his/her 
dependence on the caregiver knowing she could leave at any time and jealous of her other 
relationships. The infant also fears that (s)he has destroyed or damaged the good object 
through the hatred (s)he had been projecting on to the bad object, now knowing them to be 
one in the same. The infant also fears (s)he has destroyed the good internal as well as external 
object. Loss, guilt and hopelessness are experienced. However, this depressive experience 
mobilises the infant to make reparation and gradual resolution of the depressive anxieties. 
This occurs with the regaining of an external and internal good object. If  this position is never 
fully worked through, a situation or feelings later in life may reawaken the depressive 
experience.
From the Kleinian school emerged John Bowlby and attachment theory (1980, 1988) which 
shall be the focus for this work. Bowlby saw psychoanalysis to date as focusing too heavily 
on the internal conflict with too little emphasis on environmental factors. He also believed it 
had not progressed within science and had not established a validated body of research and 
knowledge. This theory therefore incorporates both intra-personal and interpersonal aspects 
and has empirical research to highlight many of the theoretical concepts, which for purposes 
of this work seem therefore, the most appropriate model to adopt.
Page 18
Attachment theory and depression:
Bowlby proposes humans are innately attachment seeking and that these attachments 
contribute to species survival and individual satisfaction. Attachment is therefore more than a 
derivative of feeding as proposed by Freud and is essential in the process of emotional 
maturation. Attachment bonds to the primary caregiver (usually the mother) insure proximity 
between her and infant aiding biological survival. With the continuing presence of such an 
attachment figure, the child forms a secure base from which to explore the environment 
around him/her. The base is known as the ‘internal working model’ that incorporates 
representations of others and of the self and the relationships between the two. Therefore our 
experiences of the environment and ongoing relationships are encoded within this model. 
Through loss, threat of loss or problematic early attachment experiences, the internal working 
model may not develop as a secure one and this may impact upon the formation of other 
attachment bonds. Thus depression may ensue from faulty attachment bonds in childhood.
Evidence for Attachment Theory:
These concepts have been extensively researched, with the most well known investigation 
conducted by Mary Ainsworth (1969). The ‘strange situation’ as it was known, comprised a 
mother, her baby and an experimenter together in a room. The mother left and reactions of 
baby and mother noted upon leaving and subsequent return. Three main types of attachment 
pattern were identified. The first being the ‘securely attached,' this group was upset by the 
separation and demanded and subsequently received care when the mother returned to the 
room. The baby once reassured was then able to resume playing. This is compatible with 
healthy development, with the assurance that the parents will be responsive and available. 
The other two categories are less secure with first the ‘insecure-avoidant’ label describing the 
child who was not excessively distressed by the separation. They ignored the mother upon 
return, yet were unable to resume play as they acutely watched the mother. This group is said 
to hold little belief that (s)he will receive comfort and help that is needed. They are likely to 
be hostile, emotionally insulated and demanding of attention. This may be put down to 
repeated rejections from the parental figure. The second less secure group was labelled 
‘insecure-ambivalent.’ This group, panicked by the separation, clung to the mother, however 
on return they fought her off. They too were unable to resume normal play. This has been 
proposed as being a reaction to inconsistent care giving with the child both tense and 
demanding but also passive and helpless. Main & Cassidy (1985) took this one stage further 
and demonstrated that these patterns shown in the first year were relatively stable throughout
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the first six years of life. These studies provide evidence for Bowlby’s propositions that early 
care-giving experiences of real or feared loss may create a rather stable individual 
vulnerability to depression later in life. Through affecting integrated personality 
development. Constraining the ‘strange situation’ are the rather discrete categories and lack 
of attention to individual variation. However the usefulness to think of children as beings 
who actively process their experiences and the role of attachment and interpersonal 
relationships are seen as important contributions to the understanding of vulnerability to 
psychopathology.
Bowlby postulates that relationships of individuals who are depressed would therefore reflect 
insecure attachments from their childhood. There has been some evidence to support these 
notions. Hojat (1998) in a study of 928 medical students found that perceived satisfaction 
with the mother in childhood, was associated with less depression, less loneliness and a less 
negative view of stressful life events. McCarthy (1999) found women with a secure 
attachment style were shown to have more positive ratings within love relationships and adult 
friendships than the two insecure attachment styles (ambivalent and avoidant). The latter was 
particularly associated with adult love relationship difficulties. The Adult Attachment 
Interview (AAI: De-Hass, Bakermans-Kranenberg & Van Ijzendoom, 1996) aims to surprise 
the unconscious into actually revealing itself, through asking a number of detailed 
relationship questions. Fonagy, Steele & Steele (1991) using this instrument, found that 
mother’s with secure and autonomous narratives in turn tended to have children who were 
secure when placed in the ‘strange situation.’ Dismissive parents on the other hand tended to 
have insecure-avoidant children.
Therefore these studies tend to highlight that the quality of relationships and early 
attachments have implications for personality and interpersonal relationships later on. That 
insecure attachment from real or perceived loss, or inconsistent care giving may predispose 
an individual to develop a vulnerability to interpersonal problems later on and even to 
depression. This cycle may continue through generations, as the mother with her own 
attachment patterns and internal working model may influence security and subsequently her 
own infant’s attachment pattern. However, a distinction needs to be made between 
attachment pattern as measured by the ‘strange situation’ and the ‘AAI’, which defines 
attachment through description. Therefore the former is on mechanisms and the latter on 
meaning. Therefore the important factor later in life may not be the attachment experience
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itself, but the ability to reflect upon one’s own experiences and oneself in relation to others. 
(‘Reflexive self function,’ Fonagy, Steele, Higgitt & Target, 1994). Caution is also needed 
with respect to retrospective recall bias as demonstrated by the use of personality 
questionnaires such as with the Hojat (1998) study.
In general, Bowlby’s attachment theory has made some important contributions to the 
understanding of interpersonal relationships and personality. This in turn has important 
clinical implications, such as for depression.
Comparisons Between Cognitive-Behavioural and Psychoanalytic Models of Depression:
Initially it may appear that the two schools of thought regarding depression differ 
significantly. Broadly speaking these two models do differ somewhat, especially if the 
traditional concepts of the two are upheld. One model traditionally concentrating on the 
unconscious and the past and the other on cognition’s in the here and now. However when the 
more recent theories are taken in detail such as with Beck’s Cognitive model and Bowlby’s 
attachment theory, there are a number of areas that are explained in a similar way to each 
other.
Both do not see the child as a passive recipient of information, but activity processing 
information from its experiences. The Cognitive Behavioural Model explained about 
schema’s that are laid down in childhood that serve as a filter in which the world is viewed 
and interpreted. Attachment theory similarly sees children as actively processing their 
experiences. Both these models therefore recognise the importance of early childhood 
experiences and the effects these may have later in life. The difference may lie in that the 
Cognitive model looks at these experiences with view to later effects on cognition and views 
of the self and others, whilst attachment theory links with later interpersonal relationships.
Whilst Cognitive Models are often taken as only reflecting the here and now and all on a 
conscious level, with the opposite being true for psychoanalytic models, hopefully this black 
and white distinction has been shown to be inaccurate. The Cognitive model in its causal 
hypothesis postulates latent schemas and assumptions that are out of conscious awareness. 
Attachment theory talks of the ‘internal working model’ similarly built on experiences and 
serving to shape our perception and experiences as we get older. There are conscious 
components in both models too. Notably in the Cognitive model with negative thoughts and
Page 21
the emphasis on distorted thinking patterns, but also in attachment theory as highlighted with 
the ‘AAI’ and a person’s self understanding and awareness of their experiences.
Bowlby’s ‘insecure-ambivalent’ individual parallels Beck’s ‘dependent/sociotropic’ 
individual and the ‘insecure-avoidant’ parallels Beck’s ‘autonomous’ personality. Both 
identify these as vulnerable characteristics predisposing an individual to depression later in 
life. Bowlby proposes that these attachments and subsequent personality style create specific 
cognitive biases that increase an individual’s vulnerability to depression. Similarly Beck 
emphasises cognitive biases and distortions that may continue independently from the 
situation that may have initially stimulated the response.
Therefore the Cognitive Behavioural and the Psychoanalytic models share many concepts in 
their understanding of depression. Notably the importance of the childhood experience. The 
role of the unconscious and the role of the conscious, plus the importance of cognition’s and 
personality characteristics in creating a vulnerability to depression. Perhaps the major 
differences lie therefore not so much in the conceptualising but in the treating of disorders 
such as depression.
Beck’s Cognitive therapy proposes primarily looking at the individuals ‘current’ way of 
construing the world around them without necessarily focusing on or even investigating its 
origins. The emphasis being on the negative automatic thoughts, that regardless of causation 
appear to be present in depression and exerting an influence over mood. Bowlby on the other 
hand, view's therapy as reconnecting memories and feelings and trying to help the client to 
understand the experiences that may have led him/her to feeling depressed. Therefore 
enabling the client to alter their maladaptive interpersonal relationships. The emphasis is on 
transference and countertransference to facilitate the understanding of unconscious conflicts, 
past attachments and experiences through the therapeutic relationship. Whilst both emphasise 
cognitive distortions, Beck stresses the cognition’s content and Bowlby the structure and the 
impairment of how caring relationships are mentally represented.
Summary and Conclusions:
The Cognitive Behavioural model as defined by Aaron Beck, has been extensively researched 
and evidence pertaining to its main concepts in understanding adult depression highlighted. 
Links between thoughts and mood and depression specific cognitions have been identified.
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Evidence supporting notions of selective information processing for negative information has 
also been provided. More recently causal factors have been proposed and using experimental 
methodology the results have been more encouraging. Evidence for sociotropic personality 
as a vulnerability factor has also received some support. The Psychoanalytic model, for our 
purposes ‘attachment theoiy’ as defined by John Bowbly, has also been empirically tested. 
Evidence pertaining to early attachments, their stability, predisposition to later problem 
interpersonal relationships and subsequent clinical implications has received some consistent 
support. These two models whilst differing in focus and in their therapies; theoretically and 
conceptually cover similar ground. Both emphasis the importance of childhood experiences 
and acknowledge the importance of conscious and unconscious processes. Both theories 
recognise the role of cognition, whilst personality characteristics and life events are not 
minimised by either.
Further work is needed in evidencing both models. More work is needed to understand the 
causal factors from a Cognitive perspective! To date relatively little support has emerged for 
the autonomous personality style. Within the Psychoanalytic field, recognition of the 
importance of a father figure and changing structures in society needs attention. Therefore 
whilst these two models have provided substantial information and subsequent evidence for 
concepts in depression, further work is still needed. Perhaps if opposing models drew on their 
shared perceptions a richer understanding of depression could be achieved.
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PEOPLE WITH LEARNING DISABILITIES ESSAY
Sexually Abused and/or Sexually Abusing: What is the Role of the Clinical 
Psychologist in Working with People with Learning Disabilities who have been 
Sexually Abused or who Abuse Others.
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Sexually Abused and/or Sexually Abusing: What is the Role of the Clinical Psychologist 
in Working with People with Learning Disabilities who have been Sexually Abused or 
who Abuse Others.
‘Substantial limitations in present functioning. It is characterised by significantly 
sub-average intellectual functioning (IQ<75), existing concurrently with related 
limitations in 2 or > o f  the following applicable adaptive skills areas: 
communication, se lf care, home living, social skills, community use, self-direction, 
health and safety, functional academics, leisure and work. Mental retardation 
manifests itself before age 18. ’
Luckasson, Couller, Polioway, Reiss, Schalock, Snail, Spitalink & Stark (1992).
The above quotation is a definition of learning disabilities, highlighting limitations in 
adaptive and intellectual functioning. Throughout this work, the term will be taken as 
synonymous with mental retardation, learning difficulties and mental handicap, which are 
consistently found throughout the literature.
People with learning disabilities have been found to be particularly vulnerable to sexual 
abuse, where sexual abuse is defined as:
‘Where sexual acts are performed on or with someone who is unwilling or unable to 
consent to those acts. ’ Brown & Turk (1992).
Mathews (1994) moves the focus away from that of consent to:
‘Where that person’s apparent willingness is unacceptably exploited. ’
Sobsey, Gray, Wells, Pyper & Reimer-Heck (1991) postulated that 75 to 80 percent of 
learning disabled women living in community residences had been sexually assaulted. With 
figures such as these and now a more public awareness, this complex and highly emotive area 
has begun to raise much concern and in turn investigations into work being done with regard 
this vulnerable population, especially concerning prevalence, prevention and treatment. This 
work will only focus on those abused although there is recognition that many of those abused 
later go on to be the perpetrators. This work will therefore focus on people with learning 
disabilities who have been sexually abused with the emphasis on the role a Clinical 
Psychologist can play within this complex, delicate and multifaceted area.
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Whilst highly pertinent, issues regarding ‘what is consent’ and what constitutes abuse or a 
learning disability will not be focused upon. Instead the focus will be on delineating the role 
of a Clinical Psychologist within this population. Although recognition as to the complexity 
of operationalising definitions and in turn the heightened risk in not even recognising and 
labelling abuse is acknowledged.
This work will present the main roles of a Clinical Psychologist within this client group, plus 
describe in detail the importance of tackling these areas and the impact of doing so by these 
specific health professionals.
Clinical Psychologist:
The Management Advisory Service to the NHS in 1989 produced a three-tier model of 
psychological skills that distinguish a Clinical Psychologist from other health care 
professionals. The first level describes general psychological skills all health care 
professionals can possess, such as stress management and counselling techniques, plus 
creating a therapeutic relationship. The second level illustrates the use of more discrete skills, 
such as using specific models of treatment often described through a protocol, such as people 
trained in Cognitive behavioural work only, therefore specific but limited skills. On this level 
there should also be an awareness of own limitations and when to refer to a Clinical 
Psychologist who possesses the third level skills. The third level is proposed as that obtained 
only by the Clinical Psychologist, this level includes a comprehensive psychological 
knowledge comprising many theories and skills. Working on this level requires flexibility 
and generic knowledge to be able to work with complicated presenting problems. Thus 
working at this third level sets them aside from other health care professionals, and delineates 
their general role and abilities.
Alongside this broad training clinically, Clinical Psychologists also have broad training in 
research methodology. Psychologists have the benefit of scientifically researched work in the 
field and can target skills to one area if needed without losing their breadth. Because they 
have research training they can utilise this and constantly evaluate their work by looking at 
problems in the light of new emerging evidence and theories.
Psychologists can also be seen as having a number of roles within a team. These include that 
of a ‘consultant’ by providing advice to other team members in client management. They can
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be the ‘therapist’ carrying out specific detailed work for clients. They can be the ‘educator’ 
teaching other professionals/clients/families psychological skills. They can also take the role 
o f the ‘advocate’ for the client, representing their perspective and rights within the 
multidisciplinary team and in society. They also can learn from the other professionals about 
their roles. Therefore Clinical Psychologists have varied roles on many different levels.
Thus from the above delineation of a Clinical Psychologist, it may be seen that they can 
address the issues in question at a number of levels. These can be classified (Sobsey, 1994) 
into the ‘Macrosystem’ addressing beliefs and behaviours people have regarding this client 
group, the ‘Exosystem’ looking at the context these individuals live in, therefore looking at 
protection against abuse, staff guidance and education for all involved. Finally they can also 
look at the ‘Microsystem’ and work with supporting the individual. Therefore as mentioned 
above, taking on many roles and utilising their broad base of training to work in many 
different ways with different people to deal as holistically with all aspects of sexually abused 
people with learning disabilities.
These levels that can be addressed by a Clinical Psychologist will be taken further to see how 
Clinical Psychologists can help those who are learning disabled and have been sexually 
abused. Therefore not looking only at the individual level and the therapeutic involvement, 
but the wide range of skills a Psychologist has and the wide effect of sexual abuse within this 
client group and the far reaching effects and issues that need addressing. Useful ways a 
Clinical Psychologist might work with this population can be classified into two broad areas, 
that of interventions which address the social, emotional and physical context the person lives 
in, which could be seen to incorporate the macrosystem and exosystem. Then the second, 
which addresses more specialised interventions on a more individual level (this relates to the 
microsystem). These will be taken in turn to delineate the role of a Clinical Psychologist 
working with people who have been sexually abused.
Level One:
Macrosystem
With increased literature, sexual abuse within this population is becoming recognised. Many 
Clinical psychologists have been prolific in drawing attention to this delicate area that many 
people did not want to accept was a reality and therefore addressing the macrosystem and 
society’s views of people with learning disabilities. Within this recognition emerges one of
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the most important areas, which is that of ‘risk’. In this case, the concept of harm to the 
individual. Psychologists can begin to help people with learning disabilities who have been 
abused, by learning from these incidences and recognising the situation and taking into 
account ‘risk’ at all times at whatever level of work with these clients. Then feeding this 
information back into literature and for the general public, then maybe attitudes and 
interactions can change.
Sobsey et al. (1991) found people with learning disabilities at increased risk for sexual abuse 
and sexual assault. Davis (1989) placed the figure at 75 to 80 percent of women with learning 
disabilities living in a variety of community residences having been sexually assaulted. 
Communication is a risk factor. It is easy to be taken advantage of when the person has no 
access to a vocabulary to describe their abuse. Often non-verbal communications are ignored, 
misunderstood or labelled as ‘challenging behaviour’. Many people with learning disabilities 
are dependent on others for support and can easily be taken advantage of. Many also live in a 
society where they see themselves as ‘damaged goods’ and have such low self-esteem as to 
not see the crime in what is being done to them, and that they deserve it somehow. Many also 
may have learnt to be compliant especially to those in powerful positions, and may not 
comprehend what is and what is not appropriate. Many myths see people with learning 
disabilities as less than full members of society, and somehow immune to suffering and pain. 
They may also be seen as deviant, unpredictable members of society. Clearly environmental 
attitudes continue to contribute to the vulnerability and disempowerment of this group, and 
lack of awareness regarding risk to this population. Education not only for society but given 
to the individual therefore is important as without access to education, there may be a lack of 
understanding about one’s own body and one’s rights.
Hence the understanding and recognition of risk, and alerting others to this, is a major step in 
prevention of those who could be, and recognition of those who have been sexually abused. 
Certain beliefs, lack of recognition, and not looking at issues of risk, or not believing it, may 
see a person’s environment increasing their risk for abuse. Thus this macrosystem needs to be 
addressed. The Clinical Psychologist has had training in abuse and also in learning 
disabilities. They are able to work at a therapeutic and educational level, whilst being aware 
of the current climate. With skills enabling them to be the researcher, to report findings and 
to make them public, puts them in a position to address these issues, highlighting risk and 
educating society.
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Exosystem:
Providing evidence, alerting people to the risk and working on this general level then needs to 
be taken further. Psychologists can do this, primarily through education for the many groups 
o f people involved. Much of the excessive risk can be eliminated through appropriate 
prevention strategies and through education. Work can also be done to improve awareness of 
past and present abuse, and help agencies develop their services to support survivors and 
make them accessible to this client group. These are roles that are undertaken by a Clinical 
Psychologist and will be looked at now in more detail.
Education for Carers:
Some of the roles of the Clinical Psychologist mentioned earlier were the ‘educator’ and also 
the ‘consultant’. As mentioned, often abuse goes undetected, maybe by lack of 
communication verbally and non-verbally. The front line staff are those who can help the 
people in question get appropriate support, if the abuse is recognised. Therefore helping staff 
to understand the effects of abuse, and recognise its presentation within this group of clients 
is a major step in helping those with learning disabilities that have been sexually abused. 
Clinical Psychologists can play an important role, by firstly helping to make complex models 
in understanding abuse, accessible to carers and front line staff. The metaphor o f a tree has 
been noted as a useful way of doing just this. The hidden roots can be seen to symbolise 
abuse, whilst the leaves, the most visible parts represent the behaviours and effects that often 
are what gets seen and noted. These often distract from what is underneath these, such as the 
trunk and the branches, which can be seen to represent feelings and emotions experienced by 
many survivors’ of sexual abuse, such as guilt, shame, fear and rage. This metaphor helps 
people see that behaviours cannot be taken at face value but there is a meaning to behaviours, 
and there are underlying feelings.
Clinical Psychologists can then help carers and staff, to then try and recognise signs of abuse 
and improve communication, especially non-verbal. As Fenwick (1994) questioned:
“I  cannot help but wonder just how many people with ‘challenging behaviour ’ have been 
victims o f sexual abuse at some time in their lives? ”
They also can use their knowledge not only with regards working with the learning disabled, 
but also their understanding as to the process of abuse. Helping others to be aware of the 
recovery process, such as initial disbelief/numbness often followed by distress/tearfulness,
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and anger/rage, which can then manifest itself through self-harm or aggression. Hopefully as 
memories are assimilated into their existing belief system, they are able to move on. With 
increased awareness and communication, hopefully abuse will be more readily identified and 
not mistaken for ‘challenging behaviour’ and then people with learning disabilities can get 
access to the help and resources they need.
Illustrating these ideas is a study by Brown, Hunt & Stein (1994). Over three years, they 
collected comprehensive and detailed data on sexual abuse incidences across the Southeast 
Thames Regional Health authority. The staff groups served a range of clients with a range of 
abilities from a variety of settings. Disclosure was the most frequent way in which a response 
was made to sexual abuse. Most staff knew there were guidelines regarding sexuality in their 
practice, but only around 43 percent had read them. Of these people, more than 70 percent 
could not remember the contents. They emphasised the need for training and for clear and 
simple guidelines. This supports the need for what a Psychologist can provide in terms of 
education and simple definitions. Also highlighted was the absence of clear policies and 
guidelines of how to respond within this area, especially in the face of sexual abuse. 
Therefore they also need procedures for reporting abuse and to how to detect early signs. 
Unreported and undetected cases will allow more people to be victimised and people to 
remain at risk of prolonged or repeated abuse.
Therefore the Clinical Psychologist needs to take staff education up to management and 
policy level, to encourage reporting with safe clear guidelines and boundaries for staff to feel 
safe to do so, whilst protecting their interests as well as the clients.
Where staff training has been implemented, the results have been encouraging. Hames (1996) 
offered staff from three day centres sexual abuse training. Attitudes and knowledge about 
sexual abuse issues were measured before and after training. Findings saw staff groups as 
aware of the vulnerability of people with learning disabilities to being sexually abused, and 
were aware of increased risk with increased disability. Training further increased their 
awareness. In general staff had taken on board information regarding higher vulnerability of 
people with learning disabilities to sexual abuse. However, they were less successful in 
raising awareness about risks from familiar people, especially other staff members. Therefore 
whilst training by Psychologists is highlighted as useful within this area in helping people
with learning disabilities who have been abused. If carers cannot consider colleagues as 
potential abusers, there is likely to be impairment in recognising abuse when it happens.
Thus from the above information regarding education and training for carers and staff. 
Clinical Psychologists play an important part. They can utilise their knowledge of people 
with learning disabilities and their knowledge of abuse, to educate others regarding risk, early 
detection, communication and reporting of abuse.
Education for Clients:
Timmers, DuCharme & Jacobs (1981) looked at two learning disabled adults, with similar 
levels of sexual experience. Compared to the general population, they had less sexual 
knowledge and more negative attitudes regarding sex. Simonds (1980) suggested that the 
combination of decreased cognitive functioning, less experience and little formal 
education/instruction could result in inappropriate expression of sexuality. In turn creating a 
risk for abuse, including repeated abuse and negative opinions from society. Therefore 
education as a preventative measure against abuse within this population, is vital. In absence 
of information and with inability to make decisions about their bodies and sexuality, they are 
open to abuse and exploitation. Also, of all the human behaviours, sex-related behaviour is 
one of the most complex and yet subtle and is a central component of social interaction. Sex 
education therefore is extremely important for successful integration of people with learning 
disabilities, as deviations from the norm are not viewed well. Therefore to dispel some of 
societal myths about people with learning disabilities, we must not facilitate their difference 
and isolation from the general population, by providing them with the education they need to 
integrate more efficiently.
Training ‘potential’ victims to resist or try and avoid abuse has been the standard approach. 
However it became recognised that in doing this, assigning ultimate responsibility to 
offenders was not being made. Also sex education needs to be tailored to the individual. 
Information should go beyond the biological and address emotional components as well, plus 
information regarding choices, behaviour and risks.
As before, the Clinical Psychologist can play a major role, with an up to date awareness from 
the literature and skills in using information to inform their practice. They have further skills 
in human behaviour, communication, sexuality, abuse and people with learning disabilities.
They are not limited to one field or one model or theory to understand the issues from, but 
have the advantage of having a broad base of knowledge and many different theories to work 
from and gain a much wider understanding. They can then draw on what they need whether 
it’s direct education for people with learning disabilities or consultation for a team of people, 
who might be providing the education, or researching and evaluating current programmes. 
This information can then be used to further inform the general population and health care 
professionals of client’s needs in this area. Not to mention informing any potential future 
interventions.
Clinical Psychologists can also address needs such as low self-esteem, which often stem from 
societal attitudes and previous abuse and can result in the person seeing themselves as 
unworthy and a less than full member of society. A Clinical Psychologist can employ 
assertiveness training, plus the facilitation and development of access to sexual and social 
relationships can be promoted to reduce vulnerability to more abusive ones. It is important to 
empower individuals, this includes not only improving communication and way of indicating 
no, but protection includes more choice and more control and more access to support 
networks.
Miltenberg, Robert, Ellington & Galensky (1999) looked at five unmarried women with mild- 
moderate learning disabilities, aged 33 to 37 years old. They were trained in sexual abuse 
prevention skills. A variety of scenarios were developed to assess their acquired skills and 
knowledge. After the ten week behaviour skills training, they had successfully acquired 
sexual abuse prevention skills, however these did not fully generalise to all situations, in fact 
it only did if learnt through naturalistic assessment. However these skills were maintained at 
one-month follow-up. Therefore as explained, education can work, but there is more to it than 
the biological, and the emphasis needs to be on more than just prevention of abuse, which 
carries with it the emphasis on victim blaming. This kind of research is based on a very small 
sample and as with the majority of the literature in this area, based upon those with mild- 
moderate learning disabilities, and not those severe or profound. For some, education will not 
suffice, as McLeod (1992) neatly explains:
“The areas o f sexuality and intimate relationships are arguably the most difficult o f  all 
human interaction to pursue. For many people with disabilities, they are insurmountable 
barriers. ”
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Therefore, Clinical Psychologists address the exosystem, primarily in the form of education. 
However for more education for carers and clients alike, the management and policies 
mentioned as part of the macrosystem must be in place to facilitate this. If policies are vague, 
staff unsupported and unsure regarding potential allegations and the law, this will increase 
the likelihood for abuse and decrease the likelihood of cultivating people with learning 
disabilities’ sexuality. An awareness of risk and change in public perceptions also must be 
targeted to facilitate the education and provision of services for people with learning 
disabilities. Thus this highlights the importance of being able to address these different 
levels, such as the exosystem and macrosystem and have the flexibility to work within them 
with a variety of different people, using a variety of different techniques. This emphasises the 
role therefore of the Clinical Psychologist for working with people with learning disabilities 
who have been sexually abused, whilst taking into account prevention, whether for first time 
abuse, or preventing repeated/prolonged abuse.
Level Two: (The Microsystem):
With some of the myths as outlined, surrounding negative attitudes toward the learning 
disabled and the denial of their sexuality and regarding issues of abuse, research and 
treatment funding for this client group has been a low priority. The prevailing early attitude 
suggested that people with learning disabilities did not have the ability to change (Azrin & 
Foxx, 1971). This has begun to be challenged alongside the change in societal attitudes. 
Sinason (1990) reported that those with mild through to severe/profound learning disabilities 
showed high levels of success with individual psychoanalytical psychotherapy. Mansell, 
Sobsey & Calder (1992) provided further support for this and also for the use of cognitive 
behavioural models of therapy and non-verbal techniques such as art therapy and play 
therapy. Sysmanski & Tanguay (1980) also proposed that psychotherapy can be helpful, 
again pointing to the misconceptions that the learning disabled are not bright enough or co­
operative enough to benefit from such an intervention. He also mentions the importance of 
education and awareness of issues previously outlined within level one interventions, 
comprising the macrosystem and exosystem.
Barber, Jenkins & Jones (2000) conducted group work for people with learning disabilities 
who had been abused. The aims were to foster assertiveness and improve self-image. The 
group comprised three women, aged 20 to 33 years old. They all lived in the community, and 
participants had all been referred to the Clinical Psychology department. Core conditions
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comprising unconditional positive regard and total acceptance, with deep, empathic 
understanding to be communicated, was to provide an environment of trust and acceptance, 
and respect for patients. All women attended at least eight out of ten sessions, which were for 
two hours for ten weeks. Findings indicated modest improvements for levels of personal 
assertiveness and self-esteem. Increased confidence and better communication of needs was 
suggested through subjective feedback. On the other hand, the group did not perhaps provide 
enough time to return to themes and look at individual issues in more detail and some 
disengagement was noted throughout the group. However in all, the group seemed a good 
experience and highlights the impact interventions with this client group can have and that 
changes are possible. Group therapy may add to the second level intervention as it provides a 
peer comparison group for members to share their experiences.
Therefore the needs of learning disabled people who have experienced sexual abuse, should 
not be fundamentally different from the non-disabled population. Long-term treatment should 
not concentrate only on sexual behaviour or prevention strategies, but look at the whole needs 
of the individual. The main message must delivered must be that this was not their fault and 
they are not bad. Sullivan & Scanlan (1990) highlight similar issues from reviewing sexual 
abuse literature and incorporating their experience from working with sexually abused 
learning disabled children. They define the main treatment goals as being able to alleviate 
guilt, trying to regain the ability to trust, helping to express their anger, helping combat the 
depression and teaching an affective vocabulary to help label emotions. Teaching about 
sexuality, abuse and interpersonal relationships is also outlined. Numerous techniques for 
treatment are advocated, such as counselling, psychotherapy, behaviour therapy, play therapy 
and psychodrama. The need for acceptance and a positive non-judgemental attitude is 
highlighted, along with promoting a person’s rights and learning potential.
A Clinical Psychologist can work on this one to one level and in this way. As depicted in the 
MAS report, they have a broad knowledge base comprising understanding and utilising many 
treatment models, theories and rationales. Therefore they can are not constrained to one 
model of treatment, but can be creative and can fit the therapy, drawing on what may best 
benefit the client, rather the forcing a client to fit a particular theory, being the only one that 
is known.
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There is also the importance of issues such as ‘countertransference’ which looks at the 
dynamics between client and therapist. This is important, as there is always the danger of 
mirroring the abuse dynamics, with the therapist representing the abuser, if  being seen in the 
position of power. Clinical Psychologists are trained to be aware of issues such as this, and 
have been trained to utilise supervision in which these dynamics should be investigated. 
Separating therapist feelings from client feelings can then be used to further inform the 
intervention. Clinical Psychologists can be on the giving or the receiving end of this kind of 
imperative supervision, taking the consultant, supportive, educator or therapist role. Good 
supervision is vital, as good interventions depend upon it. Supervision ensures that work is 
not led by the expectations or feelings of the therapist, carer or other health care professional, 
but by the individual themselves.
As Mansell et al. (1992), describes the lack of available treatment may be in part due to a 
lack of professionals who have adequate training, not only theoretically, but also with regard 
experience working with the learning disabled and/or working with those suffering from 
sexual abuse. In fact they saw 119 sexually abused people with learning disabilities and 
indicated access to treatment was very difficult, typically unavailable and often inappropriate. 
Reasons being mainly due to the paucity of qualified professional in this complex area.
Clinical Psychologists comprise some of the few professionals who are trained to work at 
such a level and in such a manner with this field. However, with lack of funding and without 
addressing the exosystem and macrosystem, in other words, society, attitudes and research, 
the situation will not continue to change and the downward spiral from the past will not be 
reversed. In the past, lack of awareness, negative attitudes and myths surrounding people with 
learning disabilities, saw a low priority for research and funding. This fed into a lack of 
appropriate interventions, professional training and a lack of research, this in turn then 
feeding back into the original myths and negative attitudes and lack of awareness surrounding 
sexual abuse of people with learning disabilities. The greater the awareness of the issues, the 
more research and funding, an increase in appropriate interventions and funding of trained 
staff, education and supervision, Then the more research back into the area, which will 
continue to inform and educate society, the government, health authorities, families and staff, 
creating an upward spiral of awareness, research and improved interventions.
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Therefore the role of the Clinical Psychologist is so vital when working with people with 
learning disabilities who have been sexually abused, because they can not only work on the 
individual level, which so few professionals have the breath and depth of training for. But can 
also work at a wider level, addressing, researching and educating others, to raise awareness, 
encourage funding and better support for this client group.
Summary/Conclusion:
Sexual abuse within the learning disabled population, is an extremely complex and at times 
contentious area. Even the mere definitions of these terms have generated considerable 
discussions and disputes. For appropriate action and support to be given to this client group, 
the macrosytem and exosystem needs to be addressed. Myths, negative attitudes and denial of 
people with learning disabilities rights and feelings needs to be challenged and often changed. 
This primarily will be done through education and literature evidence. The Clinical 
Psychologist has the scientific and the research skills to be able to know the current state of 
affairs and promote a climate for change. They can take on the role of the educator, helping 
carers and staff, by raising awareness of risk of those who may have been abused or be 
vulnerable to abuse. Recognising the signs and symptoms, in turn may help an individual 
who has been abused be recognised as such and get access to the help and support he or she 
needs. This kind of awareness may also provide a means of prevention with abuse being 
recognised and perpetrators being reprimanded. Education of the individual and more 
knowledge about their own sexuality and rights, plus being given more respect for their 
sexual needs and no longer being seen as a group of second class citizens who do not 
experience pain, may reduce the risk of exploitation and abuse. The Clinical Psychologist 
therefore through generating awareness of risk, plus education, supervision and more 
literature can address the issues of the learning disabled who have been sexually abuse on this 
level, primarily using the role of the researcher and educator.
Clinical Psychologists can then address the microsystem, working at an individual level, 
using their clinical training with people with learning disabilities and with people who have 
been abused, not to mention their broad and deep knowledge of theories, to provide 
individual interventions that fit the clients needs. Whether this be Psychotherapy, behavioural 
work, or art therapy. Knowledge of communication difficulties, the importance of non-verbal 
communication and transference issues, enable the Clinical Psychologist to be creative and 
work with the client on their level. Whilst not being constrained by a particular type of
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intervention or using only verbal communication. The Clinical Psychologist can take the role 
of the therapist and/or supervisor. Again the Psychologist can utilise his/her research skills to 
constantly evaluate their practice and findings, to inform the literature and again the macro 
and exosystems.
Thus the Clinical Psychologist can have many important roles when working with people 
with learning disabilities who have been abused and these comprise not only therapeutic 
interventions. In fact for appropriate therapy to be given, a recognition of risk and awareness 
of these peoples needs to permeate at the staff and carer level, but most importantly within 
society as a whole. As noted, the Clinical Psychologist does not work in isolation and just as 
his or her roles can effect and help utilise others, so can be said for other peoples roles. 
Therefore more importantly there needs to be a recognition as to each individuals combined 
and unique contributions and how best these can all be brought together to provide the best 
holistic care for those people with learning disabilities who have been sexually abused.
Page 41
References:
Azrin, N.H. & Foxx, R.M. (1971). A rapid method of toilet training the institutionalised 
retarded. Journal o f  Applied Behaviour Analysis, 4, 89-99.
Barber, M., Jenkins, R. & Jones, C. (2000). A survivors group for women who have a 
learning disability. The British Journal o f Developmental Disabilities, 46(1), 31-41.
Brown, H. & Turk, V. (1992). Defining sexual abuse as it affects adults with learning 
disabilities. Mental Handicap, 20(2), 44-55.
Brown, H., Hunt, N. & Stein, J. (1994). ‘Alarming but very necessary:’ working with staff 
groups around the sexual abuse of adults with learning disabilities. Journal o f  Intellectual 
Disability Research, 38, 393-412.
Davis, M. (1989). Gender and sexual development for women with mental retardation. The 
Disabilities Studies Quarterly, 9(3), 19-20.
Fenwick, A. (1994). Sexual abuse in adults with learning disabilities. Part 1: a review of the 
literature. British Journal o f learning Disabilities, 22,53-56.
Hames, A. (1996). The effects of experience and sexual abuse training on the attitudes of 
learning disability staff. Journal o f  Intellectual Disability Research, 40(6), 54-549.
Luckasson, R., Couller, D.L., Polloway, E.A., Reiss, S., Schalock, R.L., Snell, M.E., 
Spitalink, D.M. & Stark, J. (1992). Mental Retardation: Definition, Classification and 
Systems o f Supports. Washington D.C: American Association on Mental Retardation.
Management Advisory Service to the NHS. (1989). Review o f Clinical Psychology 
Services/Management Advisory Services to the NHS. Cheltenham: M.A.S.
Mansell, S., Sobsey, D. & Calder, P. (1992). Sexual abuse treatment for persons with 
disabilities. Professional Psychology Research and Practice, 23, 404-409.
Mathews, H. (1994). What staff need to know. It did happen here: Sexual abuse and learning 
disability. Conference Proceedings. London, St George’s Mental Health Library, Conference 
Series.
McLeod, J. (1992). More Than one Barrier: HIV and AIDS and Men with Intellectual 
'Disabilities who have Sex with Men. An Educational Needs Assessment. Australia: Victoria 
AIDS Council.
Miltenberger, R.G., Roberts, J.A., Ellington, S. & Galensky, T. (1999). Training and 
generalisation of sexual abuse prevention skills for women with mental retardation. Journal 
o f Applied Behaviour Analysis, 32(3), 385-388
Simonds, J.F. (1980). Sexual behaviour in retarded children and adolescents. Journal o f  
Developmental and Behavioural Paediatrics, 1, 173-179.
Sinason, V. (1990). Individual psychoanalytic psychotherapy with severely and profoundly 
handicapped patients. In A. Dosen., A. Van Gennep. & G. Zwanikken (Eds). Treatment o f  
Mental Illness and Behaviour Disorder in the Mentally Retarded. (pp71-80). Leiden, The 
Netherlands: Logon Publications.
Sobsey, D. (1994). Violence and Abuse in the Lives o f People with Learning Disabilities: The 
End o f Silent Acceptance? Baltimore: Paul, H. Brookes Publishing Company.
Sobsey, D., Gray, S., Wells, D., Pyper, D. & Reimer-Heck, B. (1991). Disability, Sexuality 
and Abuse: An Annotated Bibliography. Baltimore: Paul, H. Brookes.
Sullivan, P.M. & Scanlan, J.M. (1990). Psychotherapy with handicapped sexually abused 
children. Developmental Disabilities Bulletin, 18(2), 21-34.
Szymanski, L.S. & Tanguay, P.E. (1980). Emotional Disorders o f Mentally Retarded 
Persons: assessments, Treatment and Consultation. Baltimore: University Park Press.
Page 43
Timmers, R.L., DuCharme, P. & Jacob, G. (1981). Sexual knowledge, attitudes and 
behaviour of developmentally disabled adults living in a normalised apartment setting. 
Sexuality and Disability, 4,27-39.
Page 44
CHILD AND FAMILY ESSAY
Anxiety Disorders in Childhood are Fundamentally Different from Anxiety 
Disorders in Adulthood. Discuss with Reference to the Theory and Treatment of 
two Anxiety Disorders.
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‘Anxiety Disorders in Childhood are Fundamentally Different from Anxiety Disorders 
in Adulthood. Discuss with Reference to the Theory and Treatment of two Anxiety 
Disorders.’
There are a number of anxiety disorders outlined in the Diagnostic and Statistical Manual of 
Mental Health (DSM-IV; American Psychiatric Association, 1994). Although they are not 
categorised as ‘disorders usually first diagnosed in infancy, childhood and adolescence’ this 
may not necessarily restrict onset and prevalence for some of these disorders solely to 
adulthood. Over the years, discussions have emerged as to whether in fact the adult disorders 
are present in childhood and whether presentation and course of illness are the same, which in 
turn has significance for theory and treatment for these disorders.
This piece of work will look into this discussion, focusing on two anxiety disorders 
commonly found in adults, Obsessive Compulsive Disorder (OCD) and Panic Disorder (PD). 
These disorders have received a lot of attention both within child and adult literature and 
therefore provide a large source of information from which to discuss the area under 
question. The Cognitive Behavioural models for conceptualising these disorders and their 
subsequent treatment rationales will be looked at in conjunction with these anxiety disorders 
to further investigate whether fundamental differences between childhood and adult anxiety 
disorders exist. Cognitive Behavioural work has a wide research base and effectiveness of 
Cognitive Behavioural Therapy (CBT) has become increasingly well evidenced (Van 
Balkom, Van Oppen, Vermeulen, Van Dyck, Nauta & Vorst, 1994; Oei, Llamas & 
Devilly,1999). Whilst there is recognition as to other theories and treatments pertaining to 
these disorders, such as developmental theories which highlight the importance of childhood 
attachment and early separation in development of anxiety disorders such as Panic Disorder, 
(Ollendick, Mattis & King, 1994) and pharmacological models and treatments such as the use 
o f Selective Serotonin Reuptake Inhibitors in the treatment of OCD, (Thomsen, 1999), due to 
restrictions and for consistency, this work shall only focus on Cognitive Behavioural models 
and treatments.
From focusing on these specific models and treatments for each of these disorders, Obsessive 
Compulsive Disorder and Panic Disorder will be discussed in turn and evidence pertaining to 
each analysed with reference to both adults and children. Conclusions will then be drawn as
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to whether anxiety disorders in childhood are fundamentally different from anxiety disorders 
in adulthood.
There is insufficient data within much of the current literature (especially the OCD literature) 
to permit a consistent distinction to be made between children and adolescents for much of 
this piece of work. As age ranges vary across studies, children will be taken to be persons 
under the age of 18 for the purposes of this work, unless specified. In the Panic literature 
there is more of an opportunity for comparisons to be made between children and adolescents 
and the distinction will be made where possible.
Obsessive Compulsive Disorder is categorised according to the presence of obsessions, 
compulsions or both (DSM-IV; American Psychiatric Association, 1994). Obsessions are 
recurrent and persistent thoughts, images or impulses, experienced as intrusive and 
inappropriate which cause marked anxiety or distress. The person usually attempts to ignore 
or suppress the obsessional thoughts, or neutralise them with some other thought or action. 
The compulsions are performed in response to an obsession and can be repetitive behaviours 
or mental acts. They are aimed at reducing distress, or preventing some dreaded event or 
situation occurring. The obsessions and/or compulsions interfere with everyday functioning 
and cause marked distress (for full diagnostic criteria, see Appendix 1).
It is estimated that Obsessive Compulsive Disorder has a lifetime prevalence of two to three 
percent (Karno, Golding, Sorenson & Burnan, 1988). Over the years, theorists and 
researchers have attempted to understand the disorder and to successfully treat it. Hodgson & 
Rachman (1972) perhaps prepared the backbone of what one sees in treatment today. 
Obsessionals with concerns over contamination were asked to contaminate themselves, 
washing (the compulsive act) as predicted was associated with symptom decrease, not 
increase. Rachman, DeSilva & Roper (1976) exposed 12 obsessional checkers to a situation 
that provoked the urge to check, those who did not check for one hour began to notice a 
decrease in anxiety levels, known as ‘spontaneous decay’. This formed the basis of the well- 
known techniques of exposure and response prevention (ERP) as used today. The rationale 
being that repeated exposure to situations that trigger the obsessions will result in these 
thoughts and the associated anxiety. Prevention of the activity that usually leads to the 
reduction of this anxiety will then allow for the habituation of anxiety to happen. Repeated 
exposure leads to habituation or decline in anxiety, and with this the obsession becomes less
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distressing and in turn so does the frequency that a compulsive response is required. This 
work was extended and it was demonstrated that content of obsessional thoughts was not 
distinguishable from normal intrusive thoughts. Salkovskis (1985), built upon these ideas, 
and utilising Beck’s (1976) notions that anxiety occurs when situations or stimuli are 
interpreted in a negative way, he developed a sophisticated cognitive model of Obsessive 
Compulsive Disorder (appendix 3).
The theory proposes that obsessional thinking comprise intrusive cognitions, such as 
thoughts, images, or impulses which are unpleasant, or unacceptable and are interpreted in a 
negative fashion. According to this hypothesis, if intrusive cognitions are interpreted as a sign 
that the person has responsibility for harm or prevention of harm, then persistent obsessional- 
thinking patterns may occur. This then links the intrusive cognition with the experienced 
discomfort and compulsive behaviours. Other factors such as increased attention to the 
intrusions, avoidance and seeking reassurance can all serve to maintain and exacerbate the 
intrusive thoughts, and the amount of preoccupation with them.
Cognitive Behaviour therapy was then delineated and whilst important that each intervention 
is tailored to the individual, general strategies can be adopted (Salkovskis, 1999). He 
proposes that a good therapeutic relationship needs to be established and highlights the need 
for normalising, so the patients do not see themselves as mad or unusual. Therapy also should 
aim to generate and modify negative beliefs, which are central to the problem. Behavioural 
experiments are to be devised to provide evidence and information regarding issues that are 
discussed in session. Therefore through discussion and behavioural techniques, the client 
comes to an alternative way of looking at their problem. Exposure and response prevention 
remain important in helping the client understand how compulsive behaviour serves to 
maintain their beliefs and that stopping these behaviours is beneficial.
Cognitive Behavioural therapy for Obsessive-compulsive Disorder in adults has received 
substantial support. Van Oppen, De Haan, Van Balkom, Spinhoven, Hoogduin & Van Dyck 
(1995) found it to be at least as effective as behavioural treatment alone. Whilst this does not 
necessarily provide evidence as to the theoretical base, it does not call the theory to be 
seriously questioned. Van Balkom et al (1994) conducted a meta-analysis of treatments for 
OCD and concluded that Cognitive Behavioural Therapy was superior to placebo therapy. 
Exposure and response prevention remain a major component of CBT and the quick
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acceptance and good outcome findings may be that this was a well established and researched 
to be effective treatment already, of which CBT has built upon.
The strongest support emerging implicates dysfunctional appraisals and beliefs regarding 
inflated responsibility, alongside overestimation of threat and over-importance of controlling 
one’s thoughts in the pathogenesis of obsessional thinking, (Clark 2000, Clark & Beck, 
2000). With this growing body of evidence, this model and subsequent treatment package 
with reference to OCD, shall be used to discuss whether anxiety disorders in childhood are 
fundamentally different from anxiety disorders in adulthood.
There is awareness that the model of CBT for adults has not been adequately established for 
OCD. Whilst there is literature on effectiveness of CBT with OCD, there is no knowledge 
regarding which specific components of the treatment package are the most effective and 
how this links with the theoretic base. Therefore it is difficult to draw conclusions on whether 
OCD in children is fundamentally different to that in adults, when discussed in reference to a 
CBT theory and treatment that has not itself been fully established. The emphasis may 
therefore lie on presentation and outcome studies centring on the effectiveness of CBT within 
these two populations, rather than the specific mechanisms of change.
March & Mulle (1998) ascertain that a large number of children and adolescents do suffer 
from OCD, and that children with OCD often become adults who present with the illness. 
Thomsen (1999) collated a variety of studies and concluded that approximately two percent 
of children and adolescents are estimated to be affected by OCD. Despite CBT’s prevalence 
and increasing evidence base within the adult literature, there has been relatively little 
investigation into the specifics associated with CBT and OCD in children.
In a review by Geller, Blederman, Jones, Park, Swartz, Shapiro & Coffey (1998), average age 
of onset for children with OCD was proposed at being seven years and six months to twelve 
years and six months. This review also highlighted that the majority of studies showed a 
gender bias for boys, with a ratio of three: two, boys: girls, which is usually found to be 
equal in adults (Rasmussen & Eisen, 1992). There was also high comorbidity with specific 
developmental disorders and disruptive behaviour disorders. Therefore whilst evidence points 
to the existence of OCD in children, the gender distribution, comorbidity and age of onset 
appears different in children and adults. This led the authors to conclude that OCD in children
Page 49
could be fundamentally different to OCD in adults. However, the adult group who formed the 
basis for comparison, may well have contained adults with child onset and hence may not 
have been a suitably distinct comparison group. The literature was also mostly self-report and 
consequently may be prone to distortions. Therefore, whilst highlighting some differences in 
the presentation of OCD in children, it in itself is not sufficient to conclude that the disorder 
is significantly different in childhood to adulthood.
It is perhaps inevitable that certain age related differences will exist in childhood OCD and 
may have important treatment implications, but this does not necessarily highlight 
fundamental differences that cannot be understood by a particular theory and in turn 
successfully treated. Perhaps the emphasis is instead on understanding these differences and 
adapting techniques for children. Some researchers have begun to do this and whilst 
recognise, understand and treat OCD in children, they do so in a developmentally sensitive 
manner.
Perhaps the CBT that has done just that and has received the most attention in children and 
adolescent literature is that outlined and subsequently evaluated by March & Mulle (1998). 
They propose three stages of treatment, the first surrounding information gathering, the 
second concentrating on exposure, and the final stage incorporating response prevention 
supported by homework assignments. The cognitive component throughout focuses on 
cognitive restructuring, including self-statements to ‘boss back’ or cope with OCD. Parental 
involvement is promoted for at least two out of the 20 sessions. They showed that when 15 
young people (six-eighteen years old) were evaluated after completion of their CBT 
programme as outlined above, 12 participants (80 percent) showed a 30 percent or more 
reduction on symptoms of OCD as measured pre-post treatment, on the Children’s Yale - 
Brown Obsessive Compulsive Scale (CY-BOCS; Goodman, Price, Rasmussen, Mazure, 
Fleischmann, Hill, Heninger & Charney, 1989). This is one of the only consistent measures 
of OCD with high reliability and validity (Scahill, Riddle, McSeiggin-Hardin, Ort, King, 
Goodman, Cicchetti & Leckman, 1997). Nine subjects showed a 50 percent or more 
reduction on this measure and none relapsed over the 18-month follow up. In the only 
controlled study for CBT and OCD in children, 22 children were randomly assigned to a 
Clomipramine (medication condition) or CBT condition (which comprised exposure and 
response prevention with cognitive restructuring). Both treatment conditions showed
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significant improvements, but the CBT condition was significantly more effective in terms of 
reduction of symptom severity as measured by the CY-BOCS.
Therefore from these accounts, OCD can indeed be seen to be occurring in child and 
adolescent populations, and the theoretical basis and subsequent treatment protocol of CBT, 
concerning the importance of cognitions and behavioural work, appears to have high levels of 
success in understanding and treating this population, similarly to CBT with adults. Perhaps 
the difference is not one of a fundamentally different disorder, but is qualitative, in that the 
disorder needs to be understood and subsequently worked on specifically for how it presents 
in children and incorporating aspects of the child’s environment that are different to adults.
It seems to have proven incredibly difficult to compare specific cognition in childhood 
presentations of OCD with adults, due to developmental level and lower level of insight. 
Therefore information on understanding the disorder may be more limited to research into 
treatment (such as that by March & Mulle) and whether effects of treatment seriously call 
into question the theoretical base of the model in question. With successful treatment using 
CBT strategies albeit in qualitatively different ways in children and adolescents, it is difficult 
to conclude that childhood OCD is fundamentally different from adult OCD. . , -
March & Mulle (1998) also outline some specific variables regarding the process of working 
cognitive behaviourally with children with OCD. They highlight the importance of 
externalising OCD, that it’s something outside of them, eradicating blame, and something of 
which they already have some control. This can enhance motivation and compliance, because 
therapist, parents and child can then all be seen to be on the same side, battling against the 
OCD. Predictable and controllable exposure is needed, as children may be less able to 
articulate specific obsessions and situations and have less insight into these, and so tasks need 
to be gradual and under the child’s control; the treatment should not be seen as a punishment. 
Exposure should be rehearsed in the safety of the sessions first (imaginal exposure) before 
taken into the child’s environment (in vivo exposure). Finally, level of cognitive functioning, 
social maturity and level of attention should be taken into account before treating children 
and adolescents. Adolescents for example are unlikely to co-operate if their level of ability 
and maturity is not accurately considered; for example calling the OCD a nasty nickname will 
probably not be welcomed.
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An important difference between treating child and adolescent OCD compared to adult OCD 
is the apparent need for family involvement. Knox, Albano & Barlow (1996) reported that 
training the parents in some of the treatment protocols, such as exposure and response 
prevention enhanced a child’s response to treatment and led to improved outcome. Therefore 
helping the family to understand the situation and help with treatment encourages compliance 
and motivation and in turns treatment success. Whilst qualitative differences exist in the 
approach and implementation of the treatment protocol, this does not lend support to the 
proposition under discussion, that anxiety disorders in children are fundamentally different to 
those in adults, with reference to CBT in OCD.
Cognitively the relationship between obsessions and cognitions for children may be less 
clear, but it does not necessarily follow that the understanding of the illness and the actual 
anxiety disorder in question are fundamentally different in children and adolescents, but 
instead the way that it is understood and worked with may need adapting for successful 
interventions to occur.
In summary, it is not possible with the available literature to investigate the specifics 
regarding responsibility cognitions and the links between obsessional thinking and 
compulsive acts in children and adolescents, primarily due to their cognitive developmental 
level and lack of insight. Therefore to directly compare the Cognitive Behavioural theoretical 
understanding of OCD in children and adults and whether this highlights evidence that OCD 
is fundamentally different in children is incredibly difficult. There are also no current ‘gold 
standard’ measures of OCD on which to base valid and reliable diagnostic procedures. What 
instead can be ascertained, is that there are indeed differences in presentation, such as the 
predominance of male children with OCD. However, utilising the CBT approach in 
treatment, there seems emerging evidence of success with understanding and treating OCD in 
this way for children and adolescents, similar to findings in the adult population. The basic 
concepts are the same, but the qualitative manner in which it is implemented is different, such 
as with the emphasis on externalisation and the involvement of the family. Thus CBT can be 
seen as an appropriate method for understanding and treating childhood OCD in much the 
same way as it can for adults, and therefore does not lend support that these anxiety disorders 
are fundamentally different.
Panic Disorder is the second anxiety disorder that will be discussed with regards whether 
childhood anxiety is fundamentally different in children compared to adults. The main feature 
o f Panic Disorder is the occurrence of panic attacks. These are seemingly sudden feelings of 
discomfort or fear, with at least four symptoms as described in DSM-IV (appendix 2), some 
o f which are; palpitations, breathlessness, trembling, nausea, chest pain and feeling hot 
and/or cold. Panic Disorder can occur with or without the presence of agoraphobia, in which 
situations identified with the panic are avoided. For the purposes of this piece of work, this 
distinction will not be made and panic disorder will be taken to incorporate literature 
pertaining to Panic Disorder with and without agoraphobia.
The Cognitive Behavioural model for understanding Panic Disorder again emphasises the 
importance of negative thoughts (Beck, 1976). The emphasis for this specific disorder is on 
the tendency to interpret certain bodily sensations catastrophically, thus interpreting bodily 
sensations as dangerous and perceiving these sensations to be indications of impending 
mental or physical harm, for example perceiving palpitations as an indicator of an impending 
heart attack. Clark (1986) built upon these notions, outlining a cognitive model o f panic 
maintaining the centrality of perceived harm from misperception of bodily sensations, 
(appendix 4). The model incorporates a trigger that is internal or external, such as bodily 
sensations and thoughts or being in a department store (respectively). These are then 
interpreted as a sign of danger and subsequently produce a state of apprehension. This state 
then produces further bodily sensations, which are similarly interpreted as further evidence of 
impending danger and the cycle continues, culminating in a panic attack. Maintenance can be 
through hypervigilance to bodily sensations and avoidance, and also safety behaviours such 
as leaning against a wall when feeling faint. These create a pattern that maintains the belief 
that there is impending danger and the need to avoid or be careful in situations to prevent it 
from happening.
Cognitive behavioural treatments therefore aim to identify and change the misinterpretations 
of bodily sensations. Strategies include psycho-education, relaxation, cognitive restructuring 
and behavioural techniques which focus upon entering feared situations, to allow patients to 
disconfirm any negative predictions they may have about the consequences o f their 
symptoms.
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A Meta-analysis conducted by Oei et al (1999) evaluated 35 studies published between 1969 
and 1996. Results supported CBT as an effective treatment for Panic Disorder. Less 
consistent was confirmation of the cognitive model and that cognitive behavioural therapy 
did not seem to produce cognitive change when in isolation from other procedures such as 
exposure. However, a more recent study by Petterson & Cesare (1996), (not incorporated 
within the previous meta-analysis) found that CBT produced significant change on affective, 
cognitive and panic attack measures that did appear to reflect the emphasis from the cognitive 
behavioural model on the centrality of misinterpretations of bodily sensations.
Therefore it will be extremely difficult to ascertain whether childhood Panic Disorder (PD) is 
fundamentally different from adult Panic Disorder when formulated in terms of the cognitive 
behavioural model and treatment for adults, when there is still no conclusive evidence for its 
propositions for an adult population as yet.
In a review of child and adolescent literature, Olendick, Mattis & King (1994) concluded that 
Panic Disorder occurred in adolescents and also occurred, albeit less frequently in children. 
Masi, Favila, Mucci & Millepiedi (2000) administered clinical interviews to 220 children and 
adolescents aged between seven and 18. They found 23 (ten percent) fulfilled the criteria for 
Panic Disorder, although only two were children under ten years of age. Fear of dying and 
depersonalisation were more frequent among this sample, whereas other cognitive symptoms 
commonly found in adults, such as derealisation and fear of going crazy were less common. 
These studies do not lend support to the notion that anxiety disorders, such as Panic Disorder 
in this instance are fundamentally different in children and adolescents, as the DSM-IV 
criteria is being met and evidence for the cognitive model is being borne out.
One reason Panic disorder may be thought not to be present or to be fundamentally different 
in younger members of the population as compared to adults, could be that children and 
adolescents are less likely to seek treatment for their problems and hence the prevalence of 
the disorder is thought to be negligible in children. King, Ollendick, Mattis, Yang & Tonge 
(1997) studied 649 Australian youths aged between 12 and 17 years old, of which 16 percent 
reported at least one full blown panic attack in the lifetime. Approximately 21 percent 
indicated these occurred out of the blue, and cognitive symptoms were reported, although less 
frequently than somatic ones. Surprisingly frequency and intensity of panic and related 
symptomatology, such as fear and depression were not disturbing enough for them to seek
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treatment, unlike in the adult population where frequency and intensity of attacks are directly 
related to seeking treatment (Telch, Lucas & Nelson, 1989). It seemed that for these 
adolescents, it was not until agoraphobic avoidance developed that treatment was sought. 
Therefore there may well be an underestimation of children and adolescents with panic 
disorder as treatment is not sought and the problem remains unnoticed and unaccounted for. 
This may well have contributed to the ideas that anxiety disorders are fundamentally different 
in children than adults, but the difference may be more a lack of treating seeking, than 
fundamental distinction.
Ollendick (1995) treated four adolescents who had met criteria for Panic disorder, using 
sessions of CBT. These clients initially showed high levels of anxiety sensitivity, which is a 
measure of the tendency to interpret symptoms of anxiety as dangerous and fearfully react to 
bodily sensations. Therefore these symptoms appear to support the notions specified in the 
cognitive model of panic (Clark, 1986). Subsequent treatment was based on Cognitive 
Behavioural therapy, but was applied flexibly and was sensitive to developmental issues. The 
first part consisted of skills training, such as breathing, relaxation and cognitive coping 
strategies. Planning for in vivo exposure followed and a hierarchy for exposure jointly 
developed much in the same way as outlined with CBT treatment for OCD. Treatment gains 
were noticeable, with panic attacks eliminated and agoraphobic avoidance reduced. Self- 
efficacy and coping were enhanced as a result o f treatment and these gains were maintained 
at six-month follow-up.
Therefore for adolescents, it would seem that Panic Disorder presents in much the same way 
as it does for adults, and can be understood and successfully treated following the CBT model 
and treatment rationales, but as with OCD needs to be implemented in a more flexible 
manner. In all cases the adolescents reported that panic attacks had occurred first, but as 
hypothesised by King et al (1997) these were not reported and treatment not sought until 
agoraphobic avoidance had begun to interfere with their daily lives. This has implications, in 
that Panic Disorder (without agoraphobia) may well have been present at a much younger 
age, but was not reported and subsequently has fed into notions that childhood anxiety is 
fundamentally different to adult anxiety.
Given this information, it is not surprising that literature is less well established in the area of 
child panic. With the previous studies already outlined and further reports from adolescents
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and adults, there is a strong indication that panic does occur in childhood. However, the 
question is whether this is fundamentally different to adult anxiety and whether the panic is 
spontaneous and is characterised by catastrophic misinterpretations of somatic symptoms as 
described by the Cognitive model.
Nelles & Barlow (1988) hypothesise that spontaneous panic is rare if not non-existent in 
children. They conclude children do not have the cognitive ability to catastrophically 
misinterpret bodily symptoms and that until adolescence, children’s cognitive responses are 
dominated by external causation. Hence it is not until they reach adolescence that they would 
be able to make the internal catastrophic misinterpretations that are characteristic of Panic 
Disorder. Hayward, Killen, Hammer, Litt, Wilson, Simmonds & Taylor (1992) evidenced this 
further showing a striking correlation between rates of panic attacks with higher 
developmental stage. In effect, the different cognitive developmental levels of children might 
then preclude the use of cognitive behavioural strategies consistently found useful in adults 
and adolescents. This then highlights fundamental differences in understanding childhood 
anxiety and adult anxiety, as understood by the cognitive behavioural model and subsequent 
treatment (Clark, 1986).
Bibace & Walsh (1980) take these notions further. They propose a sophisticated level of 
illness explanation they term ‘psychophysiological’ where the person can identify internal 
structures and processes as a source of illness, but can recognise the importance of 
psychological factors such as feelings and thoughts. Nelles & Barlow reasoned that because 
children rely on external causality, they are not capable of reaching this level in 
conceptualising illness, and this stage cannot be reached until adolescence.
However, Bibace & Walsh found that in a study of 11 year olds, eight percent demonstrated 
the psychophysiological level of illness conception, differentiating internal and external 
causality. Similarly, Mattis & Ollendick (1997) in a study of eight, 11 and 14 year olds and 
through the use of guided imagery and imagining symptoms of panic, concluded that the 
majority of each age group reported this higher conception for their somatic symptoms. 
Therefore these studies do not support the notions that children cannot have spontaneous 
panic and cannot make catastrophic internal attributions characteristic of Panic Disorder and 
the Cognitive model of Panic. In effect these studies do not substantiate the statement that 
anxiety disorders in childhood are fundamentally different to anxiety disorders in adulthood,
with reference in this case, to Panic Disorder and the Cognitive behavioural understanding 
and treatment of this disorder.
To summarise, this is an area of considerable debate. It does seem that panic attacks are 
present in children and adolescents. The area of contention arises when the issue of 
spontaneous panic and internal catastrophic interpretations, are taken into account. Some 
researchers propose that children simply have not reached the cognitive developmental level 
for this to be a possibility (Nelles & Barlow), but others have found children do possess the 
psychophysiological level of illness conception which makes this possible (Bibace & Walsh).
It is also possible that there are other risk factors that are important in determining prevalence 
o f Panic Disorder. Ollendick (1995) found that it was attributional style in response to 
negative outcomes that was predictive of internal catastrophic thoughts, and that this 
relationship was similar to that displayed in adolescents. The prevalence of a relative with 
Panic Disorder or any depressive or anxiety disorder increased the risk of Panic Disorder 
occurring in the offspring (Moreau, Weissman & Warner, 1989).
Therefore evidence points to the existence of Panic Disorder in children and adolescents, but 
as with OCD there may be subtle differences and treatment needs to be adapted to take 
account of developmental stage. There does not seem to be adequate evidence that childhood 
Panic Disorder is fundamentally different to adult Panic Disorder as the notions that children 
cannot make catastrophic interpretations of bodily sensations have not been supported and 
there is evidence to the contrary. Thus the difference may be one of recognition and 
qualitative distinctions to utilising the cognitive behavioural model in understanding and 
treating Panic Disorder in this population.
In conclusion, in OCD literature, some differences in prevalence have been noted and there is 
a predominance of male children with OCD. In the panic literature, researchers have argued 
that children simply have not reached the cognitive developmental level to be able to make 
internal catastrophic misinterpretations, (which are necessary if to be understood and treated 
using the cognitive behavioural model and therapy for Panic Disorder as applied to adults). 
However, the evidence as a whole appears to be more supportive of the general propositions 
delineated by the Cognitive Behavioural models and subsequent treatments. Perhaps the 
important considerations are around qualitative rather than fundamental differences, such as
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recognising the importance of developmental stage, family involvement and need for control 
over treatment as much as is possible for the child. However it seems that generally CBT 
treatments for OCD and PD within a child population have been successful and do not lend 
support to the proposition that anxiety disorders in children are fundamentally different to 
those in adults.
Inferences from the literature must be made with caution as highlighted by a review by 
Kearney & Silverman (1992). They reviewed studies evidencing Panic Disorder in 
youngsters and reported many of the studies employed small inpatients samples sizes, 
evaluated few sources of information and did not always assess panic severity. Therefore 
from a methodological standpoint, cautious inferences need to be made and perhaps the 
emphasis should be on initially amending methodological flaws so as to produce quality 
research on which solid conclusions can be drawn, one way or another. Similar cautions 
apply to the adult literature where specifics of change using CBT have yet to be established 
for either OCD or PD. Therefore findings must be interpreted with caution, as the cognitive 
models and subsequent treatment for childhood anxiety disorders, are being compared to an 
unsubstantiated body of evidence within the adult population.
Finally it must be highlighted that whilst a distinction was often made between children and 
adolescents, no further distinctions have been made with regards younger children. Thus 
caution must be employed in inferring from these findings with regard generalising to all 
ages of children.
The topic under consideration is an important and highly contentious area, with vast 
implications with regards clinical practice in diagnosis and treatment of childhood anxiety 
disorders. Therefore there is a need for further research into this area with quality research on 
which solid conclusions can be drawn, on whether indeed anxiety disorders in childhood are 
fundamentally different from anxiety disorders in adults.
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Appendix 1:
DSM-IV Criteria for Obsessive-compulsive Disorder
A. Either obsessions or compulsions:
Obsessions as defined by (1), (2), (3), and (4):
1. Recurrent and persistent thoughts, impulses, or images that are experienced, at some 
time
during the disturbance, as intrusive and inappropriate, and cause marked anxiety or 
distress.
2. The thoughts, impulses, or images are not simply excessive worries about real-life 
problems.
3. The person attempts to ignore or suppress such thoughts, impulses or images, or to 
neutralise them with some thought or action.
4. The person recognises that the obsessional thoughts, impulses, or images are a product 
of his or her own mind (not imposed from without as in thought insertion).
Compulsion as definedby.(l) and (2):
1. Repetitive behaviours (e.g. hand washing, ordering, checking) or mental acts (e.g. 
praying, counting, repeating words silently) that the person feels driven to perform in 
response to an obsession, or according to rules that must be applied rigidly.
2. The behaviours or mental acts are aimed at preventing or reducing distress or 
preventing
some dreaded event or situation; however, these behaviours or mental acts are not 
connected in a realistic way with what they are designed to neutralise or prevent or are 
clearly excessive.
B. At some point in time during the course of the disorder, the person has recognised that the 
obsessions or compulsions are excessive or unreasonable. Note: this does not apply to 
children.
C. The obsessions or compulsions cause marked distress, are time-consuming (take more 
than 1
hour a day), or significantly interfere with the person’s normal routine, occupational (or 
academic) functioning, or usual social activities or relationships.
D. If another Axis 1 disorder is present, the content of the obsessions or compulsions is not 
restricted to it (e.g. preoccupation with food in the presence of an eating disorder; hair 
pulling in the presence of trichotillomania; concern with appearance in the presence of
body
dysmorphic disorder; preoccupation with drugs in the presence of a substance use 
disorder;
preoccupation with having a serious illness in the presence of hypochondriasis; 
preoccupation with sexual urges or fantasies in the presence of paraphilia; or guilty 
ruminations in the presence of major depressive disorder).
E. The disturbance is not due to the direct effects of a substance (e.g. a drug of abuse, a 
medication) or a general medical condition.
Specify if:
W ith poor insight: if, for most of the time during the current episode, the person does not 
recognise that the obsessions and compulsions are excessive or unreasonable.
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Appendix 2
DSM-IV Criteria for Obsessive 
Panic Disorder
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Appendix 2:
DSM-IV Criteria for Panic Disorder With/without Agoraphobia
A. Both (1) and (2):
f l)  Recurrent unexpected Panic Attacks
(2) at least one of the attacks has been followed by 1 month (or more) o f one (or 
more) of the following:
(a) persistent concern about having additional attacks 
fb) worry about the implications of the attack or its consequences (e.g. losing 
control, having a heart attack, ‘going crazy’)
(c) a significant change in behaviour related to the attacks
B. Absence of Agoraphobia (or Presence o f Agoraphobia i f  meeting criteria fo r  panic 
disorder with agoraphobia).
C. The Panic Attacks are not due to the direct physiological effects of a substance (e.g., a 
drug
of abuse, a medication) or a general medical condition (e.g., hyperthyroidism).
D. The Panic Attacks are not better accounted for by another mental disorder, such as Social 
Phobia (e.g., occurring on exposure to feared social situations), Specific Phobia (e.g., on 
exposure to a specific phobic situation), Obsessive-Compulsive Disorder (e.g., on
exposure
to dirt in someone with an obsession about contamination), Post-traumatic Stress Disorder 
(e.g., in response to stimuli associated with a sever stressor), or Separation Anxiety 
Disorder (e.g., in response to being away from home or close relatives).
Panic Attacks are defined as:
A discrete period of intense fear or discomfort, in which four (or more) of the following 
symptoms developed abruptly and reached a peak within 10 minutes:
(1) palpitations, pounding heart, or accelerated heart rate
(2) sweating
(3) trembling or shaking
(4) sensations of shortness of breath or smothering
(5) feeling of choking
(6) chest pain or discomfort
(7) nausea or abdominal distress
(8) feeling dizzy, unsteady, light-headed, or faint
(9) derealization (feelings of unreality) or depersonalisation (being detached from oneself)
(10) fear of losing control or going crazy
(11) fear of dying
(12) paresthesias (numbness or tingling sensations)
(13) chills or hot flushes
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Agoraphobia is defined as:
A. Anxiety about being in places or situations from which escape might be difficult (or 
embarrassing) or in which help may not be available in the event of having an unexpected
or
situationally predisposed Panic Attack or panic-like symptoms. Agoraphobic fears 
typically
involve characteristic clusters of situations that include being outside the home alone; 
being
in a crowd or standing in a line; being on a bridge; and travelling in a bus, train, or 
automobile.
Note: Consider the diagnosis of Specific Phobia if the avoidance is limited to one or only a 
few specific situations, or Social Phobia if the avoidance is limited to social situations.
B. The situations are avoided (e.g. travel is restricted) or else are endured with marked 
distress
or with anxiety about having a Panic Attack or panic-like symptoms, or require the 
presence
of a companion.
C. The anxiety or phobic avoidance is not better accounted for by another mental disorder, 
such as Social Phobia (e.g., avoidance limited to social situations because of fear of 
embarrassment), Specific Phobia (e.g., avoidance limited to a single situation like 
elevators), Obsessive-Compulsive Disorder (e.g., avoidance of dirt in someone with an 
obsession about contamination), Post-traumatic Stress Disorder (e.g., avoidance of stimuli 
associated with a severe stressor), or Separation Anxiety Disorder (e.g., avoidance of 
leaving home or relatives).
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Appendix 3
Cognitive Model of Obsessive 
Compulsive Disorder (OCD)
Appendix 3
Figure 1: Cognitive Model of OCD 
(Salkovskis, Forrester, & Richards. 1998).
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Appendix 4
Figure 2: Cognitive Model of Panic: (Clark, 1986).
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OLDER ADULTS ESSAY
‘Dementia Cannot be Cured. It Takes it’s Course.’ Critically Evaluate with a 
Discussion of Known Theories of Causes and Treatment Approaches.
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‘Dementia Cannot be Cured. It Takes it’s Course.’ Critically Evaluate with a 
Discussion of Known Theories of Causes and Treatment Approaches.’
Dementia comes from the Latin root Me mens’ indicating an observable decline in one’s 
mental abilities. The term dementia encompasses an array of symptoms that results in a 
global loss of cognitive functioning. Dementia is predominantly a disorder of later life, and is 
estimated to effect approximately five percent of people over the age of 65. The prevalence 
and incidence rises sharply with advancing age and it is estimated that up to 20 percent of 
people over the age of 80 are affected by this form of chronic disease (Terry & Katzman, 
1983).
Alzheimer’s Dementia (AD) is the most common irreversible dementia and accounts for up 
to 50 percent of cases (Tobiansky, 1993). Other types of dementia include Vascular dementia, 
accounting for approximately 20 percent of cases and Lewy-Body type dementia, accounting 
for between five and ten percent of cases. Other rare dementia’s include; post head-injury 
dementia, auto-immune deficiency syndrome dementia, frontal lobe dementia and Prion 
disease (Livingston, 1994).
Early stages of dementia and specific diagnosis seem to be impeded by lack of good 
standardised measures and clear-cut diagnostic criteria. Therefore whilst not a focus of this 
piece of work, there is acknowledgement that diagnosis and measurement of change may not 
always be totally accurate.
Alzheimer’s type dementia with late onset (after 65) will mainly be the focus for this piece of 
work, due to its predominance. AD’s most prominent features include progressive cognitive 
deficits, (namely memory loss), behavioural changes and intellectual difficulties. Other 
symptoms include disorientation, impaired language abilities; personality changes and 
disturbances of affect (Tobiansky, 1994; Bums, 1996). Some research does not specify the 
type of dementia and references may be made to work in which the exact category of 
dementia is not known. When the term dementia is used it will assume AD unless otherwise 
specified.
This work will aim to look in detail at some of the current theories and treatments available 
for AD, to determine whether Dementia is incurable and simply takes its course, or whether
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certain models of understanding and treatment approaches could effect the course of this 
disease. This work will concentrate on a selection of approaches and treatments, such as 
neurochemical, psychodynamic and psychosocial propositions. There is recognition that there 
are many other theories and treatment rationales even within the same domains, which have 
not been delineated in this work.
Neurological and Neurochemical Perspectives:
Detailed research into the neuropsychology of dementia has provided a wealth of 
information. Varying degrees of cognitive impairment have been related to underlying 
neurobiological impairment (Morris, 1996). AD is associated with enlargement of the sulci 
and ventricles of the brain, which reflects brain shrinkage (Lantos & Cairns, 1994). There are 
complications as markers of AD can also overlap with the effects of ‘normal’ ageing, as with 
the development of neurofibrillay tangles, senile plaques and gran vascular degeneration 
(Esiri, 1991). Perhaps the most important information is derived from the location of 
changes, which can provide a strong clue as to what neuropsychological changes to expect. 
For example in AD, neuropathology tends to be seen in areas concerned with high level 
integration of information, spanning visuo-spatial processing, language and executive 
functioning. Less affected typically are areas concerned with sensory processing (Bondareff, 
Raval, Coletti & Hauser, 1988). This then correlates with the relatively poor higher order 
cognitive processing typical in AD and the relatively preserved low level auditory and visual 
processing (Nissen, Corkin, Buonanno, Growden, Wray & Bauer, 1985). In AD, 
neurofibrillary tangles are found in large quantities in some of the hippocampal structures and 
entortinal cortex, which would explain the profound memory impairment associated with the 
disease. These propositions substantiate the statement that ‘dementia cannot be cured, it takes 
it’s course,’ as little has been proposed to effect these progressive, structural changes.
Neurochemical changes have also been implicated in the course of dementia, with notable 
decreases in neurotransmitter (NTM) activity. One of the most consistent findings is that 
there are alternations in enzyme systems involved in cholinergic functions, together with a 
deterioration of cholinergic neurons (Sutherland, Molchan & Zubenko, 1995). Acetycholine 
is one such important NTM affected and is associated with memory. These findings led to the 
hypothesis that pharmacological enhancement of acetycholine neurotransmission could 
potentially alleviate some of the symptoms of AD. Aricept (Donepezil Hydrochloride) is one 
such acetycholinesterase inhibitor which acts to increase acetycholine from within the
synapses of neurons, which have remained intact in the AD sufferer (Weinstock, 1999). 
Tacrine (Tetrahyroaminoacridine) was the first such compound which worked in this way. It 
was found to improve cognitive function in up to 30 percent of people with AD, who were 
given up to 160mgs a day over a six month period (Conway, 1998). However, a fifth of 
participants developed side effects and 40 percent had raised hepatic transaminase levels 
(liver toxicity). The drug therefore was not recommended for use.
Aricept is one of the newer drugs and studies have demonstrated benefits with its use. 
Rogers, Doody, Mohs & Friedhoff (1998) found that cognitive functioning, activities of 
daily living and global functioning improved in 473 patients taking five-ten mgs of Aricept, 
as compared to a placebo. No differences were found between doses. After the six-week 
washout, improvements had returned to the level of the placebo group.
Thus whilst these medications cannot and do not propose to cure AD, they appear to provide 
some symptomatic improvement of functioning in sufferers, even if only short-term. 
Therefore whilst there are no propositions surrounding a potential cure for dementia, perhaps 
it’s course can be impacted upon, even just temporarily, giving the sufferer an improved 
quality of life for longer. This then lends support to the statement that dementia cannot be 
cured, but brings into question the inevitability of its course.
Whilst traditionally there was assumed to be a causal relationship between underlying 
neuropathology and dementia, this fails to take into account the vast individual differences 
and minimises the complexity of the human experience of dementia. Kittwood (1993) 
highlights the lack of correlation between dementia as measured in the living person and the 
nature and extent of neuropathology found post-mortem. This then leads one to question the 
inevitability of the ‘course’ of dementia and the influence of psychological and 
environmental factors with regard patterns of behaviour change and deterioration.
Malignant Social Psychology:
Tom Kittwood has been influential in bringing the individual with the dementing illness to 
the forefront. Kittwood (1993) argued that the presentation of dementia was not simply a 
manifestation of underlying neuropathology. He hypothesised that the environment 
surrounding the individual could negatively impact upon the person with dementia, leading to 
greater dysfunction and disability. He termed this the ‘malignant social psychology’ which
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serves to devalue, dehumanise and depersonalise the individual with dementia. Kittwood 
therefore suggested that the presentation and accepted course of dementia might appear more 
impaired than necessitated by actual sustained neurological impairment. Thus whilst 
neurological impairments are difficult to modify and pharmacological treatments are still in 
their infancy, there are other factors which could be worked upon, which are more amenable 
to treatment. Therefore according to his theory, psychosocial interventions could address 
these factors and the nature and course of dementia could potentially be modified. Kittwood 
emphasised that whatever psychological approach employed, empathy, imagination and 
understanding are required to enable the therapist to gain insight into the unique world as 
experienced by the person with dementia.
This theory does not attempt to deny the incurable nature of dementia and the inevitable 
endpoint of death. However, it proposes that some of what are classed as aspects of the 
dementing illness are in fact determinants of the environment and society around the 
individual and can be positively impacted upon.
These considerations led to the development of ‘Individual Programme Planning’ (Woods & 
Britton, 1985), which emphasised the need for individual personalised plans for working with 
each person with dementia. At the centre should be, as many aspects of the person’s life as 
possible and the person with dementia should be consistently involved. Understanding the 
individual and his/her strengths and resources, allows interventions to be tailored in relation 
to each individual and meet their particular needs. The approaches employed are therefore 
secondary to this individual planning process. Some of these approaches will now be 
explained in more detail.
Psvchodvnamic Interventions:
Many different psychodynamic explanations have emerged in trying to understand dementia. 
Generally speaking, it has been proposed that dementia results in weakened ego functioning, 
with increased dependency and diminished mastery over the environment. Depending on 
adequacy of the individuals defences, these changes may trigger unresolved psychodynamic 
conflicts (Soloman, 1982). In the early stages of dementia, it is proposed that the ego tries to 
protect itself from any further losses, often through utilising defence mechanisms such as 
denial, withdrawal and projection. As the illness progresses, the individual becomes more 
dependent as these defence mechanisms fail and the individual often becomes distressed, as
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he or she struggles to maintain a sense of self. Agitation, hostility and isolation can then be 
witnessed. As the dementia continues, the individual relies more heavily on others, which can 
result in fear of separation and need for constant contact. In the more severe stages of the 
illness, even the ability to utilise others in this way, as a means to enhance one’s sense of self 
becomes compromised and often the result is anxiety, confusion and psychotic defences 
(Sadavoy, 1991).
Therefore in general terms, the rational behind treatment is to provide an accepting 
therapeutic relationship, where the individual can feel safe and understood (Hausman, 1992). 
The goals of treatment are primarily to help replace inadequate coping strategies with more 
adequate ones, reduce emotional distress and reorganise the sense of self to incorporate the 
dementia. In line with propositions made by Kittwood, the sense of self is maintained through 
empathic listening, use of the therapeutic relationship in providing a reassuring, supportive 
and calming presence and in validating remaining competencies.
Evidence for psychodynamic work has been scarce and remains virtually untested. Instead, 
support tends to come from clinical case vignettes. One study by Akerland & Norberg (1986) 
compared emotional and cognitive functioning in five demented inpatients after they had 
initially received reality orientation (RO), followed by psychodynamic group therapy. 
Sessions lasted an hour and a half, four times a week. Retrospective, qualitative 
interpretations made by group leaders described the participants as more active and working 
at a higher cognitive level in the psychodynamic group, than when they had been in the RO 
group. However, there were no provisions against rater bias and no control groups or 
standardised measures applied. However, this type of work can be helpful in focusing 
treatment and understanding the individual intrapsychic experience and meaning of the 
illness within a person’s sense of self. This then can be extremely helpful in working out 
specific strategies or utilising other techniques to work with the person with dementia. This 
approach does not attempt to question whether dementia can be cured, or the inevitability of 
its course. It does however attempt to understand and work on some aspects of the 
presentation, which may not necessarily be manifestations of an underlying neuropathology.
Reality Orientation (ROV.
Reality orientation has been used with dementia sufferers for more than 30 years. It was 
developed as a means of orientating a person to their environment through the use of 
continuous stimulation. RO can be applied in two ways; continuous 24 hour RO and
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classroom RO. The former involves staff involving the patient in reality throughout the day, 
making numerous changes to the person’s environment, implementing clear sign-posting of 
locations, memory aids and extensive use of notices. Classroom RO is usually conducted 
with groups of between three and five patients. Generally they meet for at least two, half hour 
sessions a week (Holden & Woods, 1995). Classroom RO has been recommended for those 
who are able to function at a fairly independent level in the community.
The theory behind Reality Orientation, was that the confused state that is often present in a 
demented individual, could be attributed to more than underlying neuropathology. That 
confusion could also be due to lack of stimulation, lack of expectations or insistence that 
normal behaviours could be performed, with the non-reinforcement of desired behaviours 
when they are performed. Thus some of the confusion could be decreased through social 
interaction, mental stimulation and adjusting behavioural contingencies (Williams, 1995). It 
was also proposed that RO could provide the person with an increased self-esteem and 
improved sense of control.
Gerber, Prince, Snider, Atchison, Dubois & Kilgour (1991) randomly assigned 24 inpatients 
with dementia to either classroom RO, a recreational activities group or a control (standard 
hospital care) for an hour a day, four times a week for ten weeks. Language and orientation 
improved in the treatment groups, but not in the control. However these returned to pre-test 
levels just ten weeks after treatment ended. Holden & Woods (1995) conducted a major 
literature review on RO. They noted many differences between studies, with only one third 
including 24 hour RO. They detailed the different materials and activities used to engage 
patients with their surroundings. They also highlighted the differences in specificity of 
diagnosis and different measures used. However even with these differences, the conclusions 
were remarkably consistent, lending support to the use of RO sessions in increasing scores on 
verbal orientation, as compared to no-treatment controls.
These findings represent positive effects on some of the symptoms of dementia, especially 
reduction in confusion, even if only in the short-term. Again this highlights that whilst RO 
does not constitute a cure for dementia and does not alter it’s severity as it progresses, some 
of the symptoms and states associated with the illness may be effected positively. This then 
questions the inevitability of all symptoms associated with dementia and encourages one to
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look at the heterogeneity of presentation, the individual and environmental influences and not 
just the underlying disease.
Reminiscence:
This method was developed specifically for older adults. Its primary aim was to facilitate the 
client in recalling past experiences. It aims to promote well being, enhance self- 
understanding and interpersonal and intrapersonal functioning. It also aims to help someone 
achieve a sense of meaning to their life (Erikson, 1959). Reminiscence is distinct from life 
review work, which comprises an evaluation and re-synthesis of experiences of the past, 
focused on resolving conflicts before one dies (Butler, 1963). When working with the 
individual with dementia, reminiscence can establish a point of contact, which often can then 
be used in reality orientation and other therapeutic approaches. Increased communication, 
socialisation and pleasure are further propositions made by this approach.
The basis for it’s utility, stems from the beliefs that remote memories are better preserved in 
individuals with dementia, and therefore this method can draw on this strength. However, 
recent investigations have failed to substantiate these notions and show performance is 
depressed compared with age matched controls, even for remote memory. What in fact is 
being shown is as with ‘normal’ older adults, older people simply recall more memories from 
early life, and these are often well rehearsed and have particular personal significance 
(Morris, 1994). However, it remains a relative strength and supports the theory behind the 
potential application of reminiscence work.
Reminiscence is usually conducted in group settings. The facilitators play an active role in 
promoting patient participation. Norberg, Melini & Asplund (1986), investigated the effects 
of music, touch and objects used to stimulate touch, smell and taste, and found that music 
alone was the most stimulating. Similar observations have been made by Lord & Garner 
(1993), who randomly assigned 20 nursing home residents to a half-hour standard 
recreational group, or a group playing big band music from the 1920’s and 1930’s. The latter 
demonstrated better recall of personal information and an increase in interaction and 
improvement in mood. Woods, Portnoy, Head & Jones (1992) suggested that music triggers 
are particularly effective for this group of individuals.
Goldwasser, Auerbach & Harkins (1987) conducted a study whereby 27 people with 
dementia were randomly allocated to a reminiscence group, an attention placebo support 
group or a no treatment control. Cognitive functioning, activities of daily living and 
depression were measured. Only measures for depression showed an improvement pre to post 
group testing in the reminiscence group as compared with the other two. However, this 
finding had disappeared by follow up. This remains a popular method as it concentrates on 
the person with dementia as an individual and capitalises on their strengths. As with all 
methods, the outcome of studies investigating effectiveness depends on what is trying to be 
achieved, whether this is an improved quality of life, or an improvement in cognitive 
abilities. What remains clear throughout these methods is the importance of the individual 
experiencing the disease and not simply the underlying pathology.
Therefore this method impacts only slightly on the presentation and course of dementia, and 
certainly does not attempt to be a cure. However, it does focus on the individual and their 
personal experiences, past and present. It can also increase the degree of staff-patient contact 
and increase carer’s knowledge about that individual. Therefore, whilst dementia remains 
incurable and taking it’s inevitable course towards death, again it seems that the exact nature 
of this course can be impacted upon. Thus certain symptom presentation, such as reduced 
interaction and depression may not be simply manifestations of an underlying pathology. 
Instead these could be viewed as partially resulting from the interaction between the 
individual and their environment, and hence be amenable to modification. Therefore perhaps 
the only thing that remains certain in dementia, is the inevitability of death. The 
accompanying symptoms and behaviours may not necessarily be incurable and on such static, 
predetermined path.
Cognition Rehabilitation Techniques:
Cognitive rehabilitation techniques have been successfully used with people with brain 
trauma for some time (Wilson, 1989). More recently there has been increasing interest in the 
applicability of these to people with dementia (Arkin, 1997).
Woods (1995) describes three main strategies. The first is concerned with the use of 
internalised mnemonics, when the person is taught strategies to aid their learning and 
retrieval, such as the use of visual imagery. These techniques have shown some success, 
despite the effort required to use mnemonics and the level of cognitive ability, which is
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obviously compromised in people with dementia (Clare, Wilson, Breen & Hodges, 1999). 
The second cognitive rehabilitation technique applied to people with dementia is concerned 
with decreasing cognitive load. The idea is that if cognitive load is decreased, then any 
retained abilities can be maximised and used in a more effective way. This can be done, 
simply by adapting the environment. Careful, clear sign posting can help, whilst distracting 
stimuli should be kept to a minimum. The environment should tap into familiar associations 
that the person has learnt well, to decrease effort and cognitive demands. External memory 
aids have been highlighted as a useful tool in decreasing cognitive load and in enhancing 
performance (Bourgeois, 1992). Memory aids can be anything from diaries, relevant pictures 
or watches. Bourgeois, (1990, 1992) studied the effects of memory aids on conversational 
skills in persons with dementia. The aids consisted of photographs and pictures of people and 
events, past and present that were important to the individual. People close to the participant 
were then encouraged to use these aids in communications with the person with dementia. 
Independent raters assessed quality of conversation and found that through using these aids, 
more statements of fact were spoken and there was a noticeable decrease in ambiguous 
utterances. It is important to note that in most of the studies that evaluated memory aids, 
specific training was required for any cues to be used by the person with dementia. Backman 
(1992) concludes that for optimal performance, support both at time of learning and at time 
of retrieval is required. Again, these methods described so far do not aim to cure any element 
o f the dementing illness, or stop the inevitable decline. However, they do suggest ways in 
which one can tap into a person’s remaining strengths to improve their day to day 
functioning. Also these findings can challenge some of what are classed as manifestations of 
the illness, but may actually be determinants of the environment. For example, to what extent 
is an individuals’ upset and confused state necessarily par of the course of the dementing 
illness? Instead, to what extent has this state resulted from the cognitive demands placed on 
an individual, residing in a large ward, with lots of other residents and constantly changing 
staff? The question remains as to whether the same pattern be seen in an individual residing 
in a small home, with a few consistent staff members and residents. These notions once again 
do not question the incurable nature of the illness, but do question the inevitability of the 
manifestations of the illness and the severity and progression of these.
Woods (2001) draws attention to the encouraging rates of forgetting in patients with 
dementia. It is thought that once information is adequately stored, the rates of forgetting after 
the first ten minutes are in fact virtually the same as that in people without dementia.
Page 82
Therefore the emphasis should be on facilitating the learning of information, and several 
techniques have been developed to achieve this. Camp, Foss, O’Hanlon & Stevens (1996) 
describe spaced retrieval, whereby one item at a time is learned. Each item is presented in 
turn and if successfully recalled the retrieval period is expanded (doubled). If  not successfully 
recalled, then the retrieval time is halved. Eventually this allows the item to be fully 
registered and subject to the normal rate of forgetting. Camp et al (1996) reported how 
patients with dementia could successfully be taught to use a calendar (an external memory 
aid), with the spaced retrieval technique. Sandman (1993) highlights that encoding can be 
maximised through the use of self-generated cues, which make the event more memorable 
and distinctive. Patients are often encouraged to develop a routine to decrease cognitive load 
and use memory aids, alongside encoding and retrieval techniques. However this must not be 
at the cost of having something worth remembering. Therefore, rich and meaningful 
experiences will enhance the associated memories. It is worth noting that for many of these 
techniques to be useful, there needs to be a shared understanding that a memory problem 
exists and needs working on. It is unclear what proportion of patients would be willing and 
able to work on their difficulties in this way. Any anxiety about one’s difficulties could well 
interfere with the learning process (Josephsson, Backman, Borell, Bernspang, Nygard & 
Ronnberg, 1993). Also, given that the person’s cognitive abilities would be expected to 
continue to decline, which has not been challenged by any theory presented, how much are 
heroics being encouraged, that are ultimately hopeless?
The focus must be on the individual and their quality of life, and this requires careful 
consideration of all techniques. Therefore in view of the question under consideration, again 
no cure is aspired to and the course of illness still very much taken as impenetrable. However, 
perhaps some of the symptoms of the illness can be altered or relieved and even some aspects 
o f the illness improved upon in the short-term. Yet other considerations emerge, such as how 
much of a benefit can there be in focusing on retrieval, if this increases a person’s anxiety. 
Plus what are the benefits to an individual, if by decreasing cognitive load and creating well 
learned routines, one takes away the richness and meaning in their everyday experiences and 
in effect removes anything worth remembering?
Behavioural Disturbance:
Disturbances in behaviour can have the greatest impact on caregivers and on decisions 
regarding pattern of care and placement allocation (Donaldson, Tarrier & Burns, 1998). Some
of the behavioural difficulties commonly associated with dementia include; lack of attention 
to personal hygiene, restlessness, eating difficulties, sexual difficulties, physical aggression 
and incontinence (Woods, 2001). In the past these have often been seen as part of an 
underlying pathology. However, through taking a person centred approach, looking at the 
interaction of the individual with the environment, this negative irreversible course could 
potentially be acted upon. As Stokes (1989) proposes, difficulties in dementia may arise, as it 
becomes increasingly difficult for the person to clearly communicate his/her needs to others. 
Gilleard (1984) similarly supported these views, commenting that there was a dimension of 
behavioural disturbance that was independent from the underlying impairment. He advocated 
understanding the behaviours and looking for alternative explanations within the individuals 
character and life history and the current environment. For example, he delineates some 
reasons why various forms of wandering might occur. The first he said could be classed as 
‘stalking old haunts’, whereby a person (usually male) has been used to routine and this habit 
remains. The difference now, is that success in making and returning from the visits may be 
compromised by the illness. Another type of wandering could be explained by restless 
activity seeking, perhaps by someone who is physically fit, but less competent mentally. They 
may well be typical of a person used to a high level of activity in their past. Understanding 
behaviour in the wider context could then encourage the use of interventions to modify these 
behaviours. Bird, Alexopoulos & Adamowitz (1995) reported success from a series of single 
case studies, whereby a highly individualised approach was adapted to challenging 
behaviours. Spaced retrieval was implemented in teaching individuals to respond to cues that 
aimed to prompt appropriate behaviours, such as going to one’s own bedroom, as opposed to 
that of other residents.
Aggression is commonly reported in people with dementia and often can be seen as the 
property of the person with dementia or the underlying illness, rather than arising from the 
interaction of the individual with the care-giving environment. Most frequently these 
behaviours can be seen as over reactions to frustrations, with their decreasing cognitive 
ability. Similarly accusations could be understood by the person misinterpreting events and 
using external sources of blame for their own incompetence. This has been termed ‘adaptive 
paranoia’ (Lieberman, 1975) as by blaming others, this reduces the distress of recognising 
one’s increasing difficulties and lack of control over one’s environment. Hussain (1983) 
reported success in reducing disruptive behaviours, through the identification of 
environmental cues for behaviour and providing a system of rewards for appropriate
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behaviour. Similarly disruptive behaviour could be better understood and then impacted 
upon, by taking a full history, and trying to understand the individual and their possible needs 
and what the behaviour is communicating.
Thus the interdependence of the individual and the connections with their environment can 
help understand more fully the person with the dementia, their needs and behaviours. Whilst 
cognitive retraining may be useful, these should be tailored and understood with regard each 
individual. Again, these concepts do not challenge the proposition that dementia cannot be 
cured, or that it takes its course. Yet again, some of the behavioural manifestations associated 
with the disease may be seen psychologically as an expression of poorly communicated or 
unmet needs, and not simply a reflection of the underlying neuropathological impairment.
Conclusion:
The term dementia encompasses an array of symptoms that results in a global loss of 
cognitive functioning. This work aimed to look in detail at some of the current theories and 
treatments available for dementia, to determine whether this disease is incurable and will 
simply take it’s course.
Detailed research into the neuropsychology of dementia has provided a wealth of information 
and proposed that varying degrees of cognitive impairments are related to underlying 
neurobiological impairment (Morris, 1996). Neurochemical changes have also been 
implicated in the course of dementia, with notable decreases in neurotransmitter activity. 
Acetycholine is one such important NTM, which is affected and is associated with memory. 
Aricept is one of the newer drugs, which enhances acetycholine neurotransmission and 
studies have consistently demonstrated benefits with its use, but only in the short term 
(Rogers et al, 1998).
Kittwood (1993) highlighted the lack of correlation between dementia as measured in the 
living person and the nature and extent of neuropathology found post-mortem. He brought 
into question the inevitability of the ‘course’ of dementia, and instead indicated the need to 
look at the influence of psychological and environmental factors with regard patterns of 
behaviour change and deterioration. In view of this, psychosocial theories and interventions 
emerged, aimed at effecting the disease, by taking into account the interdependence o f the 
individual and the connections with their environment. Reality Orientation, Psychodynamic
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therapy, Reminiscence, Cognitive rehabilitation and Behavioural remediation methods were 
outlined. Whilst none of these purport to cure dementia and none have been successful in 
slowing the course of progression of the illness. What has emerged is that some of what have 
been classed as symptoms and manifestations of dementia, such as inability to learn, 
disruptive behaviours, confusion and sociability, may not necessarily be manifestations of an 
underlying pathology. Instead they may be understood as resulting from the interaction of the 
individual with their environment, and can therefore be positively impacted upon.
In conclusion, it would seem that at this present time, dementia cannot be cured and it will 
take its inevitable course. However, manifestations of the disease may arise from an 
interaction between the individual and their environment and their course may not be so pre­
determined and impenetrable.
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CLINICAL DOSSIER
OVERVIEW
This section contains an overview of the clinical experience that has been gained over 
the course and summaries of the five case reports submitted (four from the core 
placements and one specialist report). Full details o f these reports, along with 
placement contracts, log books o f clinical experience and placement evaluation forms 
are in Volume 2. This is held in the Psychology Department within the University of  
Surrey due to the confidential nature of the documents.
N.B: all client names and identifying characteristics have been changed to protect 
anonymity.
Page 92
CORE ADULT MENTAL HEALTH PLACEMENT:
Dates: 11th October 2000 - 23yd  March 2001 Supervisor(s): Farzeen Huq (Consultant 
Clinical Psychologist) and Stacia Borenstein (Clinical Psychologist)
NHS Trust: South West London and St. Georges Hospital Trust 
Base(s):Springfield Hospital and St George’s Hospital 
Summary of Experience:
This placement provided experience in assessment and intervention, working primarily from 
a Cognitive Behavioural perspective, with a variety of adult mental health problems, such as 
anxiety, depression, anger, obsessive compulsive disorder, cognitive impairment and body 
dysmorphic disorder. Clinical work was primarily conducted on a one to one, outpatient basis 
and working as part of a community mental health team. This placement also provided 
grounding in psychodynamic concepts and the opportunity to use these in formulation and 
treatment. There was opportunity to use the BAI, BDI and Raven’s Matrices.
Meetings, Seminars, Visits and Research:
I attended weekly community mental health team meetings and case presentations for three 
months. I attended ward rounds and an open morning at a local day hospital. I met with all 
members of the team and spent time observing most of them. I also attended a Seminar on 
Dialectical Behaviour Training (DBT) given by Trudy Chalder.
CORE PEOPLE W ITH LEARNING DISABILITIES PLACEMENT
Date: March 2001 - September 2001 Supervisor(s): Dr. Britta Nagel
NHS Trust: Springfield and St Georges NHS Trust Base(s): Springfield Hospital
Summary of Experience:
This placement provided experience working with adults with learning disabilities using 
various models of treatment, with an emphasis on psychodynamic thinking. Clinical work 
comprised one to one interventions, behavioural work with care home staff and 
neuropsychological assessment, gaining skills using the WAIS-III, Vineland and Leiter. 
Meetings, Seminars, Visits and Research:
I attended Valerie Sinason’s psychotherapy supervision group on a weekly basis. I also 
regularly attended team meetings. I met with many team members, such as the community 
nurse, speech and language therapist, art therapist and chief occupational therapist. I also had 
the opportunity to observe a Communication group, Makaton group, sensory stimulation 
group women’s group. I attended a ‘stamping out abuse’ training day and ‘essential mental 
health awareness for people working with people with learning disabilities.’
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CORE CHILD AND FAMILY PLACEMENT:
D a tes: 10th October 2001 - 22n(h March 2002 Supervisor(s): Dr. Neil McGibbon
NHS Trust: South West London and St George’s Hospital Trust 
Base (s) .'Battersea Adolescent Service 
Summary of Experience:
This placement provided experience of being in a multidisciplinary team working with 
adolescents, but also providing some individual work with younger children on an outpatient 
basis at St George’s Hospital. This placement used a wide range of theories and models to 
inform psychological work, but psychodynamic thinking was often the preference in 
formulating. Clinical work comprised: assessment for interviews; neuropsychological 
assessment (WISC, WORD, WOND, STAXI, BAI and BDI-II); individual work and 
multidisciplinary work. Experience was gained over a range of presenting problems including 
depression, self-harm, anxiety, physical abuse, anger, phobias, bereavement, OCD and 
cognitive impairment An important part of this placement was the creation and planning of a 
‘chill out day’ for adolescents who have cared for/ are caring for someone with substance 
misuse problems.
Meetings, Seminars, Visits and Research:
I attended weekly seminars for trainee psychologists covering a variety of clinical areas. I 
also attended weekly team meetings and CPD for the adolescent service. There was also a 
Clinical Psychology meeting on a weekly basis and I presented a case at one of the weekly 
clinical psychology CPD sessions. I also attended a day workshop on Autism and Aspergers 
organised by Maria Callias.
CORE OLDER ADULTS PLACEMENT:
D a tes:03yd April 2002 - 20th September 2002 Supervisors): Carolyn Richardson
NHS Trust:South London and Maudsley NHS Trust Base(s):Ladywell House, Lewisham
Summary of Experience:
This placement provided experience working eclectically with older adults in hospital 
outpatient clinics, hospital wards, care homes and the community. Clinical work comprised 
assessment and intervention with problems such as bipolar affective disorder, depression, 
challenging behaviour, post-stroke depression, alcoholism and OCD. Neuropsychological 
assessment was completed using the Wechsler Test of Adult Reading (WTAR), Wechsler 
Adult Intelligence Test - Third Edition (WAIS-III), Beck Depression Inventory (BDI),
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Wechsler Memory Scale (WMS), Graded Naming Test, Trail Making test, and FAS and 
animals.
Meetings, Seminars, Visits and Research:
I attended a weekly Cognitive Behavioural Group. I also had the opportunity to observe and 
work alongside an Occupational therapist, Community Psychiatric Nurse, Social Worker, 
Psychologist and CBT therapist. I attended ward rounds and visited nursing homes and 
Domus’s in the catchment area.
SPECIALIST PLACEMENT IN PAIN MANAGEMENT:
Dates: 16th October 2002 - 28th March 2003 Supervisor(s): Dr. Rachel Vickers
NHS Trust: Guy’s and St Thomas ’ Hospital Trust Base(s): ‘INPUT’ St Thomas ’ Hospital
Summary of Experience:
This placement provided excellent experience of working with inpatient pain groups, within a 
multidisciplinary setting, based upon Cognitive Behavioural principles. Clinical work 
comprised ‘screening’ potential clients for programme suitability, one to one work and 
running psychoeducational components of the pain programme, with sessions focusing on the 
impact of thoughts and feelings on coping more effectively with pain and running sessions 
for family and friends during each programme.
Meetings, Seminars, Visits and Research:
I attended weekly team meetings, weekly diary meetings and weekly staff education 
meetings, which covered topics such as facial pain, sleep, graded exposure and a trip to the 
Body Worlds exhibition.
SPECIALIST PLACEMENT WITH CHILDREN AND FAMILIIES W ITH  HIV/AIDS.
Dates: 9th April - September 26th 2003 Supervisor(s): Brigid Hekster
NHS Trust: South London and the Maudsley Base(s): CASCAID, 307 Borough High St.
Summary of Clinical Experience: This placement involved working with children and 
families with HIV. Clinical work comprised mainly one to one work with parents (mostly 
mothers) and some family work. I also sat in a paediatric clinic fortnightly. Clinical work 
mainly centred around issues of disclosure, difficulties accepting own/child’s diagnosis of 
HIV, depression, relationship issues and difficulties in the child’s behaviour.
Meetings, Seminars, Visits and Research: I met with most team members and visited social 
services and local charity groups. I attended a workshop on safeguarding children and also on 
using CBT for trauma, with children who are asylum seekers or refugees.
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SUMMARY OF THE ADULT MENTAL HEALTH CASE REPORT:
‘Assessment and Intervention of a 30 Year Old Female Client With Obsessive 
Compulsive Disorder, Using Cognitive Behavioural Therapy.’
Main Presenting Problem:
Mrs. L was referred to the Community Mental Health Team by her Occupational Therapist 
for assessment for Cognitive Behavioural Therapy, for help with her Obsessive Compulsive 
Disorder. Her obsessional thoughts surrounded death and dying and the compulsive 
behaviour consisted of crossing in the air with her right hand, every time she had such 
thoughts. This process was happening around 30 to 50 times a day. She had seen a 
Psychotherapist for four years, but there had been no shift in her OCD, so she was seeking an 
alternative form of treatment. She was also concerned that her two-year-old daughter would 
soon start asking questions about her behaviour.
Assessment Procedure:
- Assessment for Treatment interview, drawing on the Cognitive model of Obsessive 
Compulsive Disorder (Salkovskis, 1998) and DSM-IV diagnostic criteria for Obsessive 
Compulsive Disorder.
- Psychometric Tests: the Beck Depression Inventory (BDI) and the Beck Anxiety Inventory 
(BAI).
Formulation:
Mrs. L’s problems were formulated within the framework of the cognitive model of OCD 
(Salkovsis, 1998). Mrs. L. had thoughts surrounding death and dying, which may in part been 
due to her not grieving properly for the deaths of some family members in her adolescence 
and her pregnancy termination. This was compounded by low self-esteem from bullying and 
sibling rivalry. These thoughts made her anxious and she would cross them out to reduce the 
anxiety. In the short-term this brought temporary relief, but had become less effective over 
the years. Reduction in anxiety had been associated with crossing. Avoidance of reading 
papers or watching television where images or stories on death could be found, had 
maintained and exacerbated this pattern. The low mood created by her own behaviour served 
to increase her obsessional thoughts and in turn the rituals. Crossing meant she had never 
tested the reality of the thoughts she had had and whether she could in fact cope with these.
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Intervention:
Following assessment, the formulation was shared with Mrs. L and therapeutic goals set. The 
Cognitive-behavioural intervention focused on reducing her neutralising behaviours 
(crossing) and managing her intrusive thoughts. Treatment began with education about the 
cognitive model, anxiety management and cognitive work looking at the meaning of her 
thoughts and trying to trying to modify these beliefs and appraisals that served to maintain 
OCD. Challenging inaccurate thoughts and demonstrating the relationship between thoughts, 
affect and behaviour was also undertaken and hoped to facilitate the understanding and 
coping with the behavioural strategies that were to be employed. Treatment then focused on 
exposure and response prevention. Exposure was done with a ‘loop tape’ which she had 
recorded her worst thoughts on and which she listened to as often as she could. The cognitive 
strategies and anxiety management helped her face these thoughts without crossing.
Outcome:
Mrs. L was seen for ten sessions spanning five months. She eventually began to face her 
thoughts and uncomfortable feelings that were initially encountered. She became able to cope 
more effectively with these and through no longer avoiding they no longer ‘needed’ the 
ritualistic crossing to deal with them. As the thoughts became less frightening they in turn 
became less frequent. By the end of treatment, crossing was down to four to five times a day, 
but was not longer associated with symptom alleviation, but understood as a strong ‘habit’ 
resistant to change. Depression and anxiety levels had reduced greatly over the course of 
treatment. Discomfort and urge to neutralise were also greatly reduced from initial levels. 
Treatment was to be completed by placement supervisor with the emphasis on relapse 
prevention.
SUMMARY OF THE PEOPLE WITH LEARNING DISABILITIES CASE REPORT:
‘The assessment and Intervention of a 26 Year Old Woman with Moderate 
Learning Disabilities Using Brief Psychotherapy with a Malan Framework.’
Main Presenting Problem:
Sarah was referred initially for psychological therapies assessment, following a violent 
incident earlier in the year and concerns regarding some sexualised behaviour. On assessment 
with a Consultant Psychiatrist and Honorary Consultant Psychotherapist she was seen to have 
a number of worries and deemed appropriate for psychotherapy intervention. She declined a 
group and asked to see someone individually. She had good verbal skills and high levels of 
motivation and this was deemed appropriate. There were current concerns regarding her 
withdrawn behaviour and that she did not seem happy at home. There was also a suggestion 
of abuse by male family members in the past and possible abuse by her stepfather.
Assessment Procedure:
- Assessment for treatment had already been completed and therapy was to begin without 
further assessment for suitability. The Malan framework (1979) was used to inform this 
piece of work.
- No standardised measures were used in this service.
Formulation:
The Malan framework explains how the person sees themselves in relation to others, their 
relationships in the past and relationship with the therapist. This provides information about 
the client’s inner world. The initial formulation proposed that anger and withdrawal, plus 
anxiety surrounding other feelings, were defences against hidden feelings of sadness and 
grief, which may underlie and be due to past experiences of loss and potential abuse, with 
reference to her mother, father and stepfather.
Intervention:
Principles from psychoanalytic psychotherapy informed the therapeutic work, which 
highlights the importance of the unconscious and how by providing a boundaried space, 
difficult feelings can begin to be talked about and difficult feelings can be transferred onto 
the therapist which stem from earlier relationships with significant others. The aim of the
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work was to enable Sarah to bring feelings to the conscious surface, to understand an 
experience them. The sessions provided a safe environment for Sarah to express herself and 
to use interpretations to help make links between the present and the past and to understand 
these links and subsequent emotions more fully. The importance of endings was kept in mind 
from the beginning and interpretation made throughout with regard the therapist as another 
potentially abandoning or neglectful figure.
Outcome:
Sarah was able to experience and make sense of a range of emotions upon completion of 
sessions, which she had not been able to express when she first entered therapy. She no 
longer just displayed her emotions, but verbalised them as well, which was a noticeable shift 
from the start of her therapeutic work. She was also able to express her emotions and know 
this could be contained and did not ‘damage’ the therapeutic relationship, as she always 
returned for her following session. There was also a noticeable reduction in her anger 
especially in duration and ability to link feelings back to the past. She was also able to see the 
relationship between present behaviours and experiences and those in the past, which then 
helped her make sense of these and work through them.
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SUMMARY OF THE CHILD AND FAMILY CASE REPORT:
‘The Assessment and Intervention of a 17 Year Old Female with a Problem Controlling 
her Temper, using Stress Inoculation Training.’
Main Presenting Problem:
Jenny had referred herself to her GP for help managing her temper. The GP subsequently 
referred her to a child and family service to in turn forwarded the referral to the adolescent 
service. Jenny had reported her temper as being a problem at home originally directed toward 
her younger sister, but more recently now focused upon her boyfriend.
Assessment Procedure:
- Assessment for treatment interview, drawing from a cognitive behavioural perspective. 
-Psychometric tests: Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) and 
State Trait Anger Expression Inventory (STAXI).
Formulation:
Understood in cognitive behavioural terms, Jenny had come from a family where there had 
been noticeable expression of anger, especially by her father. These experiences may have 
laid down assumptions that anger is bad and leads to aggressive behaviour, Jenny 
subsequently found expression of emotion difficult. These experiences left Jenny vulnerable 
to stressful and emotive situations. Her Nans death may have been the trigger for her current 
problems, as this highly emotive time was difficult for Jenny to express. She may have had 
thoughts surrounding how expressing her anger and emotion is bad and if she did she would 
be like her father. These thoughts may have lowered her mood and in turn increased her 
efforts to suppress her emotions, which eventually bubbled over and culminated in anger 
outbursts. This then confirmed that she could not control her anger, was like her father and 
must continue to suppress emotion. Thus leading to a vicious cycle, maintaining and 
exacerbating the problem.
Intervention:
Stress Inoculation Training for anger (Novaco, 1975), is based upon a cognitive behavioural 
understanding. Thus anger management should focus on the cognitive structuring of each 
situation and one’s appraisals and expectations. Cognitive preparation comprised the first
Page 100
stage, educating Jenny with regard the model and looking at her physiological arousal and 
cognitive processes, and subsequent impact on her behaviour. Stage two focused on skill 
acquisition, such as assertiveness training, self-monitoring and anxiety management 
techniques, such as diaphragmatic breathing and progressive muscle relaxation. The final 
concerned application training whereby all these techniques were put into practice.
Outcome:
Jenny engaged fully in the treatment process. She became adept at decreasing her arousal, 
monitoring her cognitions and implementing alternative thoughts where necessary. She began 
to use assertive communication effectively and after eight sessions and two months free of 
outbursts she was discharged. On starting treatment Jenny had mild levels of anxiety and 
depression, these had returned to non-clinical levels as she approached the end of her 
treatment. Her scores on the Staxi also demonstrated how she was now experiencing much 
less anger, accompanied by fewer outbursts. Also a reduction of her quick temper and a more 
appropriate expression of emotion was highlighted, compared with her initial pattern of 
results.
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SUMMARY OF THE OLDER ADULTS CASE REPORT:
‘Neuropsychological Assessment of an 81 Year Old Caucasian Man for Differential 
Diagnosis Between Depression and Dementia.5
Main Presenting Problem:
Mr. James had been referred to a falls clinic, after he had presented in A & E following a 
probable mechanical fall. All physical examinations were unremarkable, but whilst in the 
clinic Mr James reported that he had been experiencing gradual memory loss and low mood 
over the past three years. The clinic subsequently referred him to the Mental Health Team 
requesting an assessment to try to differentiate between depression and dementia, and to 
establish whether he had the early stages of dementia with co-morbid depression or whether 
this was a picture of pseudo-dementia.
Assessment Procedure:
Information gathering was conducted around Mr James, with regard his medical, 
developmental and social history. His nephew was contacted and reported that the memory 
difficulties dated to a few years ago and were worsening gradually. This corroborated 
information given by Mr James. A hypothesis was developed to guide the assessment which 
was for ‘Dementia o f the Alzheimer’s type ’. The following tests were administered:
- Beck Depression Inventory (BDI)
- Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)
- Wechsker Test o f  Adult Reading (WTAR)
- Parts o f the Wechsler Memory Scale - Third Edition (WMS-III)
- Trail Making Tests
- Graded Naming Test
- Verbal Fluency - FAS and Animals
Formulation:
Due to Mr. James’ complaints about his low mood, confusion, reported memory problems 
and losing track of conversation, assessment needed to focus around differentiating dementia 
and depression. Due to the reported low mood, but lack of somatic complaints and psychiatric 
history, alongside a slow and chronic progression, symptoms appeared to be consistent with a 
real dementia and not a picture of pseudo-dementia. Mr. James’ reported symptoms also did
not appear to meet criteria for major depressive episode, nor any of the mood disorders in 
DSM-IV. Therefore his presentation appeared consistent with a dementia, the specific kind of 
which could be hypothesised to be of the Alzheimer’s type, due to the reported slow, 
progressive nature of symptoms and the lack of cerebrovascular disease, physical health 
problems or history of substance misuse.
Intervention:
For my part the intervention was solely comprised of the testing, which was conducted over 
two days, three days apart and lasted approximately two hours each time. Results of the 
assessment were shared with the supervising Clinical Psychologist who arranged to feedback 
the results to Mr James as soon as possible and to work on the proposed recommendations.
Outcome:
The outcome of my work centred around interpreting the test results and making 
recommendations to the service and the Psychologist taking over care of Mr. James. In 
conclusion, it was highly likely that there was an underlying dementia, however this was 
within the context of low mood. It was recommended that Mr. James be reassessed after his 
low mood had been resolved. Recommendations centred around Mr. James receiving some 
help with his low mood, even if not meeting full criteria for a major depressive episode. This 
was suggested to be in the form of anti-depressant medication, but it was pointed out that Mr. 
James could also benefit from a form of psychological therapy, to work through the diagnosis 
and impact of dementia and help increase his confidence and self-esteem. He was also 
thought to be able to benefit from some practical help, setting up cues, making plans and 
problem solving. It was thought that Mr James’ improved recognition with visual cues as 
highlighted through assessment could be utilised in his environment to enhance his day to day 
functioning.
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SPECIALIST CASE REPORT:
‘A Four Week Inpatient Pain Management Programme for People suffering from 
Chronic Pain Conditions.’
Main Presenting problem:
All patients in the pain programmes present with a chronic pain condition. It must be satisfied 
that all reasonable attempts to relieve the pain have been offered to the patient. It is then 
clearly explained that there is no doubt as to the reality of the pain, but that the emphasis will 
now be that of management and increasing function.
Assessment Procedure:
Information is gathered from the Doctor with regards medical history, treatments and 
patient’s beliefs about the meaning of pain and given diagnosis. The Psychologist will focus 
on the array of difficulties the patient has experienced, methods of coping, mood, 
relationships, previous psychological/psychiatric contact and goals for the future. Links are 
made between how some of the often difficult feelings and beliefs may impact upon the pain 
and ability to cope with it effectively. There are a number of inclusion and exclusion criteria, 
which are followed.
Psychological Measures included:
- Beck Depression Inventory (BDI)
- Pain Catastrophising Questionnaire (PCS)
- Pain Self Efficacy Questionnaire (PSEQ)
- Tampa Scale o f Kinesophobia (TSK)
Formulation:
Chronic pain is characterised by persistent pain, which outlasts the normal duration of 
healing. This in turn may lead to a disabled state, with difficulties coping with the pain and 
associated social and psychological problems (Fordyce, 1976). Thus approaches have 
emerged to address the patients distress and dysfunction rather than attempting to identify 
and cure the cause of the pain. Experience of pain and level of disability may then partly be 
explained by the meanings ascribed to the pain, the interpretations made and the way the 
patient reacts/copes with it (Keefe, Brown, Wallston & Caldwell, 1989). Thus cognitive 
behavioural treatments address the factors which may be maintaining the maladaptive beliefs,
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thought patterns and subsequent behaviours. In multidisciplinary programmes, movement and 
physical fitness are re-introduced as the cognitive changes are being made to begin redressing 
the secondary effects that have resulted from reduced activity.
A systematic review and meta-analysis of 25 randomised controlled trials of cognitive 
behavioural treatments for chronic pain (Morely, Eccleston & Williams, 1999) found that 
when cognitive behavioural treatments were compared to controls, significant effect sizes 
were noted on all domains of measurement. In a study by Williams, Richardson, Nicholas, 
Pither, Harding, Ridout, Ralphs, Richardson, Justins and Chamberlain (1996), the inpatient 
group made greater gains that were maintained better at one year than the outpatient group. 
They also used less healthcare over this period of time.
Intervention:
This programme was a four-week inpatient multidisciplinary pain management programme. 
Two patients left after the second day. The programme consisted of medical talks, 
exercise/stretch, activities/goal setting, medication withdrawal, relaxation, sleep reduction 
and psychology sessions. There were eight psychology sessions, led by the Trainee 
Psychologist under observation of the Team Psychologist. Patients were shown to link their 
thoughts with their moods and subsequent behaviours. Specific topics covered were: fear- 
avoidance; expectations; depression; anger; flare-ups and preparation for leaving the 
programme.
Outcome:
The two patients who had high scores on the measures of catastrophising, kinesephobia and 
low self-efficacy were the two who left the programme in the first couple of days. One of 
these patients also had a high score for depression. Overall however for the six patients who 
completed the programme, measures taken at time two were improved to those upon entering 
the programme. Overall the scores on the psychological measures taken on the first and last 
days of the programme indicated reductions in depressive thinking, increases in self-efficacy, 
reductions in catastrophic thinking and reductions in pain related fear. This is in line with 
verbal feedback from the patients who expressed their gains in control and management over 
their pain and secondary effects.
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RESEARCH DOSSIER
OVERVIEW
This Section Comprises a Log Book of Research Experience, the Service 
Related Research Project Completed in Year 1 and the 
Major Research Project Completed in Year 3
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Abstract
‘Long Term Follow-up for the Effectiveness of an 8week Outpatient Cognitive- 
Behavioural Therapy (CBT) Group for Pain Management’.
Cognitive-behavioural treatments have emerged with the understanding that individuals can 
effect their experience of pain. Morley, Eccleston & Williams (1999) concluded 
psychological treatments based upon cognitive-behavioural principles were effective. 
Kelleher, Rennell & Kidd (1998) highlighted the importance of social influence on pain 
measurements.
This study was a non-randomised follow-up of 12 participants from eight-week outpatient 
cognitive-behaviour therapy pain management groups over two years. Participants were 
assessed on the Hospital Anxiety and Depression Scale, Dysfunctional Attitudes Scale and 
McGill Pain Questionnaire. Questions on life circumstances and satisfaction were also 
completed.
Analysis using Friedman tests focused on development and maintenance of gains. A 
significant reduction in anxiety developed, but was not maintained at follow-up. The attitude 
of ‘approval’ was less dysfunctional on group completion, again not maintained at follow-up. 
There were no other significant findings.
Non-significant trends showed reductions in depression, pain intensity and severity of 
experience and development of more functional attitudes. Social context did not appear to 
influence satisfaction. General feedback concluded group participation to be a positive, useful 
experience. Generally, the trends support the conclusions by Morley et al. (1999).
With no control, small sample and subjective measures, this work could be extended to 
further inform the service with regards programme effectiveness.
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Introduction:
The cost of chronic pain is immense, not only for the individual in terms of their suffering, 
but also socioeconomically with increased health care and decreased work functioning.
Theorists and health care professionals have worked to develop a better understanding as to 
the complexities of pain and in turn developed interventions to help individuals cope more 
effectively.
Melzack & Wall in 1965 developed the ‘Gate Control Theory’. This offered a 
multidimensional basis for understanding pain, comprising affective, sensory, motivational, 
environmental and cognitive components, this encouraged subsequent research into 
psychological factors.
Cognitive behavioural treatments emerged, building upon the understanding that an 
individual can effect their experience of pain, focusing on and addressing cognitive and 
behavioural factors associated with increased distress and disability. The emphasis being, that 
despite pain, patients can live more satisfying and effective lives. Cognitive Behavioural 
interventions have begun to tease out some of the complex interactions between mood, 
external stressors and pain. They aim not to eliminate pain but to enable the patient to gain 
more control and increase their quality of life. Pain intensity however, may become reduced 
as a function of the acquired skills, (Turk & Meichenbaum, 1989).
Taking a holistic view and incorporating these notions, pain management programmes have 
become well established and ideally should comprise ‘physical reconditioning, posture and 
body mechanics training, applied relaxation techniques, information and education about pain 
and pain management, medication review and advice, psychological assessment and 
intervention, graded return to activities of daily living’ (The Pain Society, 1997).
There has been a wealth of research, but mainly focused on specialist multidisciplinary 
inpatient groups. There is evidence that programmes can effectively teach pain management 
to patients, with subsequent improvements in pain ratings, mood and interference of pain in 
daily life. It has however been noted (Flor, Fydrich & Turk, 1992) that evidence regarding the 
specific components is lacking. Nicholas, Wilson & Goyen (1992) however have shown an
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advantage when there is inclusion of psychology in pain management programmes. Only a 
few studies have focused primarily on the cognitive behavioural components and 
maintenance of gains, especially in the more affordable outpatient setting.
The most recent meta-analysis and systematic review comes from Morley, Eccleston & 
Williams (1999). This analysed 25 trials comprising 221 outcome measures, the majority 
self-ratings, (74 percent). Cognitive behavioural treatments were compared to alternative 
control conditions and wait list control. Significant changes emerged in the domains of 
cognitive coping, positive coping measures/appraisal and the pain experience. No significant 
differences were obtained for mood and negative appraisals. Conclusion being psychological 
treatments, based upon cognitive behavioural principles were shown to be effective.
Two pieces of research into outpatient programmes are now outlined in more detail. The first 
by Pilowsky, Spence, Rounsefell, Forsten & Soda (1995), compared an outpatient Cognitive 
Behavioural Therapy (CBT) group, with Amitriptyline for non-malignant pain. No significant 
differences were found between conditions after the eight-week group. At six-month follow- 
up, a small non-statistically significant advantage for CBT was shown.
Basler & Rehfisch (1990) compared a CBT programme in a primary care setting with a wait 
list control. At six-month follow-up, improvements in anxiety, depression, bodily symptoms 
and decrease in pain intensity were shown for the treated group.
This research aimed to investigate these trends further, by focusing on CBT outpatient groups 
and looking at potential maintenance or development of gains over time. This study followed 
pain group members up to two years post treatment. Qualitative information was also sought 
in conjunction with statistical findings to help make sense of any results within such a 
complex area. For example Kelleher, Rennell & Kidd (1998) studied patients suffering 
Rheumatoid Arthritis. They highlighted differences in ratings between those in hospital and 
those at home and differences between patients who lived alone and those who lived with 
partners. They concluded variations in pain scores and intensity may be influenced by social 
context. Therefore issues such as life events, medication and satisfaction were be sought.
It is reasonable for patients, referrers and purchasers to expect a programme to describe in 
detail its components and expected outcomes. Evaluation is required and essential to establish
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good quality services are available and benefiting the clients. Measuring changes in pain such 
as by asking patients to provide ratings following programmes are therefore valid to 
determine service effectiveness (Feine, 2001). Providing evidence based practice, especially 
being a co-facilitator of the pain groups, reflects a further research aim.
Aims and Hypothesis:
Therefore this research aimed to focus on CBT outpatient groups for pain management and 
investigate maintenance of any gains from this specific intervention. The main hypotheses 
were:
Hypothesis 1:
‘Anxiety will decrease on completion of the pain management group and be maintained 
at follow-up.’
Hypothesis 2:
‘Depression will decrease on completion of the pain management group and be 
maintained at follow-up.’
Hypothesis 3:
‘Dysfunctional attitudes will become more functional on completion of the pain 
management group and be maintained at follow-up.’
Hypothesis 4:
‘Intensity of pain will reduce on completion of the pain management group and be 
maintained at follow-up.’
Analysis will also take into account social context and postulate that those with more life 
stressors since completing the pain group will appear less satisfied with the programme.
The research will also aim to inform the service and it’s users as to the effectiveness of the 
programme, in line with providing evidence-based practice.
Page 122
Method:
Design:
This was a non-randomised follow up of participants from eight week outpatient CBT pain 
management groups over the past two years. There was no wait list control.
Participants:
Thirty-three adult chronic pain patients who had initially been assessed for group suitability 
by Clinical Psychologists in Physical Health were approached. They had taken part in a pain 
group within the last two years, which was when the pain group became manualised and data 
collection began. They had also completed the group at least six months ago. Participants 
were excluded if they had received individual therapy sessions following group discharge and 
also if they had no measures taken on their first and last sessions of the group. This 
information was gathered from patient files and the database of pain group data, set up in the 
department. Twelve people were included in the study, it is not possible to give age and 
gender distributions, as participants did not provide this information.
Measures:
The participants were assessed on the Hospital Anxiety and Depression Scale (HADS; 
Zigmond & Beck, 1978) for anxiety and depression scores. Internal consistency assessed by 
Chronbach’s alpha was 0.93 for anxiety and 0.90 for depression (Moorey, Greer, Watson, 
Gorman, Rowden, Tunmore, Robertson & Bliss, 1991).
They were assessed on the Dysfunctional Attitudes Scale (DAS; Weissman & Beck, 1978) 
for approval, love, achievement, perfectionism, entitlement, omnipotence, autonomy and total 
score. Dyck (1992) highlighted good concurrent validity.
Finally they were assessed using the McGill Pain Questionnaire (MPQ; Melzack, 1975), 
which reported adequate concurrent, construct and predictive validity. No data was available 
on reliability. This contained 20 groups of words, reflecting pain experiences. Participants 
were assessed for number of words chosen (NWC); sensory experience labelled as Pain 
Rating Index (PRI) ‘sensory’; affective experience ‘PRI affective’; evaluative measure ‘PRI 
evaluative’; the miscellaneous class of words ‘PRI miscellaneous’ and total ‘PRI total’. They 
were also assessed for present pain intensity ‘PPI’.
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The participants had already completed these measures upon entering the group and upon 
group completion eight weeks later. Therefore these measures were naturally the ones re­
administered for this follow-up, so as comparisons could be made. Measures taken upon 
entering the group were said to be those from ‘tune one’ and those taken on completion were 
classed as ‘time two’. Measures administered in the follow-up, varying from eight months to 
twenty-four months from starting the programme, were labelled as ‘time three’ measures.
Some general questions were comprised and completed by participants. These pertained to 
life events and circumstances since completing the pain group. Medication and evaluation of 
the pain programme were also investigated. This was to potentially help identify factors that 
could help understand any statistical findings, such as reasons for significant/non-significant 
results, relapse or factors involved in maintenance of gains. For all questionnaires see 
appendix 1.
Ethical approval was not sought due to the research being audit work and in the form of 
continued evaluation of a psychological group as determined by the relevant health authority.
Procedure:
The 33 participants were sent the questionnaires, which had been collated into a small 
booklet. Included was a covering letter (appendix 2), information sheet (appendix 3) plus a 
prepaid envelope for questionnaire return. These were sent out and this first post resulted in 
11 returned questionnaires. A month later the questionnaires were sent out again to those who 
had not returned them, and four more were returned from this second posting. Therefore, of 
the 33 people deemed suitable for the study, only 15 returned their questionnaires, three of 
whom did not wish to take part. With missing data excluded, an average of ten people formed 
the basis for comparisons.
Analysis:
Data was compiled and analysed alongside measures that had been taken on first and last 
sessions of the group. Data was analysed using Friedman tests. Wilcoxon post hoc tests were 
performed where applicable. The fourth questionnaire was carefully viewed for dominant 
themes and summarised. It was then used in conjunction with the statistical results to try and 
understand the findings more completely.
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Time three data contained data from varying times after completion of the programme, from 
six months to 22 months after completing the pain groups. This data had to be put together 
for analysis because participants did not indicate on the questionnaire when they had 
completed the programme and the number of respondents was veiy small.
Feedback of the findings and recommendations to the service were then made, via a 
presentation and meeting with field supervisor (see appendix 4).
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Results:
(Results of questionnaires one - three)
Data from each returned questionnaire was collated and analysed. Since many of the 
variables were not normally distributed, non-parametric tests were used. The number of 
people the results are based on is often less than 12 due to missing data on a question, which 
then excludes those individuals total scores from analysis.
Friedman tests were conducted on the data. This test looks to see if the scores that emerged 
for each of the variables tested, are simply random results. It tests whether the time the 
measure was taken, whether this be upon entering the group, on completion or on follow up 
has no significant effect on scores obtained. Where significant results are obtained, Wilcoxon 
post hoc tests are done to show the differences between groups. Any result which is 
significant at p<0.05 is highlighted in bold demonstrating the results at this point in time are 
not simply random. It must be noted that due to the large number of tests being carried out, 
there is increased possibility that any significant results found could be due to chance.
Hypothesis 1: ‘Anxiety will decrease on completion of the pain management group and 
be maintained at follow up.’
Tablel: Results of Friedman tests testing hypothesis 1.
Variable N Mean
(2dp)
Sd
(2dp)
Chi-square Df
Asymp.sig
HADS Anxiety
time 1 10 12.50 3.60 6.222 2 0.045
time 2 10 10.40 3.63
time 3 10 10.70 2.31
Results show that scores produced for the ‘HADS anxiety’ are not random, therefore post hoc 
tests were done to see where the effect was.
Table lb: Wilcoxon post hoc comparisons for HADS Anxiety:
P a irs  o f  V ariab les Z A sym p. Sig (2 tailed )
Had anxiety (time)2- 
Had anxiety (time)l
-2.636 0.008
Had anxiety (time3)- 
Had anxiety (timel)
-1.493 0.135
Had anxiety (time)3- 
Had anxiety (time)2
-0.213 0.831
(Bonferroni correction: P<0.05/3= 0.016)
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This highlighted that the difference in scores was produced between time one and time two. 
Therefore there was a difference when leaving the group compared to entering. Direction 
from the means showed a significant ‘reduction’ in anxiety from start of group to it’s 
completion, supporting hypothesis one, although the statistical effect was not maintained at 
follow-up.
Hypothesis 2: ‘Depression will decrease on completion of the pain management group 
and be maintained at follow up.’
Table 2: Results of Friedman tests testing hypothesis 2.
Variable N Mean
(2dp)
Sd
(2dp)
Chi-square Df
Asymp.sig
HADS
Depression 10 9.70 3.65 3.211 2 0.201
time 1 10 7.50 3.57
time 2 10 7.40 2.01
time 3
There was no support for hypothesis two.
Hypothesis 3: ‘Dysfunctional attitudes will become more functional on completion of the 
pain management group and be maintained at follow u p .'
Table 3: Results of Friedman tests testing hypothesis 3.
Variable N Mean
(2dp)
Sd
(2dp)
Chi-square Df
Asymp.sig
DAS Approval
time 1 10 -2.30 3.71 6.684 2 0.035
time 2 10 0.50 4.45
time 3 10 0.70 4.67
DAS Love
time 1 07 -1.14 4.26 4.083 2 0.130
time 2 07 1.57 3.82
time 3 07 1.00 4.51
DAS
Achievement 09 3.11 4.65 0.188 2 0.911
time 1 09 3.44 3.54
time 2 09 3.78 4.97
time 3
DAS Performance 
time 1 
time 2 
time 3
08
08
08
1.13
2.00
1.88
3.7
2.88
4.85
0.267 2 0.875
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Variable N Mean
(2dp)
Sd
(2dp)
Chi-square Df
Asymp.sig
DAS Entitlement
time 1 08 1.25 4.03 3.161 2 0.206
time2 08 -2.25 4.56
time3 08 -1.75 4.13
DAS
Omnipotence
time 1 08 -1.75 4.27 1.724 2 0.422
time 2 08 -0.25 4.17
time 3 08 -0.88 2.17
DAS Autonomy
time 1 08 -1.50 3.55 0.857 2 0.651
time 2 08 -1.75 1.83
time 3 08 -2.38 2.62
Results showed that scores produced for ‘DAS approval’ were not random, therefore post hoc 
tests were done to see where the effect was lying.
Table 3b; Wilcoxon post hoc comparisons for DAS Approval:
P a irs  o f  V ariab les Z A sym p. Sig (2tailed)
Das approval (time2)- 
Das approval (timel)
-2.932 0.003
Das approval (time3)- 
Das approval (timel)
-1.838 0.066
Das approval (time3)- 
Das approval (time2)
-0.154 0.878
(Bonferroni correction: P<0.05/3= 0.016)
This highlighted that the difference in scores was produced between time one and time two. 
Therefore there was a difference when leaving the group compared to entering. Direction 
from the means showed a significantly more functional attitude at the end of the group 
compared to the start. This partially supports hypothesis three as this result is not maintained 
at follow up and is only significant for one out of the seven dysfunctional attitudes.
Hypothesis 4: ‘Intensity of pain will reduce on completion of the pain management 
group and be maintained at follow up.’
Table 4: Results of Friedman tests testing hypothesis 4.
Variable N Mean
(2dp)
Sd
(2dp)
Chi-square Df
Asymp.sig
MPQ NWC
time 1 10 11.00 6.18 1.086 2 0.581
time 2 10 11.80 5.57
time 3 10 10.10 5.65
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Variable N Mean
(2dp)
Sd
(2dp)
Chi-square Df
Asymp.sig
PRI Sensory
time 1 10 16.50 9.10 0.974 2 0.614
time 2 10 16.50 6.04
time 3 10 14.80 7.96
PRI Affective
time 1 10 5.10 4.93 2.966 2 0.227
time 2 10 4.30 4.57
time 3 10 3.50 4.93
PRI Evaluative
time 1 10 2.60 2.01 0.452 2 0.798
time 2 10 2.20 1.62
time 3 10 2.00 1.16
PRI
Miscellaneous 10 3.90 2.73 1.613 2 0.446
time 1 10 4.60 2.80
time 2 10 3.80 3.08
time 3
PRI Total
time 1 10 28.10 15.57 1.282 2 0.527
time 2 10 27.80 13.28
time 3 10 24.10 15.62
PPI
time 1 09 2.33 0.87 0.069 2 0.966
time 2 09 2.22 1.30
time 3 09 2.22 0.97
There was no support for hypothesis four.
Whilst there were only two statistically significant results overall, probably due to such a 
small number of participants responses, it can be useful to look at all the means to give an 
overall picture of direction. For the majority of items, a more positive picture after group 
completion and at follow-up is highlighted (see means in tables 1- 4).
Results of questionnaire four- Satisfaction’:
Results of the general questions from the fourth questionnaire were then summarised into 
table 5. This then gives the percentage of people who were or were not satisfied with certain 
aspects of the pain group.
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Table 5: Satisfaction with elements of the pain programme: (% to 2 decimal places)
W ere you satisfied 
w ith ...?
Yes (%) Positive
Comments
No (%) Negative
Comments
Group facilitators 11/11 (100) “Helpful & useful 
provision of 
information.” 
“Approachable & 
non-rejecting.”
00/11 (0) No comments
Groups members 09/12 (75) “Useful to see how 
others coped.” 
“Other members 
‘cordial & co­
operative’.” 
“Others were 
varied & helpful in 
explanations when 
asked questions.”
03/12 (25) “Repetitive 
conversation.” 
“Difficulty mixing 
with people of 
different abilities.” 
“People not 
completing the 
course.”
Group size 11/12 (91.67) No comments 01/12 (08.33) No comments
Group length 12/12 (100) No comments 00/12 (0) No comments
Group content 09/10 (90) “Interesting.” 
“Provided useful 
handouts.”
01/10 (10) “Cancer person did 
not mix with those 
with back 
problems.”
People rated their overall satisfaction with the pain group, the percentage is given in table 6 
below:
Table 6: Satisfaction with pain programme overall: [0 = not at all useful -> 100 = 
extremely useful]
Raw Scores Mean (%)
10, 75, 80, 80,90,100, 100, 100, 635/8 (79.38)
People described what they found to be the most useful aspects of the course; these are 
summarised as follows:
Table 7: Most useful aspects of the course:
Useful Aspect of Course: Number of people making comment
Being with other pain sufferers/ listening & 
sharing experiences.
5
Pacing 4
Relaxation 4
Imagery 1
Goal setting 1
Reducing the focus on pain. 1
Few negative comments were made about the group, but they are summarised in table 8:
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Table 8: Negative aspects of the course.
Negative Rem ark Number of people making comment
Not liking form completion 1
Difficulties using assertiveness techniques
Difficulty obtaining work 1
Inability of group to cure pain 1
Need for follow up groups 1
Wish for course to be made available earlier in 
one’s life.
1
Life stresses:
It was hypothesised that life stresses may influence effects of the group. It was found that six 
of the eight, who rated overall usefulness of the programme, also reported life stresses since 
completing the group. The mean rating for group usefulness by these people was eighty-nine 
percent (nearest percent). Life stresses included: mother in hospital, bereavement, moving 
house, new job and unspecified family difficulties. This does not support the idea that those 
with life stresses since group completion would appear less satisfied with the programme.
Medication:
In the majority there was no change in medication from time of the group to present day, 
although two had increased and three had decreased medication.
W ork status:
Generally work status had remained constant. Five were retired and one was a housewife 
upon entering the group, this stayed the same. Of the remaining four who responded, two 
were unemployed and one on incapacity benefit. This was consistent with their work status at 
the time of the group. Only one had returned to work full time. One person who was 
unemployed, specified an increase in quality and quantity of voluntary work.
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Discussion:
With regards mood (HADS), results indicated a significant decrease in anxiety from 
measures taken upon entering the group to completion, although this was not maintained at 
follow-up. Whilst non-significant, means indicate a reduction in depression across the three 
points in time, see table 2. This supports the findings of Basler & Rehfisch (1990).
From the DAS, a significant shift in ‘approval’ was obtained from beginning to end of the 
group. This was not maintained at follow-up. However the attitude was still more functional 
at the follow-up, than had been upon entering the group. No other attitudes produced 
significant findings, however for four of remaining six items, a more functional attitude was 
displayed upon follow up than upon entering the group (see table 3).
The McGill Pain Questionnaire produced no significant results. However a non-significant 
trend was highlighted (table 4) on all items showing a reduction in intensity from start of 
group to follow-up. In each case except the miscellaneous category, there was a reduction 
from entering the group to completion and again from completion to follow up. Pain intensity 
also displayed a non-significant reduction upon group completion and was maintained at 
follow up. This highlights as mentioned by Turk & Michenbaum (1989), how pain intensity 
may become reduced as a function of the acquired skills.
Therefore only two measures produced significant effects from attending the pain group. 
Caution must even be taken with the significant reduction in anxiety, as upon entering a 
group, people’s anxiety levels may be increased, this then producing an increased baseline 
measurement. Perhaps non-significant results are not entirely surprising given that eight 
weeks to implement so many changes after suffering chronic pain for years seems unlikely to 
yield significant shifts on many measures. From the feedback received (questionnaire 4), 
many life events took place after ending the group and therefore significant change or 
maintenance of gains to a significant level may have been difficult to obtain. However, the 
non-significant trends for such a small sample are very encouraging. Generally these findings 
hint towards supporting the notions of Morley et al (1999), for the effectiveness of cognitive 
behavioural psychological treatments
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Feedback from questionnaire four was extremely positive, even if not reflected through 
statistical significance. Of the eight people who rated usefulness of programme the mean was 
79 percent (nearest percent), indicating people who answered the question found the group 
very useful indeed. Few negative comments were made about the group, see table 8. Also 
with regard satisfaction, as collated in table 5, feedback on elements comprising the pain 
programme were generally very positive. This is in contrast to the non-significant results in 
terms of reduction of pain, depression and most of the dysfunctional attitudes. One likely 
reason is the low number of subjects since the majority of scores show a trend in the 
hypothesised direction.
It was hypothesised that life stresses may influence effects of the group, this was found not to 
be the case, with the mean rating for group usefulness by these people being 89 percent 
(nearest percent). In fact six out of eight of those who rated overall usefulness of the group 
were people who had significant life stresses upon group completion. These included as 
mentioned previously, bereavement, moving house, mother in hospital and unspecified 
family difficulties.
Critique:
The sample was very small, with an average of ten people forming the basis for comparisons. 
This may not be representative of all those who took part in the pain programmes. Not only 
has the analysis excluded those who did not complete measures at the beginning to end o f the 
group, but also those who had individual treatment following the group, plus those who could 
not be located, and those who did not complete the questionnaires. In effect it is hard to make 
conclusions made on such a small percentage of participants of pain programmes over the 
past two years.
There was no wait list control and only subjective measures were taken. No account was 
made as to time between participation in the pain group and follow-up. Time three data 
contains data from varying times after completion of the programme, from six months to 22 
months after completing the pain groups. This data had to be put together for analysis 
because participants did not indicate on the questionnaire when they completed the 
programme and the number of respondents was very small. Time since completing the pain 
group could be an important factor regarding maintenance of gains.
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Caution must also be employed when interpreting the fourth questionnaire, as this may reflect 
only those who returned the questionnaire. They may have returned the questionnaires 
because they had had the most positive experiences from the group. With a co-facilitator 
conducting the research, perhaps the more positive responses comprised the ones returned. 
Therefore these findings need also be interpreted with caution.
The measures were chosen by previous group facilitators and for a follow up naturally the 
same measures had to be used. Current literature shows that maybe the measures employed 
may not now be the measures of choice. The Pain Discomfort Scale (PDS; Jensen, Kardy & 
Harris, 1991) is a more recent development of a verbal scale assessing the affective intensity 
o f pain and the Modified Somatic Perception Questionnaire, (MSPQ; Main, 1983) has also 
been recommended to best assess anxious preoccupation.
Conclusion:
It is not possible to make any firm conclusions based on such a small sample, with no control 
group and using purely subjective measures. Tentatively however the significant results show 
that anxiety levels taken upon entering the group had reduced upon leaving the group, though 
this was not maintained at follow up. The attitude of ‘approval’ was less dysfunctional upon 
leaving the group than when entering, again not maintained at follow up. These were 
however the only two significant results and no firm conclusions can be drawn for the 
service.
Non-significant trends however showed a reduction in depression, more functional attitudes 
and decreased pain intensity and severity of pain experiences. Whilst non-significant, 
generally the trends are showing support for the initial hypotheses.
General feedback concluded participating in the group to be a positive, useful experience, 
even if not reflected statistically. The research trends support the general conclusion made by 
Morley et al. (1999), for the effectiveness of psychological treatments based upon cognitive 
behavioural principles.
Social context did not appear to influence satisfaction although could represent only those 
who returned the questionnaire.
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Applicability of research to service
Whilst tentative to draw conclusions on the effectiveness of the service, based upon an 
average of ten people’s data, it may be more useful to note that for the majority of people 
who took part in the follow-up, the experience seemed to be a good one. The skills, whether 
put into practice all the time, appear leamt and not forgotten. Each person seemed to take 
something away from the course.
With positive trends emerging even with such a small sample, data collection and analysis 
should be continued to investigate these trends further and a much larger sample is needed. 
Measurement needs to be consistent and perhaps explained thoroughly beforehand to 
minimise missing data. Originally the three questionnaires were given out separately which 
came across as quite daunting and was often felt to be too much. This may well have put 
people off completing them fully in the first place and wanting to repeat them for this follow 
up piece of work. The combined questionnaire booklet made for this research is smaller, 
more compact and probably less anxiety provoking than the separate ones. This has been 
given to the service who has agreed to implement this as their tool instead.
The measures should also be reviewed in line with current literature, although this will make 
analysis from previous programmes difficult. Hopefully this will then continue to inform and 
improve the service provided and enable comparisons with similar services.
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APPENDIX I
Questionnaire One to Four.
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Questionnaire 1:
Read each item and underline the reply which comes closest to how you have been feeling in 
the past week. Don’t take too long over your replies; your immediate reaction to each item 
will probably be more accurate than a long thought out response. Please answer every 
question.
I feel tense or ‘wound up’:
Most of the time 
A lot of the time 
From time to time 
Not at all
I still enjoy the things I used to enjoy:
Definitely as much 
Not quite so much 
Only a little 
Hardly at all
I get a sort of frightened feeling as 
if something awful is about to happen:
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn’t worry me 
Not at all
I can laugh and see the funny side 
of things:
As much as I always could 
Not quite so much now 
Definitely not so much now 
Not at all
Worrying thoughts go through my mind:
A great deal of the time 
A lot of the time
From time to time but not too often 
Only occasionally
I feel cheerful:
Not at all 
Not often 
Sometimes 
Most of the time
I can sit at ease and feel relaxed:
Definitely 
Usually 
Not often 
Not at all
I feel as if I am slowed down:
Nearly all the time 
Very often 
Sometimes 
Not at all
I get a sort of frightened feeling like 
‘butterflies’ in the stomach:
Not at all 
Occasionally 
Quite often 
Very often
I feel restless as if I have to be on 
the move:
Very much indeed 
Quite a lot 
Not very much 
Not at all
I get sudden feelings of panic:
Very often indeed 
Quite often 
Not very often 
Not at all
I have lost interest in my appearance:
Definitely
I don’t take as much care as I should 
I may not take quite as much care 
I take just as much care as ever
I look forward with enjoyment to things:
As much as I ever did 
Rather less than I used to 
Definitely less than I used to 
Hardly at all
I can enjoy a good book or radio or 
T.V. programme:
Often 
Sometimes 
Not often 
Very seldom
Now check you have answered all the questions.
Page 142
Questionnaire 2:
Indicate how much you agree or disagree with each attitude, by ticking the column that 
represents you estimate of how you think most if the time. Be sure to choose only one answer 
for each attitude. Because we are all different there is no ‘right’ or ‘wrong’ answer to any 
statement Recall how you look at things most of the time. Please answer all the questions.
Statement Agree
Strongly
Agree
Slightly
Neutral Disagree
Slightly
Disagree
Very
Much
1.Criticism will obviously upset the 
person who receives the criticism.
2.It is best to give up my own interests 
in order to please other people.
3.1 need other people’s approval in order 
to be happy.
4.If  someone important to me expects 
me to do something then I really should 
do it.
5.My value as a person depends greatly 
on what others think of me
6.1 cannot find happiness without being 
loved by another person.______________
7.If others dislike you, you are bound to 
be less happy.
8.If people whom I care about reject me 
it means there is something wrong with 
me.
9.If a person I love does not love me, it 
means I am unlovable.
lO.Being isolated from others is bound 
to lead to unhappiness.
11 .If I am to be a worthwhile person I 
must be truly outstanding in at least one 
major respect.
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Statement Agree Agree Neutral Disagree Disagree
Strongly Slightly Slightly Very
Much
12.1 must be a useful, productive, 
creative person or life has no purpose.
13.People who have good ideas are more 
worthy than those who do not.
14.1f I do not do as well as other people 
it means I am inferior.
15.If I fail at my work then I am a 
failure as a person.
16.1f you cannot do something well 
there is little point doing it at all._______
17.It is shameful for a person to display 
his or her weaknesses.
18.A person should try to be the best at 
everything he or she undertakes._______
19.1 should be upset if I make a mistake.
20.If I don’t set the highest standards for 
myself I am likely to end up a second 
rate person.________________________
21.If I strongly believe I deserve 
something I have reason to expect I 
should get it.____________ ______ ____
22.It is necessary to become frustrated if 
you find obstacles to getting what you 
want.
23.If I put other people’s needs before 
my own, they should help me when I 
need something from them.
24.If I am a good wife/husband/partner 
then my partner is bound to love me.
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Statement Agree Agree Neutral Disagree Disagree
Strongly Slightly Slightly Very
Much
25.If  I do nice things for someone I can 
anticipate that he or she will respect and 
treat me just as well as I treat them.
26.1 should assume responsibility for 
how people feel and behave if they are 
close to me.
27.1f I criticise the way someone does 
something and he or she becomes angry 
or depressed, this means I have upset 
him or her.
28.To be good, worthwhile, moral 
person, I must try to help everyone who 
needs it.
29.If a child is having emotional or 
behavioural difficulties, this shows that 
the child’s parents have failed in some 
important respect.______________
30.1 should be able to please everybody.
31.1 cannot expect to control how I feel 
when something bad happens._________
32.There is no point in trying to change 
upsetting emotions because they are a 
valid and inevitable part of daily living.
33.My moods are primarily created by 
factors that are largely beyond my 
control, such as past, body chemistry, 
hormone cycles, biorhythms, chance or 
fate.
34.My happiness is largely dependent on 
what happens to me.
35.People who have the marks of 
success (good looks, social status, 
wealth or fame) are bound to be happier 
than those who do not.
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Questionnaire 3:
What Does Your Pain Feel Like? Some of the words below describe your present pain. Circle 
ONLY the words that best describe it. Leave out any category that is not suitable. Use 
maximum of a single word from each category.
1 2 3 4 5
Flickering Jumping Pricking Sharp Pinching
Quivering Flashing Boring Cutting Pressing
Pulsing
Throbbing
Shooting Drilling
Stabbing
Lacerating Gnawing
Cramping
Beating
Pounding
Lancinating Crushing
6 7 8 9 10
Tugging Hot Tingling Dull Tender
Pulling Burning Itchy Sore Taut
Wrenching Scalding Smarting Hurting Rasping
Searing Stinging Aching
Heavy
Splitting
11 12 13 14 15
Tiring Sickening Fearful Punishing Wretched
Exhausting Suffocating Frightful
Terrifying
Gruelling
Cruel
Vicious
Killing
Blinding
16 17 18 19 20
Annoying Spreading Tight Cool Nagging
Troublesome Radiating Numb Cold Nauseating
Miserable Penetrating Drawing Freezing Agonising
Intense
Unbearable
Piercing Squeezing
Tearing
Dreadful
Torturing
How strong is your pain?
The 5 words below represent pain of increasing intensity. They are:
1 2 3 4 5
Mild Discomforting Distressing Horrible Excruciating
Write the number of the most appropriate word in the space beside the question:
Question: Which word best describes your pain right now? Number
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Questionnaire 4:
Age______________________
Marital Status_____________
No.of years with Chronic pain 
Medication
When took part in pain g roup________________ ___________________________________
Please answer the following questions as fully as you can:
1). Please give some information surrounding your work status at present and since 
completing the chronic pain programme. (E.g. employed; full time/part time, unemployed, 
retired etc. Is this different from when you were in the group?).
2). Are there now, or have there been since the pain group, any additional stresses in your life 
apart from chronic pain. (E.g. moving house, bereavement, relationship/family difficulties 
etc.).
3). Have you changed your medication since you were in the pain group? 
Please clarify:
4). How useful do you think the pain management programme was? Rate from 0-100, (0 = 
not at all useful, 100 = extremely useful). Please explain your answer.
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5).What have you found to be the most useful part(s) from the pain management programme?
6).What have you found to be the least useful part(s) from the programme?
7).Were you satisfied with: (please tick):
The group facilitators. Y N
(please explain your answer)
The group members. Y N
(please explain your answer)
The size of the group. Y N
(please explain your answer)
The length of the group. Y N
(please explain your answer)
The content of the group. Y N
(please explain your answer)
Thank you (main for your co-operation. please do not hesitate to contact me should 
you wish to discuss any vart o f the study.
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APPENDIX 2
Covering Letter.
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Address:
February 2001.
D e a r ............................... ,
Re: Chronic Pain Group
M y name i s ............................. , you may remember me as one o f the facilitators o f  the
pain management programme you took part in a t................................... Hospital.
I am currently a  Trainee Clinical Psychologist at the University o f  Surrey. I am 
conducting some research evaluating the chronic pain group you attended.
This research will allow us to look at long term effects o f  participation in such a 
programme and will help us to see how the service is running and to make it more 
effective. Your co-operation will enable the service to continue to develop and 
improve.
I would be really pleased if  you would agree to take part in this research. I f  you do 
please read the information sheet and then complete the questionnaire.
Thank you so much for your time.
Yours Sincerely,
Trainee Clinical Psychologist.
APPENDIX 3
Information Sheet.
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Information Sheet:
I am  a Trainee Clinical Psychologist from the University o f Surrey. I am interested in 
evaluating the 8-week outpatient psychology pain group you once participated in. I am 
especially concerned with long term effects by following up past patients.
The questionnaire to complete comprises mainly questions that were administered 
prior to the group and on the first and last sessions. There are a few  general questions 
included at the end.
The questionnaires are strictly confidential and are identifiable only to me, through 
numbers, which represent each participant in the study. The corresponding nam es are 
secure and kept separate from the data.
Please feel free to ask any questions concerning the research, by telephoning m e on
.............................(the psychology department at ...............................  Hospital). I f  I am
unavailable, please leave a message and I will get back to you as soon as possible.
Thank you for your time,
Trainee Clinical Psychologist.
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APPENDIX 4
Letter Confirming Feedback To Service.
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12th July 2001 
Dear
Thank you very much for coming to present your research on the long-term effectiveness of 
our out-patient Pain Management Programme. This research will prove very useful to me in 
the further development of the service.
Wishing you all the best for the future.
Yours Sincerely
Lead Clinical Psychologist 
to pain Management Service
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ABSTRACT:
Objectives: To investigate whether implementation intentions increased self-reported 
adherence to cholesterol-lowering medication, in patients currently attending a lipid clinic 
and reporting some level of non-adherence. Further aims were to explore the adherent and 
non-adherent participants and those who received and did not receive the intervention on a 
number of outcome measures.
Design: Prospective experimental study, with experimental and control groups determined by 
sequential allocation, with alternate participants receiving the intervention.
Setting & Participants: Sixty-four adults currently taking some form of cholesterol lowering 
medication and attending a lipid clinic in one of two hospitals in Southeast England.
Outcome Measures: All participants were measured on the Illness Perception Questionnaire 
(IPQ-R; Weinman, Petrie, Moss-Morris & Horne, 1996), Beliefs about Medicines 
Questionnaire (BMQ; Horne, Weinman & Hankins, 1999), Hospital Anxiety and Depression 
Scale (HADS; Zigmond & Snaith, 1983) and Medication Adherence Scale (MARS-5; Horne 
& Weinman, 1999). Those not fully adherent were given the MARS-5 a month later to 
investigate change in adherence levels.
Results: No support was found for the main hypothesis. In fact there was a small significant 
increase in adherence over time, for those who did not receive the intervention. Anxiety was 
found to be greater in the initially non-adherent population.
Conclusions: This study used reliable and valid measures, albeit self-report and despite 
attempts, power was not achieved. Predominantly males received the intervention and thus 
findings could reflect a gender difference. There is further to go in understanding the 
complexity of health behaviours and even further to go in changing them.
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‘Do Implementation Intentions Increase Adherence to Medication in Non- 
Adherent Patients Currently Taking Cholesterol Lowering Medication?’
INTRODUCTION
Outline:
This review initially looks at the problem of adherence to medication. Models, which 
have attempted to account for this behaviour, are then explained, with evidence and 
shortcomings pertaining to each discussed. Interventions to increase adherence are 
analysed and are extended to the specific area of high cholesterol conditions and 
subsequent medication adherence. A summary is presented illustrating the main ideas 
postulated and the main hypothesis for this study outlined.
Adherence to Medication:
In the twentieth century, there has been a noticeable growth in the number of effective drug 
treatments. Prescription of medicine has become one of the most familiar medical 
interventions utilised. However whilst appropriate use of medication has been stated as one of 
the keys to self-management, it is thought that 30 percent of prescribed medication is not 
taken as directed (Meichenbaum & Turk, 1987). This can be seen as a waste of health 
resources and a potential lost opportunity for health gain, if the prescription was appropriate. 
Non-adherence can be split into two categories, the first being unintentional non-adherence, 
such as occasional forgetting, or inability to follow instructions for treatment because of 
physical problems, such as poor eyesight, or poor understanding. The other category is 
‘intentional’ non-adherence whereby it is the patient’s decision not to take the medication as 
has been instructed and this may be the result of an elaborate decision making process 
(Weintraub, 1990). Non-adherence has been seen as a particularly complex behaviour, which 
has continued to challenge researchers and practitioners. A number of theories have been 
used to try and explain the process, but few have managed to completely account for this 
behaviour. These theories are now considered.
Theory of Reasoned Action and Planned Behaviour:
Over the years theorists have attempted to understand what influences and guides people to 
behave in certain ways. Understanding the mechanisms by which human beings behave could 
help understand how behaviour, especially non-desirable behaviour, could be changed, such 
as that of non-adherence. Perhaps two of the most prominent theories to date are the theory of
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Reasoned Action (TRA; Fishbein & Ajzen, 1980) and the Theory of Planned Behaviour 
(TPB; Ajzen, 1991), which expanded upon the earlier model. These social cognition models 
(SCM’s) posit that a person’s ‘intention’ to perform behaviour is the best predictor of 
behaviour performance. It then specifies two important determinants of a person’s intention 
to perform behaviour, which are the ‘attitude’ held towards the behaviour and ‘subjective 
norm’. The former refers to both positive and negative evaluations of performing the given 
behaviour and the latter incorporates people’s perceptions of social pressure to perform the 
behaviour, multiplied by the extent the person is motivated to comply with this perceived 
social pressure. Accumulated evidence has shown that both these factors are good predictors 
o f intentions and in turn intentions are good predictors of performing behaviours (Sheppard, 
Hartwick, & Warshaw, 1988). This model was extended due to limitations when explaining 
behaviours over which people may not have complete volitional control. As with the TRA, 
the central factor of the Theory of Planned behaviour, remained a person’s ‘intention’ to 
perform the given behaviour, which again assumed to capture the motivational factors, that 
influences behavioural performance. The TPB also posited that sometimes, performance 
depends at least some degree, on other non-motivational factors, such as opportunity and 
available resources. Thus whilst performance of a behaviour can be determined by motivation 
(intention) it depends jointly on ability or perceived behavioural control over the behaviour. 
According to the TPB, Perceived behavioural control (PBC) and behavioural intention can be 
used directly to predict behavioural achievement. The inclusion of this predictor led to 
improvements in the predictions of behaviour. The TPB went a step further and attempted to 
explain the mechanisms by which these constructs were formed. It proposed that underlying 
these constructs were three sets of beliefs. The ‘behavioural beliefs’, were postulated to 
influence attitudes, the ‘normative beliefs’ to provide the basis for subjective norms and 
‘control beliefs’ which were thought to underlie perceived behavioural control. Whilst results 
have shown there to be a relationship between beliefs and attitude formation, the magnitude 
of this has often been disappointing. Inquiries into the role of these beliefs as a foundation of 
the attitudes towards a behaviour, perceived behavioural control and subjective norm, have 
been only partly successful, with only moderate correlations emerging (Sutton, 1998). 
Perhaps this highlights how an alternative model is needed to better describe the relations 
between beliefs and global constructs and the process by which beliefs combine to form these 
global responses (Ajzen, 1991). Therefore in conclusion, whilst attitudes, subjective norms 
and perceived behavioural control can be useful in the understanding and prediction of 
human behaviour, they still do not fully account for all variance in behaviour. The exact
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processes and structures, which underlie these general constructs, have not been adequately 
explained and still remain uncertain, as do issues regarding past behaviours and ‘habits’. 
Whilst many constructs of the theory of planned behaviour have been shown to be predictors 
o f behaviour, very few studies have assessed whether changing these beliefs changes 
behaviour. This topic is complex, variance has only in part been explained, and 
methodological flaws have been highlighted throughout much of the research alongside many 
contradicting propositions.
With reference to adherence to medication, these models have been partially helpful and 
some studies have demonstrated a relationship between perceived barriers, such as beliefs 
about the extent medication taking will disrupt their normal routines, general attitudes to 
medication, such as whether it is viewed as helpful or harmful and subsequent adherence 
(Becker, Radius, Rosenstock, Drachman, Schubert & Teets, 1978). In other studies, it was 
people’s perceptions of significant others, such as that of relatives or doctors, that were the 
most significant predictors of adherence (Cochran & Gitlin, 1988). However the limitations 
o f using these social cognition models with adherence research is that there has been little 
consistency across studies and the proportion of variance accounted for, with regard 
adherence has been generally small (Marteau, 1995). Additionally it would seem that 
behaviour such as non-adherence does not arise from one off decisions, but is a far more 
complex process.
Self-Regulatory Model of Illness (SRM):
An important model developing these notions is the ‘self-regulatory model’ of illness, which 
has been extended to explain adherence, (Leventhal, Meyer, & Nerenz, 1980, Leventhal & 
Cameron, 1987, and Leventhal, Diefenbach, & Leventhal, 1992). Leventhal and his 
colleagues postulated that if patients perceive medication and it’s effects as making sense, 
they would be more likely to engage in taking their medication as directed. Determining this 
will involve taking account of patient’s experiences past and current symptoms and also their 
beliefs about illness. The beliefs about illness are said to be structured around five themes; 
the nature of the condition (identity), cause, consequences, duration (time-line) and potential 
for control/cure of the illness in question.
As noted previously, the TRA and TRB conceptualised health-related decisions in a rather 
static manner, whilst the SRM views this as a much more dynamic process. For example, the
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selection of a coping procedure is determined by a set of beliefs about the illness threat, this 
is then followed by an appraisal stage, whereby the patient evaluates the effectiveness of that 
procedure. If  thought to be ineffective, then an alternative strategy might be employed or a 
change in illness representation might even be seen. With regards adherence, the SRM 
provides a useful framework in that adherence can be seen as a form of coping procedure, and 
that decision to follow treatment will be influenced by illness representation and subsequent 
view of whether the proposed treatment is appropriate. Leventhal emphasises the need for 
coherence and that a person regulates their response to the illness threat in a way needed to 
achieve coherence for them. Thus adherence is more likely if the ideas (abstract) and 
symptoms (concrete) aspects of the illness representation are coherent and if the advice given 
by the health care professional is in accordance with the patient’s own beliefs and 
experiences. Therefore the self regulatory model takes us from quite a rigid model based 
perspective of health decision making, to a more fluid conceptualisation in which behaviour 
and beliefs interact in a much more dynamic way (Leventhal, Diefenbach & Leventhal, 
1992). Support for the theory is provided by evidence that whilst ‘content’ of illness 
representations, between individual and patient beliefs and health practitioners may vary, the 
structure of the representations seems to be constant across demographics and illness groups 
(Skelton & Croyle, 1991).
It has also been suggested that beliefs about medicines prescribed for an illness may play an 
important part in self-regulation and adherence to the treatment. Bishop (1991) showed that 
people often hold prototypic beliefs about certain diseases and these will have an important 
role in illness cognition. Horne (1997) proposed that decisions to take medication are likely 
to be informed therefore by both beliefs about illness and beliefs about medicines.
Questions were posed as to how these medication beliefs were cognitively organised and 
whether they were grouped together in themes, as with the illness beliefs from the SRM. 
There was also the important question of whether beliefs in general could be differentiated 
from specific beliefs about medicines prescribed for a specific illness. Importantly, more 
about the relationship between these beliefs and behaviour needed to be determined to 
specifically identify which beliefs were associated with non-adherence. In a pilot study, the 
beliefs of 35 patients with a variety of chronic illnesses and receiving regular medication 
were investigated (Horne & Weinman, 1995). 34 statements were generated which 
represented common beliefs about medicines. These were separated into beliefs about
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medicines in general and beliefs about medicines specific to a condition. These statements 
were then administered to more than 500 people with a range of diagnoses, who rated their 
agreement or disagreement with each on a five point Likert scale. The specific and general 
items were analysed separately and a factor analysis confirmed that beliefs could be 
organised into four factors. Beliefs about medicines prescribed for a specific condition could 
be separated into two constructs. The first construct concerned the necessity and efficacy of 
the specific medicines. The second construct pertained to people’s concerns about specific 
medicines. The beliefs for medicines in general were divided into beliefs about Doctors over­
use of medicines and beliefs that medicines in general are harmful, addictive poisons. These 
then formed the ‘Beliefs about Medicines Questionnaire’ (BMQ; Horne, Weinman, & 
Hankins, 1999). Using the BMQ as a standardised tool, these researchers believed that the 
interplay between patients beliefs about their illness and treatment perceptions could be 
investigated, which they proposed had been commonly overlooked up until this point. The 
researchers have demonstrated how these factors are important in understanding and 
predicting medication adherence. Horne & Weinman (1999) looked at these beliefs in 324 
patients across four chronic illness groups (asthma, oncology, renal and cardiac). Whilst there 
was considerable variation between the groups, some commonalties emerged. Eighty-nine 
percent of patients believed their prescribed medication was ‘necessary’ for maintaining their 
health. Whilst over a third of patients reported strong ‘concerns’ about adverse effects that 
medication could produce. The relationship between these two components became apparent, 
with those with high necessity beliefs and low concerns having higher reported treatment 
adherence and those with high concerns and lower necessity beliefs having lower adherence 
to their medication. This varied according to illness group, with asthma and cardiac patients 
being significantly more likely to perceive the costs of treatment outweighing the benefits, 
whilst for the oncology and dialysis patients this was reversed. This necessity-concerns 
differential was the strongest predictor of adherence accounting for nineteen percent of 
variance in self-reported adherence. Illness type was a large predictor, with the asthmatic and 
cardiac patients being significantly less adherent. Younger patients were also less adherent, 
which goes against previous findings of older patients being those less adherent (Griffith, 
1990). Gender and number of prescribed medicines were not found to be good predictors of 
adherence and did not explain a significant amount of the variance. However this study as 
with most, does have a number of limitations. The information was obtained via self-report 
methods, and the design was cross-sectional and therefore causality cannot be determined. 
Thus primarily what can be determined was that beliefs and behaviour were related.
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Comorbidity of conditions and medications were not identified and subsequently this 
potential course of variation not controlled for. However there are clear implications in that 
patients can be seen as active decision makers and will be more likely to adhere to their 
medicines if beliefs about it’s necessity outweighs beliefs about potential costs.
Illness Representations/Medication Beliefs and Adherence:
The Illness Perception Questionnaire, (IPQ; Weinman, Petrie, Moss-Morris. & Home, 1996) 
taps into the five constructs outlined in Leventhal’s Self-Regulatory Model of Illness. It looks 
at the constructs of identity, (the symptoms the patient associates with the current illness), 
cause (personal beliefs about the cause of illness), consequences (beliefs about outcome and 
effects), timeline (duration of illness) and finally cure/control (beliefs about potential to 
control or to cure the illness in question). This has been used in conjunction with the BMQ to 
look at representations of illness and medication together, in trying to understand patterns of 
medication non-adherence (Horne & Weinman, 1994). Forty-seven hospitalised 
haemodialysis patients completed these measures and a self-report measure of adherence. 
Recording the frequency of inter-dialysis weight gain of more than two kilograms, over a 
three-month period prior to questionnaire administration assessed adherence to fluid/diet 
restrictions. From the BMQ, the specific category of ‘concerns’ was associated with lower 
adherence to medication. However concerns about prescribed medication did not relate to 
lower adherence to fluid and dietary restrictions. Similarly those who thought that 
fluid/dietary restrictions were too strict were less likely to adhere to them, but were no more 
likely to be less adherent to medication. Therefore patients can adhere or not to some aspects 
of the treatment and not others and these differences are associated with certain beliefs about 
their treatment. From this data, it was also shown that patients with strong illness identity and 
those who perceived their illness to have more severe consequences, were in fact less likely 
to adhere to medication. It might be that these patients had a lower level of ‘coherence’ in 
that they were receiving the message that medication will help, yet the concrete experience 
was that they still felt unwell even if they did adhere. In the diabetic and asthma groups 
tested, patients who perceived their condition to have more serious consequences, a more 
chronic time-line and more symptoms, were more likely to adhere to their medication regime. 
This may be because of more coherence between the taking the medication and perceived 
symptomatic benefit. This offers tentative support for the SRM. Overall medication 
representations correlated with adherence and beliefs about illness and beliefs about 
medicines seemed to be related in a logical way, even if this sometimes goes against medical
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opinion. This suggests the value of the SRM for explaining the behaviour of adherence and 
how this may be enhanced by the inclusion of beliefs about treatments.
Use of standardised questionnaires for assessing these beliefs has enabled researchers to 
quantify the prevalence of beliefs and show how these are related to non-adherence. It was 
particularly interesting that medication non-adherence was not determined by the beliefs that 
medicines are unnecessary and instead that there is a complex interplay between beliefs and 
indeed between medication beliefs and illness perceptions. The crucial aspect of the latter 
being with regards to ‘coherence’ between the abstract ideas and concrete experiences in 
determining adherence. These findings have implications for practice and future research, 
with emphasis on eliciting patient beliefs and addressing these on an individual basis.
As seen, research has attempted to try and understand the complex nature of human 
behaviour, one aspect being that of non-adherence to medication. The SCM’s initially 
highlighted the importance of attitudes, subjective norms and perceived control in explaining 
behaviour in general. Whilst alternate research on an active cost-benefit analysis, took into 
account illness representations and medication beliefs, making links specifically with 
medication adherence. However whilst interesting findings have emerged with regard 
explaining adherence behaviours, both these models have not attempted to try and change this 
behaviour. The next section will therefore focus on interventions that do aim to change 
adherence behaviour and the development and application of ‘Implementation Intentions’.
Interventions to Increase Adherence:
Haynes, McDonald, Garg, & Montague (2002), updated a systematic review summarising the 
results of randomised controlled trials of interventions, which aimed at helping patients take 
their medicines as directed. Computerised searches were made and relevant studies 
determined, based upon ability to report an unconfounded randomised controlled trial to 
increase adherence and measure both adherence and treatment outcome. The main findings 
highlighted those only one out of three interventions that had been reported in three of the 
trials, showed an effect on both of these measures. Of 36 interventions that had been reported 
from 30 of the trials, 18 showed an improvement in adherence only and only 16 showed 
improvements in treatment outcome. A range of disorders were evaluated including two acute 
disorders - acute asthma episodes (Levy, Robb, Allen, Doherty, Bland, & Winter, 2000) and 
Helicobacter Pylori Infection (Henry & Bately, 1999). The remaining twelve studies which
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were added to this review concerned chronic conditions such as hypertension (Girvin, 
McDermott, & Johnston, 1999) and Schizophrenia (Razali, Hasanah, Khan, & Subramaniam, 
2000). Interventions included changes in dosing schedule, such as a reduction from two daily 
doses to one (Girvin et al, 1999), patient education from specialists (Katon, Rutter, Ludman, 
Von Korff, Lin, Simon, Bush, Walker, & Unutzer, 2001), drug information leaflets (Henry 
& Bately, 1999) and psycho-educational programmes (Tuldra, Fumaz, Ferrer, Bayes, Amo, 
Balague, Bonjoch, Jou, Negredo, Paredes, Ruiz, Romeu, Sirera, Tural, Burger, & Clotet, 
2000). The findings were still weak and rigorous trials on adherence are still relatively 
lacking. Little evidence emerged that adherence to medication could be consistently 
improved, with the available resources in clinical settings. Many of the interventions were 
labour intensive and could be difficult to practically apply in everyday non-research settings. 
Most of the measures were self-report and somewhat imprecise. The inclusion criteria were 
quite stringent and therefore only represent certain research and findings. Only 11 of the 
studies to date had enough patients to deem the study powerful enough to detect clinically 
significant effects. None of the studies measured clinical endpoints, with regard mortality and 
morbidity and most of the time, follow-ups were relatively short-term, the longest being 24 
months. Implications emerged from this review regarding the need for simpler, more 
practical cost-effective interventions to improve medication adherence in a clinical setting. 
More information on treatment methods themselves is needed and a better understanding of 
adherence and non-adherence behaviour still required. Whilst some important notions have 
been and continue to be proposed to explain variance in adherence, how this then translates 
into a workable intervention to increase adherence is an often overlooked matter, with limited 
success to date. Joint working across the disciplines may be important, as there are no 
findings proposing adherence to medication to be regimen or disease specific. A potentially 
simple and effective method of improving adherence is discussed below.
Implementation Intentions:
A more recent advance in trying to understand the complexities of human behaviour and 
various actions in differing circumstances has emerged from Gollwitzer (1990). He argued 
that perhaps the enactment of goal intentions was in fact a two-stage process. The first stage 
he described as the ‘motivational’ stage and could be seen as encompassing the main 
components of Ajzen’s Theory of Planned Behaviour’. This stage concerns the costs and 
benefits of the said behaviour and culminates in the ‘intention’ (decision) to perform that 
behaviour. He then described what he saw as a ‘cognitive’ stage or ‘implemental’ stage,
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which concerned how the intention to behave in a certain way, was to be acted upon. At this 
second stage people form ‘implementation intentions’ which specify when and where one 
will perform the behaviour, in order to achieve the goal intention. In this way, 
implementation intentions commit a person to a course of action, when conditions in the 
environment are met and thus facilitate translation of a goal intention into action.
Evidence has begun to emerge on the effectiveness of making implementation intentions. 
Gilholm, Ettema, Selart, & Garling (1999) asked undergraduates to indicate from a list of 
activities, which ones they intended to carry out on the following day. In the experimental 
group, they were also asked to specify the place and time for this activity to be performed. 
Both the control group and experimental group selected approximately the same number of 
activities. Many of the activities were ones that may have been habitual which can be seen as 
a methodological flaw of this study (Ronis, Yates, & Kirscht, 1989). However more of the 
activities were subsequently performed by those in the experimental group and they had 
chosen to plan activities other than those they simply indicated they would perform. They 
were also more likely to carry them out than the control group. In a second study Gollwitzer 
& Brandstatter (1997) asked students to write a report on how they spent their Christmas and 
return it in a specified period. Participants in the experimental group were also asked to 
indicate where and when they would do this piece of work. In the control group, only 
intention to write the essay was indicated. As predicted more students in the experimental 
group completed the piece of work (71 percent compared to 32 percent). These reports were 
also mainly written at the time that had been indicated by their implementation intention. 
This highlighted a strong link between intended behaviour and specified situational context. 
It is thought that these links promote the completion of the goal, as the behaviour gets 
triggered when the specified context is subsequently encountered. Planning was not shown to 
increase the strength of the intention, but only whether the intention was subsequently 
implemented. Therefore planning appears to effect intention-behaviour consistency. Knowing 
if someone has planned how and when to complete an activity improves the possibility o f 
predicting its performance, than having information about intention alone. However, there* are 
limitations to these studies, in that a student population had been used on both occasions, who 
might not be seen as representative of other groups. The research was also only concerned 
with single activities that were relatively easy to incorporate into every day activity. The 
same propositions may not so easily be applied to more complex behaviours.
Page 166
Other studies have taken these ideas further and investigated more intricate behaviours with 
different populations. One such study by Mitchie, Dormandy, & Marteau (In Press), looked at 
a sample of 88 women intending to go for pre-natal screening and the impact of making plans 
on the implementation of this intention. In the intervention group, i.e. those who made action 
plans as to when and where they would attend for screening, 84 percent subsequently 
attended. This was compared to just 47 percent in the control group, where no such plan was 
devised. There were no differences in the intention to go for screening, just the 
implementation. When differences between the two groups, such as ethnicity and socio­
economic status were controlled for, the differences remained. However only 63 percent of 
the intervention group completed the action plan and it could be hypothesised that those who 
completed a plan represented those already more likely to attend for screening. The sample 
size was also small and the study powered at a medium effect size. Yet unlike other studies, 
the behaviour in question was not one that was that easy to incorporate into daily activity and 
not likely to have become routine. This research also used a clinical as opposed to student 
population.
In another study by Sheeran & Orbell (2000), women registered at the same medical practice 
were asked to complete measures on the main constructs outlined in the theory of planned 
behaviour. These included attitudes, subjective norms and perceived behavioural control. 
Additionally half of the participants were instructed how to form implementation intentions, 
specifying when, where and how they would make their appointment for cervical screening 
for cancer. Whilst the variables from the theory of planned behaviour, did act as good 
predictors of attendance for cervical screening, participants who formed the implementation 
intentions were much more likely to attend (92 percent compared with 69 percent). 
Interestingly, forming implementation intentions also impacted upon habit and past 
behaviour. The correlation between previous delay in going for screening and subsequent 
attendance was significantly lower for those participants who had formed implementation 
intentions, compared to those who had not. Orbell, Hodgkins & Sheeran, (1997) attempted to 
explain these findings; by proposing that the cognitive underpinnings of habit and 
implementation intentions are similar. They proposed that implementation intentions involve 
cognitive rehearsal of the link between the behaviour in question and the context of its 
proposed enactment. This cognitive rehearsal is thought to be the process, which defines a 
habit. In both, there is an association made between environmental cues and an action 
schema. As the participant is asked to specify what will be performed and when, previous
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tendencies will be suppressed and the new behaviour activated instead. However, there are 
criticisms of this research, in that the non-respondents had a previously recorded longer delay 
in attendance than the respondents. Thus those who attended may have over-represented 
those who attended their appointments regularly anyway. Differences in previous delay could 
also have reflected differences in perceptions of self-consciousness (Fenigstein, Scheier, & 
Buss, 1975), social anxiety (Schlenker & Leary, 1982), or even fear of negative evaluation 
(Leary, 1983), which were not taken into account and may be salient especially for this type 
of invasive medical examination. Further research is needed to investigate these explanations 
further and examine whether implementation intentions could be effective in enhancing other 
health behaviours, such as eating a healthy diet, or adhering to medication. Although further 
research is needed, these findings suggest that these interventions are a potentially powerful 
means of changing behaviour, or at least encouraging people who wish to perform the 
behaviour to enact this intention. It is also cost-effective and easy to implement.
The theory of reasoned action and the theory of planned behaviour have explained a moderate 
proportion of variance in human behaviour. Illness perceptions and beliefs about medicines 
have also explained a proportion of variance with regard the specific behaviours involved in 
adherence to medication. However, little evidence has emerged regarding how these 
constructs can be applied to change behaviour and with the latter example, to increase 
medication adherence. Perhaps the emphasis should shift away from the beliefs, constructs 
and person’s intentions, and as with Gollwitzer’s Implementation Intentions, shift the focus 
into the environment. This way, the person is committed to a course of action, when 
conditions in the environment are met and this facilitates the translation of the goal intention 
into an action. No research to date appears to have looked at using implementation intentions 
to increase medication adherence, whilst also looking at psychological constructs such as 
illness perceptions and beliefs about ones specific medicines and medication in general.
High Cholesterol Conditions:
Cholesterol is a chemical that is made in the liver, from the fatty foods that have been eaten. 
Whilst some cholesterol is needed to keep healthy, high cholesterol levels can put a person at 
increased risk of developing atheroma. Atheroma are plaques of fatty deposits which develop 
in the inside lining of arteries, making the artery narrower and subsequently reducing blood 
flow. This can then lead to stroke, heart disease, transient ischaemic attacks and peripheral 
vascular disease (narrowing of the arteries to the legs). Therefore lowering cholesterol levels
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can help reduce the risk of these health problems. Lowering cholesterol can be achieved by 
taking prescribed medicines and eating a diet that is low in saturated fat. For many people 
with high cholesterol, taking medicines is the best way of achieving a lower cholesterol level. 
Current cholesterol-lowering therapies, especially the range of ‘statins’ have been shown to 
be effective in reducing morbidity and mortality (Shepherd, Cobbe, Ford, Isles, Lorimer, 
MacFarlane, McKillop & Packard, 1995). Statin drugs are generally well tolerated by patients 
and reported side effects are mild and transient (Knopp, 1999). Adherence has been found to 
be higher for statins than for cholestyramine (Erikson, Hadell, Walldius & Kjellstrom, 1998). 
Possibly this is due to the fewer side effects, less doses and having been shown to be more 
effective than other medicines in lowering cholesterol. However, Insull (1997) in review of 
the literature, reported that still up to 50 percent of patients receiving cholesterol lowering 
medicines will not take their medication as explicitly directed, either in terms of 
recommended dose or time to be taken.
Very few studies have attempted to investigate the association between adherence and high 
cholesterol conditions. One study by Kiortis et al (2000) found that in 193 hyperlipidaemic 
patients, higher self-reported adherence was associated with having a routine way of taking 
medication, fewer reported side-effects, smoking less, being older and perceiving their 
treatment as more effective. Perceiving a role for cholesterol in causing cardiovascular 
disease, mood, stress and perceived risk of oneself for developing cardiovascular disease 
were found not to be related to self-reported adherence in this study.
In attempting to understand this health behaviour, Brewer, Gretchen, Chapman, Brownlee 
and Leventhal (2002) conducted a study on 169 patients with hypercholetserolaemia 
(chronically elevated blood cholesterol levels). These patients are at high risk of coronary 
heart disease and coronary related disability and death. Therefore non-adherence to 
medication is an extremely important behaviour to be understood and targeted in this 
population. Meyer, Leventhal & Gutman (1985) had investigated a specific kind of model 
with patients with hypertension, stemming from the self-regulatory model of illness, and 
found that some patients saw it as a chronic asymptomatic condition that required long-term 
treatment with medication, exercise and diet. Others had a lay-model of the condition, which 
depicted the disease as acute, with identifiable symptoms and caused by stress and relieved 
by behaviours such as meditation. Those possessing the lay model were more likely to miss 
medication and had poorer blood pressure control. Brewer et al (2002), attempted then to
apply this model to hypercholesterolaemia as a similarly chronic, symptomless disease with 
severe consequences, such as stroke and heart attacks and requiring regular health 
behaviours, such as taking medication, diet and exercise. They proposed that as with the 
study by Meyer et al, the expert based mental model might also be related to adherence 
among this population. Ten survey questions based on the five components of the SRM, were 
used and patient adherence measured by asking patients whether they were adhering to their 
medicines and examining blood tests to see whether they were adhering to their LDL 
cholesterol treatment goals (low-density lipoprotein - most important component of blood 
cholesterol to be lowered). As predicted it was found that those who possessed the expert 
model of illness showed improved control and improved adherence. Of the five attributes of 
patient’s illness as proposed by the SRM, three proved important predictors of cholesterol 
levels and medication adherence. These were symptoms, consequences and timeline. 
Therefore those who believed the consequences were that of heart attack and stroke had 
better report adherence and LDL control. Those who believed that the condition produced 
physical symptoms showed poorer LDL control. Similarly those who believed the timeline of 
their condition was stable again were more likely to meet their LDL targets. Cause and cure 
did not show any relation to adherence or LDL cholesterol control. This study highlights 
some important ideas concerning understanding people’s perceptions in relation to adherence 
with this kind of condition. However interventions to increase cholesterol-lowering 
adherence as outlined previously have shown very low rates of success. This study suggests 
that educating patients about the consequences, asymptomatic and stable nature of their 
condition may be effective in promoting the desired behaviours. However, this study was 
cross-sectional, with the sample comprising predominantly white, well educated males, with 
a mean age of 67 and therefore caution must be applied in generalisation of findings.
A study by Senior, Marteau, & Weinman (In Press) looked at self-reported adherence to 
cholesterol lowering medication. Illness perceptions, mood and demographics in 333 patients 
with familial hypercholesterolaemia were investigated. Overall, 63 percent of participants 
reported some level of non-adherence. Whilst measures were self-report, biochemical 
evidence showed those reporting total adherence had lower total cholesterol levels than those 
reporting partial adherence. Total adherence was found to be more likely with the older 
patients, those with a history of cardio-vascular disease and those with a lower total 
cholesterol level. Partial adherence was generally reported to be due to occasional forgetting 
than intentional deviation from the recommended regimen. Lower perceived risk of raised
cholesterol in the future, having greater control over the condition and perceiving cholesterol 
and genes to be important determinants of having a heart attack were subsequently associated 
with increased adherence. There were no differences between genders and neither anxiety nor 
depression was associated with adherence to medication. There were limitations to this study 
in that whilst the sample size was good, the population comprised regular attendees from a 
lipid clinic and all had already agreed to take part in a trial of genetic testing. Thus they were 
a highly motivated and complaint group, which may not be representative of other samples. 
The authors suggest that as only small associations were found between behaviour and illness 
perceptions, in a group like this, where non-adherence would largely be non-intentional, 
perhaps interventions that help establish routines would be more beneficial than those aimed 
at challenging beliefs. Thus implementation intentions were recommended by the authors as 
ways of potentially effecting change and encouraging adherence to cholesterol lowering 
medication.
The present research aims to introduce implementation intentions to those patients currently 
non-adherent to some degree with their cholesterol lowering medication regimes. The aim is 
to investigate whether this specific intervention can change human behaviour within this 
complex domain. Illness perceptions and beliefs about medicines are also examined, as these 
have previously explained some variance in adherence behaviours and it will be interesting to 
see whether Brewer et al’s notions of the expert mental model and adherence are supported 
with this sample. This may also help identify whether there are certain patients, or certain 
beliefs that are held which make it more or less likely to be adherent and in turn, who are 
more or less amenable to behavioural interventions such as implementation intentions.
Aims and Hypotheses:
The aims of this study are to investigate whether there were any differences in patient details, 
illness perceptions, mood and medication beliefs in those who were initially fully adherent 
and those who were not.
There will also be an exploration into differences in patient characteristics between those that 
did and did not receive the intervention, within the non-adherent group who received the 
follow-up questionnaire. This will help identify any other factors, which could potentially be 
affecting change in adherence.
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The main hypothesis, which will be investigated, is whether:
'Forming Implementation Intentions increases self-reported adherence to cholesterol 
lowering medication, in patients currently attending a lipid clinic and reporting some level o f 
non-adherence over the past month ’
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Method
Participants:
These comprised 64 adults currently taking some form of cholesterol lowering medication, 
and attending lipid clinics in one of two hospitals in the Southeast o f England. Participants 
were excluded if they did not have an adequate level of English to be able to complete the 
questionnaires fully, or if they were currently pregnant, as this effects use of medication. 
They were also excluded if they were new to the clinic and were currently not prescribed any 
cholesterol lowering medication. Of the 64 participants, 42 were at some level non-adherent 
and were given the second questionnaire and 41 of these were returned.
In advance of the study, number of participants required had been predicted. This was 
calculated using the G-power programme, (Faul & Erdfelder, 1992), see appendix 1. Effect 
size was calculated, using a power of 0.8 and an effect size of 0.5, for an analysis using T- 
tests. A predicted sample of 102 was required for this research. More data than this needed to 
be collected, as the main hypothesis was concerned only with those who were at some level 
non-adherent and could receive the implementation intention. Similarly, there would also be 
expected to be some people who would not respond to the questionnaire at all. In total 213 
questionnaires were given out.
Design:
This was a prospective experimental study, with the experimental and control group 
determined by sequential allocation, with alternate patients receiving the intervention and the 
other patients comprising the control group. Only those classed as partially or non-adherent 
were used to test the main hypothesis, concerning the impact of an implementation intention 
on adherence.
The Intervention
Participants in the intervention group had the following statements inserted in their 
questionnaires.
'You are more likely to carry out your intentions to take your cholesterol lowering 
medication every day for the next four weeks, i f  you make a decision about when and where 
you will do so. Decide now, when and where you will take your medication over the next four
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weeks. You may find  it useful to take a tablet just before or just after something else that you 
do on a regular basis, such as brushing your teeth. ’
‘Please write in the space below, when and where you will take your medication, every day 
for the next four weeks. E.g. In my bedroom at 7.30pm after my evening meal. ’
Measures:
Patient Details:
These were gathered by asking some general questions. Gender, age and ethnicity were 
requested, as was information concerning details of the cholesterol condition for which the 
current medication was being taken. Information surrounding past and present cholesterol 
lowering medication and other conditions and related medicines was also sought, through the 
use of open-ended questions. Length and frequency of attendance at the lipid clinic was 
determined by asking ‘please give the length o f time you have been attending this lipid clinic 
and how often you have appointments? ’
Illness Perceptions:
These were assessed using questions from the Revised Illness Perceptions Questionnaire 
{Appendix 2), which has been shown to have internal consistency, test-re-test reliability and 
concurrent, discriminant and predictive validity all to be within acceptable limits (IPQ-R, 
Moss Morris, Weinman & Petrie, 2002). All items on the IPQ-R were rated on five point 
Likert Scales, (strongly disagree =1, disagree = 2, neither agree not disagree = 3, agree = 4, 
strongly agree 5). The wording was altered to be specific to patients in this study, with 
‘illness’ and ‘medication’ changed to ‘high cholesterol condition’ and ‘cholesterol lowering 
medication’.
Timeline of illness was assessed using questions 1-5 from the IPQ-R.
Consequence of illness was assessed by asking patients to rate how much they believed the 
statement ‘My illness is a serious condition ’ (item 6 from IPQ-R)
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Personal control, treatm ent control, illness coherence, timeline cyclical and emotional 
representations were assessed using the corresponding items from the IPQ-R, which were 
items, 17-25,26-31, 32-36, 37-42 and 43-50 respectively.
Possible causes of the patient’s high cholesterol condition was assessed using the 18 items 
from the IPQ-R. Heredity was assessed again with a further item and commonly used term, 
‘genes Again these items were assessed using the same five point Likert Scale.
Perceptions of Risk:
This was assessed with a simple item:
‘How likely do you think you are to have a raised cholesterol level over the next ten years? ’ 
This was rated on a seven point Likert scale, ranging from [0] = ‘not at all likely, to [6] = 
‘extremely likely’. This is the same as that used in the study by Senior et al (In Press).
Emotional State:
Anxiety and Depression were assessed using 14 items from the Hospital Anxiety and 
Depression Scale, see Appendix 3 (HADS; Zigmond & Snaith, 1983). This is a widely used 
scale with good validity and internal consistency (alpha = 0.93 for anxiety and 0.90 for 
depression; Moorey, Watson, Gorman, Rowden, Tunmore, Robertson & Bliss, 1991). The 
items were rated from 0-3, the larger the number corresponding to greater severity of 
symptoms.
Medication Beliefs:
These were assessed using the two scales of the Beliefs about Medicines Questionnaire, see 
Appendix 4 (BMQ; Horne, Weinman & Hankins, 1999). They report the two scales to have 
good test-retest reliability and good criterion related and discriminant validity. Both scales 
were also reported to have satisfactory internal consistency.
The first scale assesses views about medicines specifically prescribed for the patient, which 
has 11 items (the final item being a new addition to the scale). Five of these relate to the 
necessity of taking such medication (Specific-Necessity) and five to concerns about the 
danger and long-term toxicity and dependence (Specific-Concerns). The second scale is 
concerned with views on medicines in general and comprises eight items. Four of these 
assess beliefs that medicines are addictive, harmful poisons (General-Harm) and the 
remaining four are with regard people’s beliefs about doctors over-prescribing (General-
Overuse). Each item is rated on a Likert scale from five to one (5 = strongly agree, 4 = agree, 
3 =  uncertain, 2 = disagree and 1 = strongly disagree).
Adherence:
Self-reported adherence to medication was assessed using the five-item Medication 
Adherence Report Scale, see Appendix 5 (MARS-5; Home & Weinman, 1999). This has been 
found to have good test-retest reliability, r = 0.7 and good internal reliability, alpha > 0.7 in 
all but one sample. Validity was also good when compared with other measures of adherence. 
Convergent validity was also strong and the beliefs about medicines questionnaire (BMQ; 
Horne, Weinman & Hankins, 1999) strongly correlated in the majority of samples (Horne & 
Weinman, 1999). Deviation from the prescribed medication regimen was assessed over the 
past month using five response choices (always, sometimes, occasionally, rarely and never). 
This was the same scale used to assess adherence as that by Senior et al (In Press) in their 
study patients with familial hypercholesterolaemia.
The questions were compiled into one booklet for easier completion (Appendix 6).
Procedure:
Ethical committee permission to conduct this study was sought after and subsequently 
obtained from the St Thomas’ Hospital Research Ethics Committee (Appendix 7) and 
University of Surrey Advisory Committee on Ethics (Appendix 8).
Patients attending the two lipid clinics in the study were approached and asked to participate 
in some research, primarily looking at views about their high cholesterol condition and their 
medicines that they had been subsequently prescribed. If appropriate, patients were asked as 
to their ability to read and write English. If  possible, new patients, those currently not on 
medication and pregnant patients were identified as they entered the clinic and not 
approached to take part. If patients verbally agreed to take part, they were handed a pack 
containing an information sheet (Appendix 9), a consent form (Appendix 10), a questionnaire 
booklet (Appendix 6) and a Freepost envelope for questionnaire return. Alternate booklets 
contained the intervention, which described and encouraged the making of an implementation 
intention. The investigator remained at the clinic as much as possible so as to answer any 
queries that might arise. On two occasions the receptionist at one clinic handed out the 
questionnaires and the level of information given to patients might have varied. At the other
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clinic, the two Consultant Chemical Pathologists involved with the research gave out the 
questionnaires themselves each week. Due to administration difficulties and time constraints, 
it was not feasible to send out a follow-up questionnaire to remind people to send back their 
initial questionnaire. Responses were eyeballed and where some level of non-adherence had 
been indicated (on the MARS-5), a covering letter (Appendix 11) and a further questionnaire 
(Appendix 12) were sent a month later. This four week period after receiving the intervention 
(or not) could then be analysed. This enabled comparisons for whether adherence had 
changed in the non-adherent group over the month, dependent on whether they were in the 
intervention or control group and thus had subsequently completed the implementation 
intention. After data collection was complete, information sheets explaining the importance 
of medication adherence and the potential benefit of using implementation intentions were 
placed in the clinics (see Appendix 13).
Data Analysis:
Data was entered into an SPSS file. Three participant’s data initially had to be removed 
before analysis could begin, as they were not currently taking cholesterol-lowering 
medication. The data of the remaining 64 individuals was analysed using SPSS 10 for 
windows software and statistics package (SPSS Inc., 2000). Internal consistency of all sub­
scales was assessed using Cronbach’s alpha statistic. This also enabled one to see whether if 
there was any item that was not a reliable indicator for the construct in question and could be 
removed in which to increase reliability. Results of reliability analysis are displayed below. 
All calculations are displayed to two decimal places throughout.
Reliability Analysis:
Illness Perceptions Questionnaire:
For the IPQ, certain items from each sub-scale had to be re-coded so all items were reflected 
the same direction of the scale. For five out of the seven sub-scales: Timeline; Consequences; 
Personal Control; Coherence and Emotional all had very good reliability above .8 (ranging 
from .85 to .93). For the sub-scale of treatment control, when item 26 was removed, 
reliability increased from .65 to .72. Similarly for the sub-scale of timeline cyclical, when 
item 42 was removed, reliability improved to a very good level at .83, from .66. Thus with 
the removal of two items, the IPQ showed itself to be a very reliable scale with this sample.
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Hospital Anxiety and Depression Scale
For both the anxiety and depression constructs which comprise the HADS, there was very 
good reliability; .85 and .78 respectively.
Beliefs About Medicines Questionnaire:
Specific Medicines: Concerns .76 Necessity .70
Medicines in general: Overuse .75 Harm .69
As can be seem above, al aspects of the beliefs about medicines questionnaire had good 
reliability, with only the construct of harm being slightly less reliable than the other scales.
Medication Adherence Scale:
This scale had excellent reliability of .87.
Normal Distribution:
All scales were assessed for normality, using the Kolmogorov-Smimov statistic. In this study 
all aspects of the IPQ-R, except ‘IPQ timeline cyclical’, and all aspects of the BMQ except 
‘general overuse’ alongside HADS depression total and MARS total at time 1, were found to 
violate the assumptions of normality and therefore non-parametric tests were used to analyse 
this data. For IPQ timeline cyclical, HADS anxiety total and BMQ general overuse, as found 
to be normally distributed, parametric tests could be used on these scales.
Analysis:
The data is initially looked at with regards general descriptions of the sample. This is then 
extended to look at the sample as a whole, looking at views about raised cholesterol, 
perceived causes of raised cholesterol and beliefs about medicines. The mood of the sample 
is also described. This is done by calculating correlation coefficients.
Following on from this, comparisons are then made between those who were initially at some 
level non-adherent to those fully adherent. General characteristics and behaviours, alongside 
the main scales of medication beliefs, illness perceptions, mood and perceived causation are 
also investigated. This is done using T-tests and Mann Whitney Tests, as the Independent 
variable is categorical (adherent vs. non-adherent).
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The analysis then progresses to the less than fully adherent group who received and 
subsequently returned a follow-up questionnaire. Differences and similarities between those 
who received and did not receive the intervention are examined. The main hypothesis is then 
tested.
RESULTS:
In total, 213 questionnaires were handed out at Guys and St Thomas’ Hospital Lipid clinics. 
O f these, 107 contained an implementation intention and 106 did not.
O f the questionnaires given out, 67 (31.5 %) were returned. Three people’s data had to be 
excluded from the study, as they were not currently taking cholesterol-lowering medication. 
O f the remaining 64 people who formed the basis of all analysis 42 (65.5%) indicated some 
level of non-adherence to their cholesterol lowering medication and received a follow-up 
questionnaire. Of these, 41 (97.6%) were returned. It was not possible to compare those who 
did not return their questionnaires at either time.
INITIAL DSCRIPTION OF GENERAL SAMPLE:
Table 1: Frequency with Regard Gender
Gender Frequency Percent (%)
Male 30 46.9
Female 34 53.1
Total 64 100
There was almost an even split between males and females completing and returning the 
initial questionnaire.
Frequency with Regard Age
The mean age of participants in this study was 57.73, standard deviation of 10.72. The 
youngest participant was 34 and the oldest was 82 years old.
Table 2: Frequency with Regard Ethnicity
Ethnicity Frequency Percent (%)
Caucasian 57 89.1
Afro-Caribbean 02 3.1
Asian 04 6.3
Mixed Race 01 1.6
Total 64 100.0
The majority of people who participated in this research by completing the questionnaire 
were Caucasian, with very few other ethnic backgrounds represented.
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Table 3:Frequencies with regard Statin Use
On Statin, or not on Statin? Frequency Percent (%)
O ther cholesterol lowering medication. 03 4.7
On Statin 55 85.9
Don’t know 6 9.4
Total 64 100.0
As can be seen from table 3, more than 85 percent of the people who completed the 
questionnaires were currently on Statins to reduce their cholesterol. The don’t know category, 
was for those who could not currently remember the name of their cholesterol lowering 
medication.
Table 4: Frequency with Regard Use of Other Medication, Other than Cholesterol
Lowering Medication
O ther Medication? Frequency Percent (% )
No 12 18.8
Yes 39 60.9
Don’t Know 13 20.3
Total 64 100.0
More than 60 percent of participants were also taking other forms of medication for other 
conditions aside from high cholesterol.
Table 5: Frequency with regard Time Been a Patient of the Lipid Clinics
Time in Clinic Frequency Percent (%)
<1 year 02 3.1
1-5 years 22 34.4
5-10 years 14 21.9
>10 years 21 32.8
Don’t know 5 7.8
Total 64 100.0
Most people attending these clinics had been doing so for between one and five years, or for 
more than 10. This variable had to be grouped in categories as displayed above, due to 
differences in methods of reporting time in the clinics. Some participants gave exact 
months/years in the clinic, while others were less specific, giving rough periods of time. Thus 
categories were comprised and no means can therefore be calculated for this variable. There 
were further difficulties in analysing the frequency of visits to the clinics, as this often 
changed over the course of time. Patients beginning treatment could be seen every few 
months, but as their condition stabilised, this could then change to six monthly or yearly
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appointments. Thus calculations on frequency of appointments could not be accurately 
analysed.
Illness Perceptions:
The table below shows the means and standard deviations of the seven sub-scales of the IPQ, 
each mean has been calculated and divided by the number of items in that scale. This way 
each sub-scale can be interpreted on a scale from one to five.
Table 6: Means and Standard Deviations of IPQ Sub-scales:
IPQ Sub-Scale N Mean Standard Deviation
Timeline 61 (3 missing data) 4.00 0.90
Consequences 61 (3 missing data) 3.95 0.92
Personal Control 60 (4 missing data) 2.21 0.71
Treatm ent Control 61 (3 missing data) 2.62 0.67
Illness Coherence 61 (3 missing data) 2.19 0.81
Timeline Cyclical 56 (8 missing data) 4.28 0.70
Emotional Representations 60 (4 missing data) 2.53 0.89
High scores for IPQ ‘timeline' represented people who believed the condition to be more 
chronic and permanent. Thus with a mean of four, in general, most people perceived their 
condition in this way.
IPQ ‘consequences’ was a sole item which was ‘My high cholesterol is a serious condition’ 
With a score of one being least serious perceptions and five being the most serious, with a 
mean of just under four, people were on average perceiving their condition to be rather 
serious.
The sub-scale of personal control, reflected people’s perceptions of their control over the 
condition. High scores represented lower perceptions of control over their illness and low 
scores indicated people’s perceptions of greater control. With a mean of just over two, people 
were edging towards perceiving themselves as having somewhat good control over their 
condition.
The sub-scale of ‘treatment control’ looked at how much people perceived their medication 
to be effective in controlling their condition. Low scores represented high control with 
medication and high scores indicating perceptions that medication can not control symptoms
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well. A mean of 2.62 showed people on average perceived medication to be quite useful in 
controlling symptoms of their high cholesterol condition.
High scores on the sub-scale of ‘illness coherence’ indicated low levels of understanding and 
low scores indicated high levels of understanding. From table 6 it can be seen that on 
average, people reported themselves as having quite good perceived levels of understanding 
about their condition.
High scores on the sub-scale of ‘timeline cyclical’ indicated perceptions of a more fixed 
condition and lower scores were indicative of more changeable times. With a mean over four, 
this shows people generally perceived the symptoms of their condition to be very fixed.
This final sub-scale of the IPQ highlighted emotional reactions to the condition. High scores 
represented higher perceived levels of distress. With a mean of 2.53, people reported 
moderate levels of distress.
Perceived Causes of High Cholesterol Condition:
There were 19 proposed causes of a person’s high cholesterol condition. Each one was rated 
on a five point Likert scale with five being highly agreeing with that perceived cause and one 
highly disagreeing. The means for each item are listed in table 7.
Table 7: Mean & Standard Deviations for Perceived Causes of High Cholesterol
Causes: Mean Sd N
My Genes 4.17 1.75 59
Heredity 3.95 1.12 61
Diet or Eating Habits 3.62 0.90 60
My own Behaviour 2.97 1.13 59
Stress and Worry 2.83 1.13 54
Ageing 2.63 1.09 60
Alcohol 2.63 1.10 59
Smoking 2.63 1.29 59
Altered Immunity 2.45 0.83 56
Chance or Bad Luck 2.37 1.07 60
Overwork 2.36 1.01 59
My Emotional State 2.34 0.95 58
Family Problems or Worries 2.24 0.95 59
My Personality 2.22 0.88 60
Poor Medical Care in Past 2.12 0.76 60
My Mental Attitude 2.10 0.96 59
Pollution in Environment 1.93 0.73 60
Accident or Injury 1.83 0.67 60
A Germ or Virus 1.80 0.71 59
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Heredity, diet and genes were the three most highly rated causes of high cholesterol, and a 
germ or virus, accident/injury and pollution in the environment were the three items rated 
lowest overall for causing the participant’s conditions.
Mood:
Table 8 below shows that on average people had low levels of both anxiety and depression, 
but on average, score lower for depression. A score of seven, indicates approaching clinical 
anxiety and thus on average people were approaching having clinical levels of anxiety.
Table 8: Anxiety and Depression Totals
Mean Standard Deviation N
HADS Anxiety Total 7.11 4.20 62
HADS Depression Total 4.51 3.34 63
This is highlighted again when levels of anxiety and depression are looked at more 
specifically.
Table 9: Anxiety Level
Anxiety Level Frequency Percent
Not anxious 32 50
Mild Anxiety 19 29.7
M oderate Anxiety 8 12.5
Severe Anxiety 3 4.7
Missing 2 3.1
Total 64 100
Table 10: Depression Level
Depression Level Frequency Percent
Not Depressed 50 78.1
Mild Depression 9 14.1
M oderate Depression oO 4.7
Severe Depression 1 1.6
Missing 1 1.6
Total 64 100
These highlight again, that the majority of people were neither anxious nor depressed. 
However nearly a third of participants had mild levels of anxiety, whilst only 14 percent had 
mild depression. Very few had moderate levels of depression, yet more than 12 percent had 
moderate anxiety. Few had severe levels of anxiety or depression.
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Beliefs About Medicines:
The table below shows the means and standard deviations of the four sub-scales of the BMQ, 
each mean has been calculated and divided by the number of items in that scale. This way 
each sub-scale can be interpreted on a scale from one to five.
Table 11: Means and Standard Deviations of IPQ Sub-scales:
IPQ  Sub-Scale N Mean Standard Deviation
BMQ-specific Concerns 64 2.64 0.71
BMQ-specific Necessity 64 3.69 0.62
BMQ-general Overuse 62 (2 missing data) 2.22 0.71
BMQ-general Harm 63 (1 missing data) 1.79 0.64
A middle score of 2.64 indicates that on the sub-scale of ‘concerns’ people had on average 
neither too high or too low concerns about their cholesterol lowering medicines.
With the sub-scale of ‘necessity’, this time a higher mean highlights that people in average 
had believe more strongly about the necessity of taking their cholesterol lowering medicines.
Relatively low means for the sub-scales of ‘overuse’ and especially ‘harm’ with regards 
taking medication in general, highlighted that people on average did not tend to believe that 
Doctors over-prescribed and that medications were harmful.
CORRELATIONS IN THE GENERAL SAMPLE:
Correlations are concerned with describing the direction and strength of relationships 
between variables. This is expressed as a correlation coefficient, ranging from -1 (perfect 
negative relationship, through zero (no relationship), through to +1 (perfect positive 
relationship). Spearman’s Correlations are used when investigating variables where there 
was a violation of the assumption of normality. Pearson’s Correlations were used when 
variables were found to be normally distributed as outlined previously.
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Correlations Within The IPO:
Table 12: Correlation Between IPQ Sub-scales
b c d e F g 1
Timeline .438** .196 .261* -.151 .369** .022
(a) N=60 N=59 N-60 N=60 N=55 N=59
Consequen .041 .170 -0.54 -.050 .391**
ces (b) N=59 N=60 N=60 N=55 59
Personal .041 .624** -.092 .212 .031
Control ( c) N=59 N=60 N=59 N=55 N=59
Treatm ent .170 .624** .087 -.007 .170
Control (d) N=60 N=60 N=60 N=56 N=60
Coherence -.054 -.92 .087 -0.230 .299**
(e) N=60 N=59 N=60 N=56 N=60
Timeline -.050 .212 -.007 -.230 -.252
Cyclical (f) N=55 N=55 N=56 N=56 N=56
Emotional .391** .031 .170 .299** -.252
Representa 
tions (g)
N=59 N=59 N=60 N=60 N=56
** = significant at the 0.01 level 
* = significant at the 0.05 level.
Timeline was correlated with consequences, treatment control and timeline cyclical. This was 
a positive direction and thus the more serious the condition was perceived to be, the less 
treatment control was perceived and the more fixed the condition was thought to be.
Consequences and emotional representation were positively correlated suggesting that the 
more serious the condition was perceived to be the higher the affective distress. The more 
people perceived their medicines to be able to control their condition, the less serious 
consequences they perceived the condition to have.
Personal control and treatment control also had a significant positive correlation indicating 
that the more personal control one perceived themselves to have, the more they also 
perceived the medication to be able to control their condition.
Coherence was positively correlated with emotional representations, which indicated that the 
more the condition made sense to a person the less distressed they were.
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Correlations Between Illness Perceptions and Mood.
Table 13: Correlations Between IPQ Sub-scales and HADS Anxiety and Depression 
Totals.
Total Anxiety Total Depression
Timeline -.121 -.124
N=60 N=61
Consequences .149 .268*
N=60 N=61
Personal Control -.051 .019
N=59 N=60
Treatm ent .105 .136
Control N=60 N=61
Coherence .046 .028
N=60 N=61
Timeline Cyclical -.335* -.297*
N=55 N=56
Emotional Representations .397** .428**
N=59 N=60
** = significant at the 0.01 level 
* = significant at the 0.05 level.
IPQ consequences and HADS depression total were positively correlated. This highlights that 
worse perceived consequences were associated with higher depression scores.
IPQ ‘emotional representation’ was positively correlated with both anxiety and depression 
totals from the HADS. The higher the perceived distress, the higher the anxiety and 
depression levels.
IPQ ‘timeline cyclical’ was negatively correlated with anxiety and depression totals, so that 
the more the condition is perceived to be fixed and unchangeable the less the distress.
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Correlations Between Illness Perceptions and Beliefs About Medicines;
Table 14: Correlation Between IPQ Sub-scales and the BMQ.
IPQ:
BMQ:
Concerns
BMQ:
Necessity
BMQ:
Overuse
BMQ:
Harm
Timeline -.081 .189 -.170 -.230
N=61 N=61 N=59 N=60
Consequences .153 .202 -.072 -.009
N=61 N=61 N=59 N=61
Personal Control -.074 -.025 -.177 .024
N= 60 N=60 N=58 N=59
Treatm ent -.038 -.206 .076 .133
Control N=61 N=61 N=59 N=60
Coherence .490** -.183 .314* .420**
N=61 N=61 N=59 N=60
Timeline Cyclical -.139 -.017 -.171 -.186
N=56 N=56 N=55 N=55
Emotional Representations .443** .141 .277* .387**
N=60 N=60 N=58 N=59 .
** = significant at the 0.01 level 
* = significant at the 0.05 level.
As detailed in table 14 above, higher scores for coherence were positively correlated with 
higher scores for concerns about cholesterol lowering medicines. This means that less 
perceived understanding about the condition was associated with higher concern about 
cholesterol lowering medicines. Similarly less perceived understanding was also correlated 
with greater beliefs about harm from medicines in general and overuse of medication by 
Doctors.
There were significant correlations between emotional representations and ‘concerns’, 
overuse and harm categories from the BMQ. Thus higher perceived distress was associated 
with higher concern over the harmful effects of cholesterol lowering medication and greater 
beliefs about medication overuse by Doctors in general, and also about the harm of medicines 
in general.
Interestingly, the beliefs that cholesterol-lowering medicines are necessary were not 
associated with any of the beliefs about the condition.
Correlations Between Anxiety and Depression
Anxiety total and depression total were positively correlated r(62)=.639, p=<0.01, 2-tailed 
test. Therefore higher anxiety was correlated with higher depression scores.
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Correlations Between Mood and Beliefs About Medicines:
As can be seen in table 15 below, anxiety total was correlated with the BMQ-specific variable 
o f ‘concern’ thus higher anxiety was associated with higher level of concern about 
cholesterol lowering medicines. A higher anxiety total was also correlated with higher beliefs 
about harm of medicines in general. Also as displayed in the table below, higher levels of 
depression were correlated with higher concerns about cholesterol lowering medicines and 
higher beliefs about its necessity.
Table 15: Correlations Between Mood and the BMQ
IPQ:
BMQ:
Concerns
BMQ:
Necessity
BMQ:
Overuse
BMQ:
Harm
Anxiety Total 393** .185 .227 .291*
N=62 N=62 N=60 N=61
Depression Total .290** .261* .180 .182
N=63 N=63 N=61 N=62
** = significant at the 0.01 level 
* = significant at the 0.05 level.
Correlations Between the BMP Domains:
Table 16: Correlation Between IPQ Sub-scales and the BMQ.
BMQ:
Necessity
BMQ:
Overuse
BMQ:
Harm
BMQ: Concerns -.110 41 j * * .675**
N=64 N=62 N=63
BMQ: Necessity -.308* -.179
N=62 N=63
BMQ: Overuse -.308* .667**
N=62 N=61
BMQ: Harm -.179 .667**
N=63 N=61
** = significant at the 0.01 level 
* = significant at the 0.05 level.
From table 16, it can be seen that beliefs about medication overuse and harm in general were 
positively correlated with concerns over harmful effects of specific cholesterol lowering 
medication. Beliefs about overuse were also positively correlated with beliefs about the 
intrinsic harmful nature of medicines in general. Beliefs about necessity of taking specific 
medicines were negatively correlated with beliefs about Doctors over-prescribing. So those 
who had higher beliefs that medicines were necessary had lower beliefs that Doctors over­
prescribed.
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Adherence
The MARS adherence scale comprised five items, rated from 1-5 on a Likert scale and a total 
score, which was the sum of all these items. Any one who did not have a score of 25 and thus 
full adherence on each item was said to be at some level non-adherent; 65.5% fell into this 
category. Whilst many people were not fully adherent, to the extent that they did not deviate 
in any way from the medication regime, it would seem that non-adherence in this sample was 
primarily a question of occasional forgetting as shown in table 17 below:
Table 17: Means and standard deviations of the MARS sub-scales.
MARS Sub-scale N Mean (2dp) Standard Deviation 
(2dp)
Forget to take 64 4.22 .81
A lter dose 64 4.86 .58
Stop taking for a while 64 4.86 .56
Decide to miss a dose 64 4.77 .56
Take less than instructed 64 4.84 .54
Correlations Between the MARS and the IPO:
The MARS total (the culmination of all the items relating to methods of non-adhering) was 
negatively correlated with emotional representations from the IPQ, r(64)= -.261, p=<0.05, 2- 
tailed test. Therefore greater adherence was associated with less emotional distress. His was 
the only item of the IPQ to be correlated with adherence.
Correlations Between MARS and mood as measured by the HADS:
Total MARS score was negatively associated with anxiety, in that greater adherence was 
associated was associated with less anxiety, r(62)= -.320, p<0.05, 2-tailed test. There was no 
association between adherence and depression, r(63)=-.218, p>0.05,2-tailed test.
Correlations Between MARS and BMQ:
There were no significant correlations between adherence (MARS Total) and any of the four 
constructs of the BMQ.
!
Correlations Between MARS and Perceived Causes of Low Cholesterol Condition.
There were no significant correlations between adherence and any of the perceived causes of 
having a high cholesterol condition.
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There was a significant negative correlation between adherence and how likely people 
thought they would be to have high cholesterol in the next ten years, r(61)= -.315, p<0.05, 2- 
tailed test. Thus the more adherent, the strongly one believed they would have high 
cholesterol in the future.
ADHERENT Vs. NON-ADHERENT PARTICIPANTS: 
Table 18: Frequency with Regard Adherence to Medication
Adheres to Cholesterol 
Lowering Medication?
Frequency Percent (%)
No 42 65.6
Yes 20 31.3
Don’t know 2 3.1
Total 64 100.0
If  people circled any answer other than ‘never’ to any of the questions around non-adherence 
on the MARS, they were taken as having some level of non-adherence. It was found that a 
large proportion of the people who completed the questionnaire were not fully adherent to 
their cholesterol lowering medication, as can be seen in table 18 above. Where answers had 
been omitted these were classed as not known answers. The next part of the analysis focuses 
on the differences between those who were and were not fully adherent.
Description of two samples:
Chi-Square tests were used to compare the two samples. No significant differences were 
found with regard gender, age, ethnicity, statin use, time in clinic and whether on any other 
medication for other conditions.
Comparisons Between the Adherent and Non-Adherent Populations:
Mann Whitney tests were conducted on all of the sub-scales of the IPQ, except the sub-scale 
of ‘timeline cyclical’ which was normally distributed and where an Independent T-test was 
conducted instead. Results are displayed below. Means and standard deviations for each 
group are displayed. Means (and subsequently the standard deviations) have been divided by 
the number of variables that comprised them, this way each sub-scale can be interpreted on a 
scale from one to five.
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Table 19: Results after comparing adherent and non-adherent participants on the IPQ.
Mann Asymp. N Adherent Non-adherent
Whitney- Sig (Adherent/ Mean & Mean and
U CZ- non­ (Standard (Standard
tailed) adherent) Deviation) Deviation)
IPQ  Timeline 324.0 .358 19,40 3.84, (0.99) 4.12, (0.85)
IPQ  Consequences 335.0 .552 18,41 3.94, (1.21) 3.95 (.80)
IPQ  Personal Control 333.5 .655 18,40 2.28, (0.74) 2.18(0.73)
IPQ Treatment 338.0 .607 18,41 2.54, (0.52) 2.65, (0.75)
Control
IPQ  Coherence 334.5 .566 18,41 2.09, (0.98) 2.21, (0.72)
IPQ  Emotional 245.5 .078 17,41 2.13, (0.62) 2.65, (0.94)
Representation
* = significant at the 0.05 level
An independent T-test also found no significant difference on the IPQ sub-scale of ‘timeline 
cyclical’ between the two groups, T(52)=-1.582, p=>0.05, 2-tailed test. Means for the 
adherent and non-adherent group were 4.53(sd=0.62) and 4.20(sd=0.72) respectively. 
Therefore there are no significant differences between any of the sub-scales of the IPQ and 
those who are adherent and those who are not.
Anxiety level as measured by the HADS and adherence were found to be related. There 
seemed to be a significant interaction between anxiety and whether a person was adherent or 
not. T(58)=2.450, p<0.05,2-tailed test. When means were explored, it would seem that those 
who were non-adherent had higher levels of anxiety than those who were fully adherent, 
8.02(sd=4.04) and 5.26(sd= 4.11) respectively.
The results from HADS depression total and the BMQ are displayed in table 20 below. The 
table below also shows the means and standard deviations of the scales, and for the BMQ, 
each mean has been calculated and divided by the number of items in that scale. This way 
each sub-scale can be interpreted on a scale from one to five.
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Table 20: Results after comparing adherent and non-adherent participants on the 
HADS and BMQ.
Mann
Whitney-
U
Asymp.
Sig
C^ -
tailed)
N
(Adherent/
non­
adherent)
Adherent
Mean
(Standard
Deviation)
Non-Adherent
Mean
(Standard
Deviation)
HADS:Depression 315.0 .187 19,42 5.26, (2.52) 5.00, (3.62)
Total
BMQ: Concern 337.5 .210 20,42 2.41, (0.82) 2.73, (0.65)
BMQ: Necessity 363.0 .386 20, 42 3.61, (0.63) 3.73, (0.62)
BMQ: Harm 338.0 .336 19, 42 1.73, (0.65) 1.83, (0.65)
* = significant at the 0.05 level
An independent T-test was performed on the BMQ general sub-scale of ‘overuse’ which 
produced a non-significant result, T(58)=1.156, p>0.05, 2-tailed test. Means were 
2.09(sd=0.73) and 2.27(sd=0.68) for the adherent and non-adherent groups respectively. 
Therefore there were no significant differences between any of the sub-scales of the BMQ 
and those who were adherent and those who were not.
For the item ‘How likely do you think you are to have a raised cholesterol level over the next 
ten years?’ there was found to be no significant difference between the adherent and non­
adherent groups: Z(19, 40)=297.5, p>0.05, 2-tailed test. Means were 0.32(sd=0.47) and 
4.05(sd=l .75) for adherent and non-adherent groups respectively.
Poor medical care in the past, as a perceived cause of high cholesterol, was found to be 
significantly different between the adherent and non-adherent groups. Z(18, 40)=254.5, 
p<0.05, 2-tailed test. When means were explored it was found that the adherent group had a 
mean of 2.39(sd=0.85) and the non-adherent of 1.95(sd=0.64). Thus those who were fully 
adherent were likely to also perceive that poor medical care in the past was a cause of their 
high cholesterol condition than those who were less adherent.
NON-ADHERENT POPULATION:
This population comprised those who reported some level of non-adherence on the initial 
questionnaire and subsequently received a follow-up questionnaire. 41 out of a possible 42 
people returned this follow-up questionnaire. The analysis looked at whether there were any 
differences in this population between those who received the intervention to increase 
adherence and those who did not.
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Exploring the Non-Adherent Population:
There were 41 people who initially comprised the non-adherent population and who 
subsequently received a follow-up questionnaire. Whilst there was an even split between 
males and females, this was not the case for implementation intention distribution.
Table 21: Gender distribution in the non-adherent sample between those who received 
and did not receive the intervention.
Given Action Plan?
No Yes
Gender: Male 06 14
Female 14 07
Total 20 21
Gender was significantly associated with being given the action plan, X 2(l,  n = 41)= 5.512, 
p<0.05. There was a predominance of males who received the intervention and predominance 
of females who did not. There were no significant differences in this sample with regards age, 
ethnicity, statin use or whether on any other medication.
EPQ:
There were no significant differences with regard Illness Perceptions for those who did and 
did not receive the intervention.
Table 22: Results for those in the non-adherent sample, who received the intervention
and those who did not on the sub-scales of the IPQ.
Mann
Whitney-
U
Asymp.
Sig
O^ -
tailed)
N
(Intervention/
No
Intervention)
Intervention
Mean
(Standard
Deviation)
Non-
Intervention
Mean
(Standard
Deviation)
IPQ Timeline 155.5 .349 21, 18 3.95, (0.95) 4.28, (0.72)
IPQ Consequences 153.5 .215 21. 19 3.81, (0.75) 4.16, (0.83)
IPQ Personal Control 134.0 .120 20, 19 2.09, (0.81) 2.30, (0.65)
IPQ Treatm ent 
Control
111.5* .016 21, 19 1.92, (0.74) 2.28, (0.46)
IPQ Coherence .979 .979 21, 19 2.18, (0.69) 2.24, (0.80)
IPQ Emotional 
Representation
174.5 .503 21, 19 2.79, (1.12) 2.53, (0.71)
* = significant at the 0.05 level
As shown in table 22, treatment control was significant and means show that those who 
received the intervention in this initially non-adherent group were more likely to view their
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treatment as having more control over their condition than those in the group who did not 
receive the intervention.
An Independent Test was conducted for the IPQ sub-scale of ‘timeline cyclical’ and was also 
found to be non-significant. T(38)=-1.213, p>0.05, 2-tailed test. Means for the intervention 
and non-intervention group were 3.70(sd=0.62) and 3.44(sd=0.69) respectively
HADS totals and BMQ sub-scales:
There were no significant differences between those who received the intervention and those 
who did not with regard anxiety and depression levels as measured by the HADS, or for any 
o f the sub-scales of the BMQ.
Table 23: Results after comparing those who received the intervention, from the
population who received the follow-up questionnaire, on the HADS depression and 
BMQ.
Mann
Whitney-
U
Asymp.
Sig
en­
tailed)
N
(Intervention/
non­
intervention)
Intervention
Mean
(Standard
Deviation)
Non-
Intervention
Mean
(Standard
Deviation)
HADS: Depression 
Total
164.5 .232 21, 20 4.48, (3.50) 5.75, (3.68)
BMQ: Concern 188.5 .572 21, 20 2.77, (0.60) 2.73, (0.70)
BMQ: Necessity 168.0 .267 21, 20 3.64, (0.58) 3,80, (0.67)
BMQ: Harm 185.0 .509 21, 20 1.87, (0.53) 1.80, (0.79)
* = significant at the 0.05 level
Independent T-tests were used for the sub-scales of HADS Anxiety total and BMQ-general 
‘overuse’. These results are displayed in table 24 below:
Table 24: Results after comparing those who received the intervention, from the 
population who received the follow-up questionnaire, on the sub-scales of HADS anxiety
and BMQ ‘overuse’.
T-
value
Degrees
of
freedom
Asymp.
Sig
(2-
tailed)
N
(Intervention/
Non­
intervention)
Intervention
Mean
(Standard
Deviation)
Non-
Intervention
Mean
(Standard
Deviation)
HADS: Anxiety 
Total
.547 38 .588 20, 20 7.8, (4.20) 8.5, (3.89)
BMQ: Overuse -.817 38 .419 20, 20 2.95, (0.66) 2.78, (0.69)
* = significant at the 0.05 level
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A Mann Whitney U test indicated that there was a difference as to whether ageing’ and 
‘alcohol’ were likely to be seen as causative in people’s high cholesterol condition, and 
whether a person received the intervention or not, (Z(21, 18) = 97.5, p<0.01, 2-tailed test and 
Z(21, 18) = 121.5, p<0.05, 2-tailed test respectively). Means are displayed below in table 25 
below. Higher scores indicate more belief that the item is causative in one’s high cholesterol 
condition.
Table 25: Means for perceived causes of high cholesterol condition and whether given 
the intervention or not.
Alcohol Ageing
(Mean 2dp) Standard
Deviation
(2dp)
(Mean 2dp) Standard
Deviation
(2dp)
Given Intervention Yes 2.95 1.16 3.00 1.18
No 2.22 1.06 2.00 0.59
Therefore it can be seen that for those given the intervention they had greater beliefs that 
alcohol and ageing were causes of their high cholesterol condition.
Analysis of the individual adherence items, showed no significant differences in the way in 
which people were non-adherent, and whether they received the intervention or not.
Table 26: Adherence Items and Intervention.
Mann Asymp. N Intervention Non-Adherent
Whitney- Sig (Intervention/ Mean Mean
U C^ - Non­ (Standard (Standard
tailed) intervention) Deviation) Deviation)
Forgot 200.0 .751 21,20 3.76, (0.83) 3.90, (0.55)
A lter Dose 199.0 .614 21,20 4.67, (0.97) 4.90, (0.31)
Stop for a while 190.0 .385 21,20 4.76, (0.89) 4.80, (0.41)
Decide to miss a 200.0 .735 21,20 4.67, (0.73) 4.70, (0.47)
dose
Take less than 190.5 .408 21,20 4.67, (0.80) 4.85, (0.49)
instructed
* = significant at the 0.05 level
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TIME 1 to TIME 2
Non-adherent participants as identified by less than full scores on the MARS, were sent 
another questionnaire four weeks after completion of the first. After this period, and having 
filled in and sent back the second questionnaire, four participants now reported being fully 
adherent, two of whom had received the implementation intention and two had not.
Total on the MARS showed an increase from time one (mean=22.83, sd=2.85) and time two 
(mean=23.29 2dp, sd=1.57) showing a general increase in adherence over time for the whole 
sample. This however did not reach statistical significance: Z(41)=-1.514, p>0.05, 2-tailed 
test.
To test the main hypothesis, it was hoped that a mixed between-within subjects analysis of 
variance could be conducted to see the effects of time on adherence, the intervention on 
adherence and the interaction between these two variables. However due to violation of 
normality and of homogeneity of variance, this test could not be conducted. It was also not 
possible to transfonn the data to correct for these violations, because the distributions in the 
two groups were violating these assumptions in different ways. With no non-parametric 
equivalent, some individual tests were conducted to attempt to explore the hypothesis.
A variable was created which calculated adherence at time two, minus adherence at time one. 
Thus this variable represented the difference between time 1 and time 2 with regards 
adherence. A Mann Whitney-U test was performed on this data, looking at any difference 
between whether someone received the intervention and difference in their adherence scores 
over time. The results are shown in table 27 below:
Table 27: Mann Whitney-U to test the difference between Intervention and Difference 
in Adherence over time.
Mann
Whitney-
U
Asymp.
Sig
(2-
tailed)
N
(Intervention/
Non­
intervention)
Intervention
Mean
(Standard
Deviation)
Non-
Intervention
Mean
(Standard
Deviation)
Difference in 
Adherence
198.0 .731 21, 20 0.52, (2.79) 0.40, (0.75)
* significant at the 0.05 level.
From table 27 it can be seen that there were no significant differences in adherence at the two 
points in time and whether the participant received the intervention.
To clarify further, adherence levels were looked at over time, separately for the intervention 
and non-intervention groups, the following results emerged.
Table 28: Adherence totals from time one - to time two, in both the intervention and 
non-intervention groups.
Wilcoxon 
Signed Ranks
Asymp.
Sig
(2-tailed)
N Time 1 
Mean 
(Standard 
Deviation)
Time 2 
Mean 
(Standard 
Deviation)
T1 -T 2
In Intervention Group
-.605 0.545 21 22.52, (3.76) 23.05, (1.96)
T1 - T2
Non-intervention
Group
-2.33* 0.020 20 23.15, (1.39) 23.55, (1.00)
* = significant at the 0.05 level
Thus ‘within’ each group there was an effect for increased adherence for those whom did not 
receive the intervention. This is illustrated again in figure one below:
Figure 1: Adherence Totals and Intervention.
Mean
IBS 
;  • ■
I ; MARS Total timel
Plgg MARS Total time2
Given action plan
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Table 29: Total adherence levels, between the intervention and non-intervention groups
at both points in time.
Mann
Whitney-U
Asymp.
Sig
(2-tailed)
N (given 
intervention/ 
not given 
intervention)
Intervention
Mean
(Standard
Deviation)
Non-
Intervention
Mean
(Standard
Deviation)
M ars Total 
Time 1
207.5 .942 21,20 22.52, (3.76) 23.15, (1.39)
M ars Total 
Time 2
195.0 .669 21,20 23.05, (1.96) 23.55, (1.00)
* = significant at the 0.05 level
Therefore adherence levels were roughly the same at time one for both those given the 
intervention and those not, and similarly at time two, adherence was roughly the same 
between the two groups. This then highlights that whilst ‘within’ each of the groups there was 
a significant difference in adherence from time one to time two for those who did not receive 
the intervention; there were no significant differences ‘between’ the groups at the two points 
in time.
Differences in the individual variables that comprised the MARS were also investigated to 
see whether the type of non-adherence varied between the groups that received and did not 
receive the intervention over time.
Table 30: Individual variables from the MARS, from time one - to time two, in both the
intervention then the non-intervention groups.
Wilcoxon 
Signed Ranks
Asymp.
Sig
(2-tailed)
N Time 1 
Mean 
(Standard 
Deviation)
Time 2 
Mean 
(Standard 
Deviation)
Intervention Group:
Forget to take cholesterol -1.155 .248 21 3.76, (0.83) 3.95, (0.59)
medication
Alter the dose -1.633 .102 21 4.67, 4.86 0.97, (0.48)
Stop taking for a while -2.72 .785 21 4.76, 4.81 0.89, (0.60)
Decide to miss a dose -5.75 .565 21 4.67, 4.57 0.73, (0.68)
Take less than instructed -1.633 .102 21 4.67, 4.86 0.80, (0.48)
Non-intervention Group
Forget to take cholesterol -1.732 0.083 20 3.90, (0.55) 4.05, (0.60)
medication
Alter the dose -1.732 1.000 20 4.90, (0.31) 4.90, (0.31)
Stop taking for a while -0.577 0.564 20 4.80, (0.41) 4.85, (0.49)
Decide to miss a dose -1.732 0.083 20 4.70, (0.47) 4.85, (0.37)
Take less than instructed -0.447 0.655 20 4.85, (0.49) 4.90, (0.31)
* = significant at the 0.05 level
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Therefore from table 30, it can be seen that there were no significant changes over time for 
the individual variables of the MARS, in either the intervention or non-intervention groups.
From table 31 below, it can also be seen that there were no differences in type of adherence, 
from the individual MARS variables between the intervention and non-intervention group, 
when looked at each point in time. Thus as with total adherence, there was no effect between 
the groups, and unlike general adherence there was also no difference within each group over 
time.
Table 31: Separate adherence variables, between the intervention and non-intervention
groups at both points in time.
Mann Asymp. N (given Intervention Non-
Whitney-U Sig (2- intervention/ Mean Intervention
tailed) not given (Standard Mean
intervention) Deviation) (Standard
Deviation)
Time 1:
Forget to take 
cholesterol
200.0 .751 21, 20 3.76, (0.83) 3.90, (0.55)
lowering
medication
Alter the dose 199.0 .614 21, 20 4.90, (0.31) 4.67, (0.97)
Stop taking for a 
while
190.0 .395 21, 20 4.80, (0.41) 4.76, (0.89)
Decide to miss a 200.0 .735 21, 20 4.70, (0.47) 4.67, (0.73)
dose
Take less than 190.5 .408 21, 20 4.85, (0.49) 4.67, (0.80)
instructed
Time 2
Forget to take 
cholesterol
193.0 .597 21, 20 3.95, (0.59) 4.05, (0.60)
lowering
medication
Alter the dose 210.0 1.00 21, 20 4.90, (0.31) 4.86, (0.48)
Stop taking for a 
while
210.0 1.00 21, 20 4.85, (0.49) 4.81, (0.60)
Decide to miss a 168.5 .148 21, 20 4.85, (0.37) 4.57, (0.68)
dose
Take less than 210.0 1.00 21, 20 4.90, (0.31) 4.86, (0.48)
instructed
*= significant at the 0.05 level.
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DISCUSSION:
Overview of sample:
O f the 31.5 percent of people who returned the initial questionnaire, 65.5 percent of these 
people were at some level non-adherent and subsequently received a follow-up questionnaire; 
all except one person returned this. Therefore it can be seen that those who completed the 
first questionnaire were extremely likely to complete another. This could then pose questions 
about the features of those who did and did not complete the questionnaires and the 
generalisability of findings to the general population. Of the people who initially returned the 
questionnaires there was an even split between males and females and a wide age range. 
However the sample comprised mainly of Caucasian participants and thus is not 
representative of other ethnic groups.
Initial Exploration:
The study first explored the characteristics of the initial sample and the general trends that 
emerged from initial questionnaire completion.
Illness Perceptions:
Most people appeared to perceive their high cholesterol condition to be chronic and serious 
and their medicines useful in controlling symptoms. The majority also perceived themselves 
as having a good understanding of their condition. As expected, many of the sub-scales of the 
IPQ correlated well with each other. LeventhaTs self-regulatory model of illness, proposes 
that beliefs about illness are structured around certain themes and good correlations found in 
this study between these constructs would seem to lend support to these propositions.
With the notions of illness perceptions being extended to Home’s (1997) notions of 
medication beliefs, a large number of correlations were expected between these two scales, 
but this research found only a few constructs to be associated with each-other. Illness 
coherence (perceived understanding of the illness), was associated with stronger beliefs about 
harm of medicines in general, overuse by doctors and concerns specifically about cholesterol- 
lowering medicines. High distress understandably was related to high concerns over the 
harmful effects of the medicines under discussion and medicines in general and concerns 
with regard doctors over-prescribing. Perhaps surprisingly, those who perceived treatment as 
useful in controlling symptoms had fewer beliefs about the necessity of this medication.
Page 201
Mood:
Nearly a third of participants had mild levels of anxiety and 10 percent had moderate levels, 
however this was much lower for depression. High anxiety could however reflect the stress 
associated with attending the clinic appointment, or anxiety with regard completing the 
questionnaires.
Perceiving the condition as more serious, was associated with higher levels of depression. 
Whilst perceiving the high cholesterol condition to be fixed and unchangeable was associated 
with less anxiety and less depression. Higher anxiety levels were also correlated with higher 
beliefs about harm from medicines in general and specifically with regard concern about 
cholesterol lowering medication. Higher levels of depression were correlated with higher 
concerns about these specific medicines in question and higher beliefs about its necessity. 
Thus believing the medicine was really necessary was associated with a lower affect.
Higher anxiety was also associated with greater non-adherence overall as measured by the 
MARS.
Beliefs About Medicines:
Most people believed in the necessity of taking their cholesterol lowering medicines and did 
not believe that Doctors over-prescribed and that medicines in general were harmful. The 
sub-scales of the BMQ correlated well with each other.
Causes:
With regard perceived causes of high cholesterol condition, heredity, genes and diet were 
endorsed as the most likely determinants. Germs/viruses, accident/injury and environmental 
pollution were seen to be the least likely causes by the initial sample.
This then comprises and an overview of the general sample and is as yet not concerned with 
exploration of differences between adherent and non-adherent groups, and the effects on 
health-related behaviour. However it would seem that fewer correlations emerged between 
illness perceptions and beliefs about medicines, than would have been expected given current 
literature. Other factors such as mood also appear to be correlated with certain illness 
perceptions and beliefs about medicines and at present have not been specifically 
incorporated into such current models of health behaviour. Thus perhaps these models are as
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yet still not sufficiently explaining all the complex links in behaviour, as demonstrated with 
‘affect’ being important in this study and being correlated with many illness perceptions and 
medication beliefs. With comprehension of health behaviours still not clear, perhaps 
successfully changing such behaviour may prove even more difficult to achieve.
Adherence and Medications:
This study found just over 65 percent of people taking cholesterol-lowering medication to be 
at some level non-adherent. This was found to be more a case of occasional forgetting than 
intentional deviation from the recommended medication regimen. This is in line with the 
research by Senior et al (In press), where 63 percent of their sample was found to be non­
adherent and again most frequently reporting occasional forgetting. Both these studies used 
participants from the same clinic (although with different diagnosis). Adherence levels from 
both this and the current study were lower than those found by Insull (1997) who found up to 
50 percent of participants displaying some level of non-adherence. Medications in general 
were shown to have a 30 percent non-adherence rate and thus cholesterol-lowering 
medication would seem to have an overall poorer figure. Perhaps this could be due to the 
chronic nature of the condition and lack of symptoms and subsequent symptom relief from 
taking this long-term medication. Nearly all patients in this study were on Statins and thus 
findings are assumed only to relate to the taking of this form of medication. However more 
than 60 percent of patients were also on some form of other medication, but due to lack of 
specificity and consistency in description, detail of these could not be adequately used in 
analysis and thus it is impossible to exact the effect of this and co-morbidity of illnesses on 
medication taking behaviour.
Exploration of the Adherent and Non-adherent Groups:
Initial aims of the study highlighted the need to explore differences in patient details, illness 
perceptions, mood and medication beliefs in those who were initially fully adherent and those 
who were not. This could potentially help to identify any characteristics, which differentiated 
those who were at some level non-adherent from those who strictly adhered to their 
medication regime. This could also then be interpreted with reference to research in this area, 
to see whether this study produced similar findings to those already delineated.
Descriptive statistics showed very few main differences between the adherent and non­
adherent groups of participants. There were no differences in illness perceptions or beliefs
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about medicines as might have been expected. Anxiety total and the perceived cause of ‘poor 
medical care in the past’ were the only scales that that significantly differentiated those who 
were adherent from those who initially were not. Therefore, those who had high levels of 
anxiety were less likely to be adherent to their cholesterol lowering medication. This did not 
support the study by Senior et al (in Press) who found no associations with anxiety or 
depression with adherence. However this is not causational and it could be that by being non­
adherent this could serve to increase distress and anxiety levels. Or there could be some other 
mediating factor(s) as yet unidentified in this research. This finding is in conflict with other 
research such as that by Dimatteo, Lepper & Croghan (2000) who found no consistent 
relationship between anxiety and adherence in a meta-analysis using data from patients with a 
variety of chronic conditions. They did however find depressed patients three times more 
likely to be non-adherent than non-depressed patients. This may then reflect a difference in 
the nature o f the condition under investigation but highlights the need for mood to be looked 
at more consistently. As mood was initially correlated with aspects of medication beliefs and 
illness perceptions in this study, perhaps further research is needed to investigate how affect 
can be understood in connection with these models of health behaviour.
Those who were fully adherent were more likely to perceive poor medical care in the past to 
be a cause of their high cholesterol condition than those who deviated from the medication 
regime. Perhaps those who have had negative experiences of medical care in the past take it 
upon themselves to monitor their conditions and take responsibility of their regimes than 
those who have not had such experiences in the past and do not perceive this to have 
contributed to their present condition.
No support was therefore given to the propositions made by the self-regulatory model of 
illness which postulated that if by perceiving medication and advice to take it as common 
sense then participants would be more likely to take their medicines as directed. Differences 
in illness perceptions and leading on from this, medication beliefs between the two groups 
would then have been expected. Horne & Weinman (1999) proposed that adherent people 
would score more highly for beliefs about medication necessity and have lower concerns 
about these medicines, whereas non-adherent persons would have higher concerns and low 
necessity beliefs. In this study, no evidence was found to support these propositions. This 
could perhaps be due to the type of condition and medication under investigation. With high 
cholesterol conditions being chronic and asymptomatic, medication effects may not be so
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apparent to be able to be viewed in this cost-benefit way. Thus this may highlight differences 
in understanding this type of chronic condition and the need for specific research for different 
conditions and medications. Brewer et al (2002) specifically highlighted issues prominent for 
those suffering from high cholesterol conditions, and found that an expert-based model of 
illness, with perceptions of the condition being chronic, symptomless and with severe 
consequences would be associated with higher levels of reported adherence, however this was 
also not borne out in this study. However as Senior et al (In Press) highlighted, with non­
adherence predominantly in the form of occasional forgetting and with such small 
associations between illness perceptions and behaviour (in this study no such associations), 
the rational for needing to establishing routines and establishing environmental contingencies 
instead of focusing on changing perceptions, was supported.
Main Hypothesis: ‘The intervention’
Thus the rational behind investigating implementation intentions seems to have been borne 
out in this study, with few differences found between the adherent and non-adherent groups 
and non-adherence being primarily in the form of occasional forgetting. Thus determining 
whether the intervention could effect change seems to be a necessary continuation from 
current research and substantiated again through this piece of work so far.
Initial aims highlighted the need to also explore any differences in patient characteristics 
between those who did and did not receive the intervention, within the non-adherent group 
who received the follow-up questionnaire. This was to help identity any other factors, which 
could potentially be affecting change in adherence. The main hypothesis could then be 
explored which aimed to see whether:
‘Forming Implementation Intentions increases self-reported adherence to cholesterol 
lowering medication, in patients currently attending a lipid clinic and reporting some level o f  
non-adherence over the past month. '
O f the initially non-adherent participants, roughly equal numbers received and did not receive 
the intervention. These two groups within this non-adherent population were similar across 
most measures, except that those who received the intervention were predominantly male. 
Those who received the intervention in this initially non-adherent group were also more 
likely to view their treatment as having more control over their condition than those in the 
group who did not receive the intervention. No other differences were found between these
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groups, although findings must be interpreted whilst bearing in mind that any significant 
result could represent a gender difference or differences in perception of control from one’s 
treatment.
Over time, no differences were found in adherence totals between the two groups. However 
when taken separately and adherence over time for each group separately analysed, there was 
a significant increase in adherence for the group that did not receive the intervention, so 
‘within ’ this group there was a significant effect. However at both points in time, there was 
no significant difference ‘between’ the two groups. Whilst significant this then shows that the 
actual effect was small and spurious as it was not a strong enough effect to differentiate 
between the two groups. However as previously mentioned, the group that received the 
intervention was predominantly male and the group who did not receive the intervention was 
predominantly female and thus this finding could reflect a gender difference. This does not 
however lend support to the main hypothesis.
With most non-adherent behaviour being due to forgetting rather than intentional deviation 
from the medication regime, it would have been predicted that implementation intentions 
should have helped commit a person to a course of action, when conditions in the 
environment were met. Therefore the intervention would have been thought to help utilise the 
environment to help trigger the action of medication taking and thus helping with non­
adherent behaviour such as forgetting. This was not found to be the case.
The effect of gender cannot be overlooked as previous research into implementation 
intentions has used primarily student populations (Gilholm et al, 1999; Gollwitzer & 
Brandstatter, 1997). The more recent attempts to investigate implementation intentions with 
regard health related behaviour has also been confined to studies on women; such as Mitchie 
et al’s (In Press) study on implementation intentions and pre-natal screening and the Sheeran 
& Orbell (2000) study on women attending for cervical screening. Whilst both of these 
studies lent support for the use of implementation intentions in increasing the implementation 
of these health related behaviours, this could also be highlighting a gender effect. This 
current study found the intervention did not have a significant effect, but in this study the 
intervention group were predominantly male. Gender therefore needs to be investigated 
further in the future.
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The group that received the intervention in this study also had stronger perceptions that 
treatment could control their high cholesterol condition better than the group that did not 
receive the intervention. Thus lack of effect from the intervention could reflect an already 
present perception that their treatment was effective in controlling their condition and why 
attempts to alter the method of medication, which was already deemed successful did not 
change behaviour.
This then brings into question the basis of implementation intentions, which describe how 
they work by committing a person to a course of action, when conditions in the environment 
are met, and thus facilitating translation of a goal intention into action (Gollwitzer, 1993). 
However this study could perhaps be showing that this is too simplified and that maybe there 
are still complex interaction with other areas such as affect, perceptions and patient 
characteristics, such as gender which need to be investigated further.
Critique:
This research utilised widely used standardised and reliable measures. Many attempts were 
used to achieve power, such as the handing out of more than 200 questionnaires and the 
researcher’s presence at the clinics, but unfortunately power was not attained.
The study relied on self-report measures of adherence. Due to time constraints and 
administrative difficulties in locating files, no corresponding blood results could be utilised to 
see whether reported pill taking corresponded to actual cholesterol levels in the blood at time 
of completing first questionnaire. As most participants did not complete the questionnaire in 
the clinic, people would have had to come in for specific testing. Also adherence was looked 
at a month after initial return of questionnaire and the majority of patients would not have 
another appointment until six months after their last visit. Thus conclusive monitoring of 
blood was not possible without having specific blood tests provided for this purpose as well. 
This simply was not possible with the available resources. There is ongoing debate over the 
accuracy of self-report measures, such as with Stephenson, Rowe, Macharia, Leon & Haynes 
(1993) reporting such methods to overestimate adherence. However Senior et al (In Press) 
with participants from the same clinic (with a diagnosis of familial hypercholesterolaemia) as 
used in this current research, found biochemical evidence for the validity of the self-report 
adherence measure used in this study.
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There was a low response rate, which could be partially due to handing out questionnaires to 
people whist waiting for fasting blood tests, and thus in a potentially stressful situation. This 
clinic also conducts a lot of research and it could be that many patients did not want to take 
part in any more. Data collection also took place in the two months leading up to the 
Christmas holidays and similarly for the few months following this period. Thus this can be a 
stressful time of year, and a time when adherence may be particularly difficult and people 
may not wish to disclose the nature of their medication taking behaviour over this time. A 
follow-up questionnaire to remind people to send back their initial questionnaires would have 
been potentially useful for increasing response rates, but again due to administration 
difficulties and time constraints, this was not feasible. A smaller sample than anticipated 
therefore meant that statistical power was not obtained, despite handing out a large number of 
questionnaires, having the Doctors re-iterate the importance of the research in their 
appointments and having the researcher present in the clinic and available to answer any 
queries.
This sample may also not be completely representative of other patients with high 
cholesterol, as this sample was predominantly Caucasian and out of those not fully adherent, 
a majority of males had received the intervention. Whilst an even split between males and 
females returned the initial questionnaire, out of those who returned the second questionnaire, 
not an even proportion had received and not received the intervention. This would have 
probably been evened out with a higher response rate. This study only used one hospital trust 
and again cannot be generalised to other clinics and patients attending clinics in different 
parts of the country.
Nearly two thirds of patients were currently taking some other form of medication, exact 
nature of these conditions and associated medication were not accurately and consistently 
recorded to enable this to be accounted for in the analysis. Therefore co-morbidity of 
illnesses and multiple taking of medicines was not accounted for in this research.
Most patients whilst not fully adherent in the form of not deviating in any way from the 
medication regime, all still generally had high levels of adherence, with occasional forgetting 
comprising the majority of non-adherent behaviour. No attempt was made to investigate how 
people were currently taking their medicines and whether they already were using action 
plans. Therefore intricacies of behaviour and qualitative detail was not obtained around this
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area beforehand. With the low level of intentional deviation from medication regimens and 
still relatively low levels of forgetting, it may have been important to see how the participants 
were already taking their medicines, before one can draw conclusions as to whether an 
intervention was successful.
There was no information on those who did not return the questionnaires, and findings can 
only be interpreted for those who did. It could be that those who were already fully adherent 
or actively non-adherent were the ones who did not complete the questionnaires and on this 
there is no data.
Results could be an artefact of doing multiple comparisons, although the Bonferroni 
correction was not applied as with a small sample, applying this method of correction could 
have lost important trends.
However despite the limitations, and the lack of support for the self-regulatory model of 
illness and the application of implementation intentions, these findings can themselves be of 
use. This research allows more questions to be asked about the complexity of perceptions, 
adherence and strategies to enable change, and expands on the research to date, beginning to 
combine several recent understandings and applications with one-another.
Future Research:
Future research in this area would aim to use a larger sample and finding methods to achieve 
a higher response rate. Blood tests would need to be taken at time of initial measuring o f self- 
reported adherence and at any follow-up times. This would enable data to investigate the 
validity of self-report measures.
Ideally comparisons would be made between those with high cholesterol conditions alone and 
taking cholesterol lowering medications only, from those with other conditions and taking 
other forms of medication, to enable comparison with regards co-morbidity and multiple pill 
taking.
Other services and provisions of care could be looked at, such as other trusts and GP 
practices. This would enable investigations into the way information and medication is given 
out and the effects on understanding illness and medication taking behaviours.
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Research could start with eliciting people’s specific beliefs and behaviours to begin with and 
there could then be comparisons made between those who are given individually tailored 
plans versus those who receive general information and interventions.
Mood and gender differences would also need to be systematically taken into account.
Clinical Applications:
What is clear from this research is that there is still a long way to go in firstly understanding 
people’s perceptions of their specific illness and then trying to impact upon any unhelpful 
behaviour. Whilst aspects of illness perceptions, medication beliefs and mood correlate well 
with each-other, there is still no fully accepted model for understanding the complex links. 
Even with the progress in this area, this then does not seem to help in adding any 
considerable understanding to changing certain health related behaviours. Whilst 
implementation intentions have been shown to have helping shape behaviour, this has yet to 
have consistent evidence with regard complex health related behaviours in clinical 
populations, such as found in this study of adherence and gender differences have perhaps 
been overlooked. Perhaps trying to understand the person on an individual level, looking at 
their personal belief systems, alongside the environmental contingencies they may already be 
using, and then by creating individually tailored plans may be the first step into 
understanding people’s complex set of beliefs and behaviours, and beginning to effect 
change.
Reducing anxiety levels may however be an important element previously overlooked which 
has emerged from this study and may be effecting medication-taking behaviours. This could 
perhaps be interfering with a patient’s ability to take on board information that is being 
provided by important health professionals. Indeed these relationship variables are 
themselves important and deserve future consideration. What is certain is there is still a long 
way to go in understanding human perceptions, belief systems and behaviours, and an even 
further way to go in trying to change these.
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Appendix 2
Revised Illness Perception Questionnaire <TPO-m
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YOUR VIEWS ABOUT YOUR ILLNESS
Listed below are a number of symptoms that you may or may not have experienced since your 
illness. Please indicate by circling Yes or No, whether you have experienced any of these symptoms 
since your illness, and whether you believe that these symptoms are related to your illness.
I have experienced this This symptom is related to
symptom since my illness my illness
Pain Yes No Yes No
Sore Throat Yes No Yes No
Nausea Yes No Yes No
Breathlessness Yes No Yes No
Weight Loss Yes No Yes No
Fatigue Yes No Yes No
Stiff Joints Yes No Yes No
Sore Eyes Yes No Yes No
Wheeziness Yes No Yes No
Headaches Yes No Yes No
Upset Stomach Yes No Yes No
Sleep Difficulties Yes No Yes No
Dizziness Yes No Yes No
Loss of Strength Yes No Yes No
We are interested in your own personal views of how you now see your current illness.
Please indicate how much you agree or disagree with the following statements about your illness by 
ticking the appropriate box.
VIEWS ABOUT YOUR ILLNESS STRONGLYDISAGREE DISAGREE NEITHER AGREE NOR 
DISAGREE
AGREE STRONGLY
AGREE
ip i My illness will last a short time
IPZ My illness is likely to be permanent rather 
than temporary
1P3 My illness will last for a long time
IP4* This illness will pass quickly
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VIEWS ABOUT YOUR Illness STRONGLYDISAGREE NEITHER AGREE NOR 
DISACREE
AGREE STRONGLY
AGREE
I expect to have this illness for the rest of my 
life
IP6
"TFT
My illness is a serious condition
My illness has major consequences on my life
"TpF" Mv illness is easv to live with
My illness does not have much effect on my 
life
My illness strongly affects the way others see 
me
My illness has serious financial consequences
My illness strongly affects the way I see 
myself as a person____________________
My illness causes difficulties for those who are 
close to me
My illness has a negative impact on me
My illness is not a problem for me
Mv illness doesn’t bother me much
There is a lot which I can do to control my 
symptoms______________________________
What I do can determine whether my illness 
gets better or worse
Recovery from my illness is largely dependent 
on chance or fate
The course of my illness depends on me
IP 21* Nothing I do will affect my illness
I have the power to influence my illness
My actions will have no affect on the outcome 
of mv illness
My symptoms are beyond my control
My symptoms will be around whatever I do
My illness will improve in time
There is very little that can be done to 
improve my illness__________________
My treatment will be effective in curing my 
illness
The negative effects of my illness can be 
prevented (avoided) by my treatment
VIEWS ABOUT YOUR ILLNESS STRONGLYDISAGREE DISAGREE NEITHER AGREENOR 
DISAGREE
AGREE STRONGLY
AGREE
1P30* My treatment can control my illness
« b ' ►
IP31* There is nothing which can help my condition «
IP32 The symptoms of my condition are puzzling to 
me
IP33 My illness is a mystery to me
IP34* I don’t understand my illness
IP3Sa My illness doesn’t make any sense to me
IP36* I have a clear picture or understanding of my 
condition
IP37 The symptoms of my illness change a great 
deal from day to day
IP38* My symptoms come and go in cycles
!P39* My illness is very unpredictable
IP40* My illness condition is present all the time.
IP41* I go through cycles in which my illness gets 
better and worse.
IP42* I experience my illness symptoms pretty much 
all of the time.
IP43* The symptoms of my illness are distressing to 
me
- IP44 . I get depressed when I think about my illness
IP45* When I think about my illness I get upset •
. !P4d*... My illness makes me feel angry
1P47* .. My illness does not worry me
IP48* Having this illness makes me feel anxious
1P49* I worry a lot about my illness
IP50* My illness makes me feel afraid
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CAUSES OF MY ILLNESS
We are interested in what vou consider may have been the cause of your illness. As people are very 
different, there is no correct answer for this question. We are most interested in your own views about the 
factors that caused your illness rather than what others including doctors or family may have suggested to 
you. Below is a list of possible causes for your illness. Please indicate how much you agree or disagree that 
they were causes for you by ticking the appropriate box.
POSSIBLE CAUSES STRONGLYDISAGREE DISAGREE NEITHER AGREE NOR 
DISAGREE
AGREE STRONGLY
AGREE
Cl Stress or worry
C2 Hereditary - it runs in my family
£3 ' A Germ or virus
C4 Diet or eating habits
C5 Chance or bad luck
£6 Poor medical care in my past
£i~~ Pollution in the environment
C8 My own behaviour
C 9 My mental attitude e.g. thinking about life 
negatively
CIO Family problems or worries caused my 
illness
Cll* Overwork
C12* My emotional state e.g. feeling down, lonely, 
anxious, empty
C13* Ageing
C14* Alcohol
C15* Sm oking
C16* Accident or injury
C17* My personality
0 8 * Altered immunity
In the table below, please list in rank-order the three most important factors that you now believe caused 
YOUR illness. You may use any of the items from the box above, or you may have additional ideas of your 
own.
The most important causes for me:-
3.
Items for IPQ-R Subscales
Identity (sum of yes-rated symptoms in column 2 on p. 1)
Timeline (acute/chronic) items IP1 - IP5
Consequences items IP6 - IP16
Personal control items IP17 - 1P25
Treatment control items IP26 - IP31
Illness coherence items IP32 - IP36
Timeline cyclical IP37 - IP42
Emotional representations IP43 - 50
Causes Cl - C17
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Appendix 3
Hospital Anxiety and Depression Scale flFIADSt
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Hospital Anxiety and 
Depression Scale
BFE?
N a m e...................................................  Date
I
I
I
I
I
I
I
A I
3 1
2 1 
! 1
0 1
1
1
D
1
1
1
0 1
1 1
2 1
3 1
1
1
1
A ' 
1
3 1
t
2 1 
1
1 I •
0 I
I
C lin ic ians a re  a w a re  th a t em o tions  p lay  a n  im portant p a rt in m ost 
i lln e s se s . If yo u r clinician know s a b o u t th e s e  feelings s h e  o r h e  will 
b e  a b le  to he lp  you m ore .
This q u e s tio n n a ire  is d e s ig n e d  to h e lp  you r clinician to know  how 
you  feel. Ignore  th e  n u m b e rs  prin ted  o n  the  left of the q u estio n n a ire . • 
R e a d  e a c h  item  a n d  u n d e r l in e  the  reply w hich c o m e s  c lo se s t  to how  
you h a v e  b e e n  feeling  in the  p a s t  w eek .
D on 't take  too  long over your rep lie s ; yo u r im m ediate  reac tio n  to 
e a c h  item  will p ro b ab ly  b e  m ore  a c c u ra te  than a  long though t-ou t 
re s p o n s e .
I feel te n s e  o r ‘w o u n d  u p ’:
Most of the time 
A lot of the time 
From time to time, occasionally 
Not at all
I still en jo y  th e  th in g s  I u s e d  to  en jo y :
Definitely a s  m uch 
Not quite so m uch 
Only a  little 
Hardly at all
I g e t a s o r t  of f r ig h ten ed  feeling  a s  if so m e th in g  awful Is 
a b o u t to  h a p p e n :
Very definitely and  quite badly
Yes, but not too badly
A little, but it d o esn 't worn/ m e
Not at all
(co n tin u ed  overlea f)
fo
ld
 
al
on
g 
da
sh
ed
 
li
n
e
Page 227
H O S P I T A L  A N X I E T Y  A N D  D E P R E S S I O N  S C A L E
I c an  laugh  a n d  s e e  the  funny  s id e  o f th in g s :
As m uch a s  I alw ays could 
Not quite so  m uch now 
Definitely not so  m uch now 
Not a t all
W orry ing  th o u g h ts  g o  th ro u g h  m y m in d :
A g reat deal of the time 
A lot of the time
From time to time but not too often 
Only occasionally
I feel ch ee rfu l:
Not a t all 
Not often 
S om etim es 
Most of the time
I c a n  s it  a t e a s e  a n d  feel re lax e d :
Definitely 
Usually 
Not often 
Not at all
1 feel a s  if I am  s lo w e d  d ow n:
Nearly all the time 
Very often 
Som etim es 
Not at all
I g e t a s o r t  of fr ig h te n ed  feeling  like 'b u t te r f l ie s ’ in th e  s to m a c h :  
Not at all 
O ccasionally 
Quite often 
Very often
(continued overteal)
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H O S P I T A L  A N X I E T Y  A N D  D E P R E S S I O N  S C A L E
I I h a v e  lo s t In te re s t In m y a p p e a ra n c e :
Definitely
I don 't take a s  m uch care  a s  I should 
I m ay not take quite a s  m uch care  
I take just a s  m uch ca re  a s  ever
I feel r e s t le s s  a s  if I h a v e  to  b e  on  th e  m ove :
Very m uch indeed 
Quite a  lot 
Not very m uch 
Not a t all
I lo o k  fo rw ard  w ith e n jo y m e n t to  th in g s :
As m uch a s  ev er I did 
R ather le ss  than I u sed  to 
Definitely le ss  than  I. u sed  to 
Hardly a t all
I g e t s u d d e n  fe e lin g s  of p a n ic :
Very often indeed  
Quite often 
Not very often 
Not a t all
I c a n  en jo y  a  g o o d  b o o k  o r  rad io  or TV p ro g ram m e:
Often
Som etim es 
Not often 
Very seldom
Now c h e c k  th a t you  h a v e  a n sw e re d  all th e  q u e s tio n s
For office u se  only:
0 : 0  Borderline 8 -1 0  
A : D  Borderline 8 -1 0
©  Zigmond and Snaith. 1983. From 'The Hospital Anxiety and D epression  
S ca le ,' Acta Psychiatrica Scandinavica  67, 3 6 1 -7 0 . Reproduced by kind 
perm ission of M unksgaard International Publishers Ltd, C openhagen.
This m easu re is part of M easures  in Health  Psychology: A User's Portfolio, 
written and com piled by P rofessor  Marie Johnston, Dr Stephen Wright and 
Professor John W einm an. O nce the invoice h as b een  paid, it m ay be  
photocopied for u se  w ith in  th e p u r c h a s in g  Institu tion  only. Published  
by The NFER-NELSON Publishing Com pany Ltd, Darville H ouse, 2  Oxford 
R oad East, Windsor, Berkshire SL4 1DF, UK. Code 4 9 2 0  03 4
Appendix 4
Beliefs About Medicines Questionnaire fRMO)
BMQ-SG Project Number
YOUR VIEWS ABOUT
MEDICINES PRESCRIBED FOR YOU
• We would like to ask you about your personal views about medicines prescribed for you.
• These are statements other people have made about their medicines.
• Please show how much you agree or disagree with them by ticking the appropriate box.
There are no right or wrong answers. 
We are interested in your personal views
Views about MEDICINES PRESCRIBED FOR YOU: Strongly Agree Agree Uncertain Disagree StronglyDisagree
□SI My health, at present, depends on my medicines
BS2 Having to take medicines worries me
BS3 My life would be impossible without my medicines
ass I sometimes worry about long-term effects of my medicines
BS-i Without my medicines I would be very ill
BS6 My medicines are a mystery to me
BS7 My health in the future will depend on my medicines 1
BS4 My medicines disrupt my life
BS9 [ sometimes worry about becoming too dependent on my medicines
BS10 Vfy medicines protect me from becoming worse
BSIt fhese medicine give me unpleasant side effects
YOUR VIEWS ABOUT
MEDICINES IN GENERAL
• These are statements that other people have made about medicines in general.
• Please show how much you agree or disagree with them by ticking the appropriate box.
Views about MEDICINES IN GENERAL Strongly Agree Agree Uncertain Disagree Strongly
Disagree
BGl Doctors use too many medicines
BG2 People who take medicines should stop their treatment for a while 
every now and again
BGJ Most medicines are addictive
BG4 Natural remedies are safer than medicines
BG5 Medicines do more harm than good
BG6 All medicines are poisons
BG7 Doctors place too much trust on medicines
BGl If doctors had more time with patients they would prescribe fewer 
medicines
O If Horm Ucwwjity of on IW4
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Appendix 5
Medication Adherence Report Scale (MARS-5)
Your cholesterol-lowering medicines
16. Have you been prescribed any medicines (either tablets or powders) to reduce 
your cholesterol level?
Please tick one statement
□ Yes
□ No
| | D on’t know
• I f  you answered “yes”, please answer questions 17.
• I f  you answered “no” or “don’t know”, please go to question 18.
17. M any people find a way o f  using their cholesterol-lowering medicines which 
suits them. This m ay differ from the instructions on the label or from what their 
doctor has said. Below are a few questions about how YOU use your cholesterol- 
lowering medicines.
Here are some ways in which people have said that they use their cholesterol-
lowering medicines. Thinking about your cholesterol-lowering medicines OVER
THE PAST MONTH, please circle a number for each statement.
Always Often Sometimes Rarely Never
a. I forget to take my cholesterol-lowering 1 2 3 4 5
medicines
b. I alter the dose o f m y cholesterol- 1 2 3 4 5
lowering medicines
c. I stop taking my cholesterol-lowering 1 2 3 4 5
medicines for a while
d. I decide to miss out a dose 1 2 3 4 5
e. I take less than instructed 1 2 3 4 5
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Appendix 6
Combined Questionnaire Booklet
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Patient Details: [Study Number: ]
Please fill in the following information in as much detail as possible.
Please circle appropriate gender...........................................................................Male /  Female
Please give date of birth.............................................. .................................................................
Please give your ethnicity (e.g. White/British, Asian, Affo-Caribbean)
Please give details of condition for which you are taking cholesterol lowering medication(s) 
(when diagnosed/ family history):
Please give details of cholesterol lowering medication you have taken previously and are 
currently taking. (Name /  Dose / How long taking / Reason for stopping / Side effects etc.)
Please give details of any other medical conditions and associated medications:
Please give length of time you have been attending this lipid clinic and how often you have 
appointments:
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VIEWS ABOUT YOUR HIGH CHOLESTEROL CONDITION:
We are interested in your own personal views of how you see your current high cholesterol 
condition.
Please indicate how much you agree or disagree with the following statements about your 
illness by ticking the appropriate box.
Statement Strongly
Disagree
Disagree Neither
Agree
nor
Disagree
Agree Strongly
Agree
My high cholesterol condition will last a 
short time
My high cholesterol condition is likely to 
be permanent rather than temporary
My high cholesterol condition will last for 
a long time__________________________
This high cholesterol condition will pass 
quickly_____________________________
I expect to have this condition for the rest 
of my life___________________________
My high cholesterol is a serious condition
There is a lot which I can do to control my 
symptoms of my high cholesterol condition
What I do can determine whether my high 
cholesterol condition gets better or worse
Recoveiy from my high cholesterol 
condition is largely dependent on chance 
or fate
The course of my high cholesterol 
condition depends on me_______________
Nothing I do will affect my high 
cholesterol condition
I have the power to influence my high 
cholesterol condition
My actions will have no affect on the 
outcome of my high cholesterol condition
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Statement Strongly Disagree Neither Agree Strongly
Disagree Agree Agree
nor
Disagree
My symptoms of my high cholesterol 
condition are beyond my control_________
My symptoms of my high cholesterol 
condition will be around whatever I do
My high cholesterol condition will improve 
in time
There is very little that can be done to 
improve my high cholesterol condition
My treatment will be effective in curing 
my high cholesterol___________________
The negative effects of my high cholesterol 
condition can be prevented (avoided) by 
my treatment_________________________
My treatment can control my high 
cholesterol condition
There is nothing which can help my high 
cholesterol condition
The symptoms of my high cholesterol 
condition are puzzling to me____________
My high cholesterol condition is a mystery 
to me
I don’t understand my high cholesterol 
condition
My high cholesterol condition doesn’t 
make any sense to me_________________
I have a clear picture or understanding of 
my high cholesterol condition___________
The symptoms of my high cholesterol 
change a great deal from day to day______
4
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Statement Strongly Disagree Neither Agree Strongly
Disagree Agree Agree
nor
Disagree
My symptoms of my high cholesterol 
condition come and go in cycles_________
My high cholesterol condition is very 
unpredictable________________________
My high cholesterol condition is present all 
the time
I got through cycles in which my high 
cholesterol condition gets better and worse
I experience my high cholesterol symptoms 
pretty much all of the time______________
The symptoms of my high cholesterol 
condition are distressing to me _______
I get depressed when I think about my high 
cholesterol condition
When I think about my high cholesterol 
condition I get upset__________________
My high cholesterol condition makes me 
feel angry________________________-
My high cholesterol condition does not 
worry me___________________________
Having this high cholesterol condition 
makes me feel anxious
I worry a lot about my high cholesterol 
condition
My high cholesterol condition makes me 
feel afraid
Page 238
We are interested in what YOU consider may have been the cause of your high cholesterol 
condition. As people are very different, there is not correct answer for this question. We are 
most interested in your own views about the factors that caused your high cholesterol condition 
rather than what others including Doctors or family may have suggested to you. Below is a list 
of possible causes for your high cholesterol condition. Please indicate how much you agree or 
disagree that they were causes for you by ticking the appropriate box.
Possible Causes Strongly
Disagree
Disagree Neither
Agree
nor
Disagree
Agree Strongly
Agree
Stress or worry
Heredity- it runs in my family
A germ or virus
Diet or eating habits
Chance or bad luck
Poor medical care in my past
Pollution in the environment
My own behaviour
My mental attitude e.g. thinking about life 
negatively___________________________
Family problems or worries caused my 
illness
Overwork
My emotional state e.g. feeling down, 
lonely, anxious, empty________________
Ageing
Alcohol
Smoking
Accident or Injury
My personality
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Possible Causes Strongly Disagree Neither Agree Strongly
Disagree Agree Agree
nor
Disagree
Altered immunity
My genes
How likely do you think you are to have a raised cholesterol level over the next 10 years?
Please rate from 0= not at all likely to 
6= Extremely likely._______________
Y O U R  FEELIN G S 
Questionnaire 1:
Read each item and underline the reply which comes closest to how you have been feeling in 
the past week. Don’t take too long over your replies; your immediate reaction to each item will 
probably be more accurate than a long thought out response. Please answer every question.
I  feel tense or ‘wound up’:
Most of the time 
A lot of the time 
From time to time 
Not at all
I  get a sort of frightened feeling as 
if something awful is about to happen:
Very definitely and quite badly 
Yes, but not too badly 
A little, but it doesn’t worry me 
Not at all
I still enjoy the things I  used to enjoy:
Definitely as much 
Not quite so much 
Only a little 
Hardly at all
I  can laugh and see the funny side 
of things:
As much as I always could 
Not quite so much now 
Definitely not so much now 
Not at all
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W orrying thoughts go through my mind:
A great deal of the time 
A lot of the time
From time to time but not too often 
Only occasionally
I can sit at ease and feel relaxed:
Definitely 
Usually 
Not often 
Not at all
I  get a sort of frightened feeling like 
‘butterflies’ in the stomach:
Not at all 
Occasionally 
Quite often 
Very often
I feel restless as if I have to be on 
the move:
Very much indeed 
Quite a lot 
Not very much 
Not at all
I get sudden feelings of panic:
Very often indeed 
Quite often 
Not very often 
Not at all
I  feel cheerful:
Not at all 
Not often 
Sometimes 
Most of the time
I feel as if I am slowed down:
Nearly all the time 
Very often 
Sometimes 
Not at all
I  have lost interest in my appearance:
Definitely
I don’t  take as much care as I should 
I may not take quite as much care 
I take just as much care as ever
I  look forward with enjoyment to things:
As much as I ever did 
Rather less than I used to 
Definitely less than I used to 
Hardly at all
I can enjoy a good book or radio or 
T.V. programme:
Often 
Sometimes 
Not often 
Very seldom
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YOUR VIEWS ABOUT MEDICINES PRESCRIBED FOR YOUR HIGH 
CHOLESTEROL CONDITION
• We would like to ask you about your personal views about medicines prescribed for your 
high cholesterol condition.
• These are statements other people have made about their medicines.
• Please show how much you agree or disagree with them by ticking the appropriate box.
There are no right or wrong answers. We are interested in your personal views.
Views about
MEDICINES PRESCRIBED FOR 
YOUR HIGH CHOLESTEROL 
CONDITION:
Strongly
Agree
Agree Uncertain Disagree Strongly
Disagree
My health, at present, depends on my 
medicines
Having to take medicines worries me
My life would be impossible without 
my medicines_____________________
I sometimes worry about long term 
effects of my medicines________ .
Without medicines I would be very ill
My medicines are a mystery to me
My health in the future will depend on 
my medicines_____________________
My medicines disrupt my life
I sometimes worry about becoming too 
dependent on my medicines _
My medicines protect me from 
becoming Worse___________________
These medicines give me unpleasant 
side effects
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YOUR VIEWS ABOUT MEDICINES EN~ GENERAL
• These are statements that other people have made about medicines in general
• Please show how much you agree or disagree with them by ticking the appropriate box.
Views about
MEDICINES IN GENERAL:
Strongly
Agree
Agree Uncertain Disagree Strongly
Disagree
Doctors use too many medicines
People who take medicines should stop 
their treatment for a while every now 
and then
Most medicines are addictive
Natural remedies are safer than 
medicines
Medicines do more harm than good
All medicines are poisons
Doctors place too much trust on 
medicines
If Doctors had more time with patients
they would prescribe fewer medicines_______________________________________________
YOUR CHOLESTEROL LOWERING MEDICATION
Have you been prescribed any medicines (either tablets or powders) to reduce your cholesterol 
level?
Please tick one statement:
YES □ NO □ Don’t know □
If you answered ‘yes’ please answer the next question:
Many people find a way of using their cholesterol-lowering medicines which suits them. This 
may differ from the instructions on the label or from what their Doctor has said. Below are a 
few questions about how YOU use yoU cholesterol-lowering medicines.
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Here are some ways in which people have said that they use their cholesterol-lowering 
medicines. Thinking about your cholesterol-lowering medicines OVER THE PAST 
MONTH, please circle a number for each statement.
Always Often Sometimes Rarely Never
a. I forget to take my cholesterol- 
lowering medicines
b. I alter the dose of my cholesterol- 
lowering medicines
c. I stop taking my cholesterol- 
lowering medicines for a while
d. I decide to miss out a dose
e. I take less than instructed
Thank you very much for taking the time to complete this questionnaire.
Here are some ways in which people have said that they use their cholesterol-lowering 
medicines. Thinking about your cholesterol-lowering medicines OVER THE PAST 
MONTH, please circle a number for each statement.
Always Often Sometimes Rarely Never
a. I forget to take my cholesterol- 1 2  3
lowering medicines
b. I alter the dose of my cholesterol- 1 2  3
lowering medicines
c. I stop taking my cholesterol- 1 2  3
lowering medicines for a while
d. I decide to miss out a dose 1 2  3
e. I take less than instructed 1 2  3
‘You are more likely to carry out your intentions to take your cholesterol lowering 
medication every day for the next four weeks, if you make a decision about when and 
where you will do so. Decide now, when and where you will take your medication over the 
next four weeks. You may find it useful to take a tablet just before or just after something 
else that you do on a regular basis, such as brushing your teeth.’
‘Please write in the space below, when and where you will take your medication, every day for 
the next four weeks. E.g. In my bedroom at 7.30pm after my evening meal. ’
4 5
4 5
4 5
4 5
4 5
Thank you very much for taking the time to comylete this questionnaire.
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Appendix 7
Hospital Ethical Approval
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Guy's and St Thomas' Hospital 1
ST THOMAS’ HOSPITAL RESEARCH ETHICS COMMITTEE
Medical Committee Office 
Block 5, South Wing
C o -C h a irm e n  - D r A H o p p e r/D r A W illiam s 
A d m in is tra to r  - i\Is S H irsch
10 July 2002 
iVIs I Bergson
Trainee Clinical Psychologist 
Department of Psychology 
University o f Surrey 
Guildford GU2 7XH 
St Thomas' Hospital
NHS Trust
S t T h o m a s ' H o sp ita l 
L a m b e th  P a la c e  R o ad  
L o n d o n  SE1 7EH
Tel: 0 2 0  7 9 2 8  9 2 9 2 .
Ex t  2 0 9 7  F a x  0171  92 2 S I M  
Sleil;i.hirscli(i7<Kstt.stli:im c.s.ii/i.s.uk
Dear Ms Bergson
EC02/087 Investigation into peoples beliefs about their cholesterol lowering medication Ms f
Bergson, Dr A Wierzbicki, Dr M  Crook, Dr VSenior PIS
P a tien t C onsen t form, S tandard  consen t form, Q uestionnaire, Gpower - predicting n ece ssa ry  sam p le  size,
’ questionnaire  refs and validation
Thank you for amendments to consent form received by the Research Ethics Committee at its meeting on 30
July 2002. This is satisfactory and I am happy for the study to commence. Approval extends to the Guy’s
site.
Please note the following conditions to the approval:
• T he  pro ject num ber and the principal-investigato r m ust be clearly stated on the consen t form  ( i f  applicable). I f  approval is given 
to  nam ed investigators only, these nam es m ust a lso  be stated on the form.
• In the case o f  research on patien ts, a copy o f  the consen t form ( i f  applicable) m ust be p laced  in the p a tie n t’s m edical records, 
together w ith a note o f  the date o f  com m encem ent o f  h is/her participation in the research. A label m ust appear on the outside 
cover o f  the records when the patien t is partic ipating  in the research.
• A ny  am endm ents to the protocol m ust be notified to the com m ittee for approval.
• A pproval is for the length o f  tim e specified  in y o u r application . I f  you require an extension , a letter from  the p rincipal investigator 
to the C hairm an, is required to extend the research.
• T h e  com m ittee snouio be notified o f  any serious adverse  events (please apply  fo r s tandard  SA E report form ), o r  :f the study :s 
term inated  prem aturely
• T h e  investigators m ust adhere to the published  G uidelines o f  the C om m ittee and provide the C hairm an w ith annual progress 
reports and an end o f  study report. T he research shou ld  start w ithin 12 m onths o f  the date o f  approval.
This pro ject carries a reference num ber, noted above, w hich  m ust be quoted in any fu ture correspondence.
The St Thomas’ Hospital Lj&ECTis compliant with the ICH GCP requirements.
Yotiis sincerely
Dr A Hopper 
Co-Chairmen
Research.Ethics Committee Encl.
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University Ethical Approval
Urn’S
30 September 2002 University Registry 
of Surrey
Ms Ingrid Bergson 
Trainee Clinical Psychologist 
Department of Psychology 
University of Surrey
Guildford
Surrey GU2 7XH, UK 
Telephone
+ 44 (0)1483 3 0 0 8 0 0  
Facsim ile
+ 44  (0)1483 683811
Dear Ms Bergson
Investigation into people’s beliefs about their cholesterol lowering medication 
fACE/2002/73/Psvch) -  FAST TRACK
I am writing to inform you that the University Advisory Committee on Ethics has 
considered the above protocol under its ‘Fast Track’ procedure and has approved it on the 
understanding that the Ethical Guidelines for Teaching and Research are observed. For 
your information, and future reference, these Guidelines can be downloaded from the 
Committee’s website at http://www.suirey.ac.uk/Surrey/ACE/.
This letter of approval relates only, to the study specified in your research protocol 
(ACE/2002/73/Psych) - Fast Track The Committee should be notified of any changes to 
the proposal, any adverse reactions and if the study is terminated earlier than expected, 
with reasons.
Date of approval by the Advisory Committee on Ethics: 30 September 2002
Date of expiry of approval by the Advisory Committee on Ethics: 29 September 2007
Please inform me when the research has been, completed.
Yours sincerely
Catherine Ashbee (Mrs)
Secretary, University Advisory Committee on Ethics
cc: Chairman, ACE
Dr V Senior, Supervisor, Dept of Psychology 
Dr M Crook, Co-Investigator, Guys Hospital 
Dr A Wierzbicki, Co-Investigator, Guys Hospital
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Patient Information Sheet
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Guy's and St Thomas' Hospital ACA FACB pni& etn H a ia^  Koao 
London -SGI f hh
Tel: (44) 20-7928-9292x2027
Fax: (44) 20-7928-4226
E-mail:
Research Information Sheet Investigating Patient’s 
Beliefs About Cholesterol Lowering Medication.
You are being invited to take part in a research study. Before you decide, it is important for you 
to read the information provided on this sheet, so you fully understand the purpose o f  the 
research and what taking part will involve. Please ask us i f  there is anything that is not clear, or 
i f  you would like more information. Entering the study is completely voluntary, you are free to 
withdraw a t any time and this will NOT affect you care you receive.
Purpose of this Study:
This research will look at individual’s views of cholesterol lowering medication and how they take 
their medication. It is hoped this will help us identify ways of understanding what people think of 
their medicines and how we can help them to take their medicines as recommended. If used 
correctly, these medicines can help reduce the likelihood of heart attacks at an early age..
W hat does taking part involved?
After reading this information sheet and if you agree to take part in the research, you will be given 
a consent form to sign and a questionnaire, looking at your views about your medication.
You will be asked to complete this as fully as possible whilst in the clinic. If this is not possible, 
you can collect a Free-post envelope so you can complete the questionnaire at home and return it 
free of charge.
Approximately one month after returning this questionnaire, a second similar questionnaire may be 
sent out to you, for you to complete. Again a Free-post envelope will be provided for its return.
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What are the benefits of taking part?
The study will not directly benefit you, but will be used to develop better services in the future. 
Your decision to take part will not be disclosed to your physician and will not affect the care you 
receive.
Will the information be Confidential?
YES: Each patient who agrees to take part will be given a study number. Study numbers and 
patient details will not be kept together. Consent forms will be detached from questionnaires
upon return. Once all information has been collected, patient details will be destroyed and only 
study numbers will be used. This will keep all information confidential. No one will be referred to 
byname.
What Should I do Now?
♦ If you have any questions, please feel free to ask the person administering the questionnaires. If 
you have any further queries please telephone Ingrid Bergson (study co-ordinator) or Dr. Vicky 
Senior (supervisor) at the University of Surrey on 01483 259441.
♦ Please think about whether you would like to take part in this study. If you do not wish to take 
part, this decision will not affect your care.
♦ If you are satisfied with the information provided and would like to take part in the study, 
please sign the consent form attached to the questionnaire and then continue to fill in the 
questionnaire. (The consent form will be detached from the questionnaire upon completion).
♦ If you are unable to complete the questionnaire in the clinic, please ask for an envelope so you 
can complete it at home and send it back free of charge.
Thank you for taking the time to read this information. We very much hope that you are 
interested in this study and that you want to take part.
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Appendix 10
Patient Consent Form
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Guy's and St Thomas' Hospital ACAFACB ;ndon
Tel: (44) 20-7928-9292x2027
Fax: (44) 20-7928-4226
E-mail: ________________________________________
Consent Form:
Project: Investigating patient’s beliefs about cholesterol lowering medication.
Full Name.........................................................................................................
Address..............................................................................................................
Contact Telephone:  ...... , ...........................................................................................
I have read the information sheet and hereby consent to take part in the above 
investigation. Any questions I wished to ask have been answered to my satisfaction. I 
understand that this research is strictly confidential and no one will be referred to by name. 
I understand that I may withdraw from the study at any time, without having to give an 
explanation, and that this will not affect my care as a patient in any way. I give permission 
for the researchers to access sections of my medical records if needed.
Signed (Volunteers signature)..................................................................................
Date..................... ........................................................................................................
Signed (Doctor/Investigator)..........................................................................................
Date..............................................................................................................................
Post Code:
Please sign BOTH copies of the consent form and hand ONE back/send one back with 
completed questionnaires. (This will be separated and kept apart from questionnaires). 
The other copy is for you to keep alongside the client information sheet.
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Appendix 11
Covering Letter for Follow-up Questionnaire
Page 255
Guy's and St Thomas' Hospital
X|UC T  L ondon  SE 1 7 E H
Tel: (44)20-7928-9292x2027
Fax: (44) 20-7928-4226
E-mail: Anthony.Wierzbicki@.kcl ac nk______________________
Name... 
Address.
Date
D ear.....................................
Thank you for taking the time to kindly complete the questionnaire that was given to 
you in the lipid clinic, regarding your cholesterol condition and associated medication. 
As mentioned initially, there is one more very short questionnaire which I need you to 
fill in and send back in the free-post envelope provided as soon as possible.
As stated previously, your responses are strictly confidential and your details will be 
separated from your responses as they are received.
Thank you very much for taking part in the research, full details of which will be made 
available when the research is complete.
Yours Sincerely,
Ingrid Bergson 
Principal Investigator
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Appendix 12
Follow-up Adherence Questionnaire
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Participant Number............
Questionnaire time 2:
Many people find a way of using their cholesterol-lowering medicines which suits them. This 
may differ from the instructions on the label or from what their Doctor has said. Below are a 
few questions about how YOU use you cholesterol-lowering medicines.
Here are some ways in which people have said that they use their cholesterol-lowering 
medicines. Thinking about your cholesterol-lowering medicines OVER THE PAST 
MONTH, please circle a number for each statement.
Always Often Sometimes Rarely Never
a. I forget to take my cholesterol- 
lowering medicines
b. I alter the dose of my cholesterol- 
lowering medicines
c. I stop taking my cholesterol- 
lowering medicines for a while
d. I decide to miss out a dose
e. I take less than instructed
Thank you very much for taking the time to complete this questionnaire.
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Appendix 13
Information Sheet for all Patients After 
Data Collection.
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Guy's and St Thomas' Hospital G Z Z  3 JC A  FACB St Thomas’ HospitalLam beth Pa lace  Road London SE1 7EH
NHS Trust
Tel: (44) 20-7928-9292x2027
Fax: (44) 20-7928-4226
E -m ail: A n th o n v .W ie rz b ic k i@ k c l.a c .u k ,
You and Y our Cholesterol-lowering M edicines
High cholesterol remains one o f the major risk factors for Coronary Heart Disease, 
which is still the leading cause o f death in the UK. Lowering your cholesterol can help 
to reduce your risk o f having heart disease. Lowering cholesterol can be achieved by 
taking medicines prescribed by your doctor and eating a diet that is low in saturated 
fat. For many people with high cholesterol taking medicines is the best way o f 
achieving a lower cholesterol level.
We realise that sometimes people find it difficult to take their medicines as their doctor 
recommends. This may be because o f side effects o f the medicine, having to take lots 
o f  different types o f medicine, or simply forgetting. Unfortunately not taking your 
medicines as recommended means that they will not be as effective at lowering your 
risk o f heart disease. Taking your cholesterol-lowering medicines as recommended by 
your doctor is very important in maximising the benefits o f  your treatment.
It is thought that you are more likely to take your medicines correctly i f  you make a 
decision about when and where you will do so. Some participants in this study were 
asked to do this. Making ‘action plans’ as they are called have been found to help 
people remember to take their medicines. It can be useful to take a tablet just before or 
just after something, such as brushing your teeth. An example o f an action plan is as 
follows:
7 will take my tablet in my bedroom, at 7.30pm after my evening meal. ’
You were not asked to make these plans during the study, but as they have been shown 
to help people take their medicines correctly, you may still wish to do so.
If  you have any concerns about your cholesterol-lowering medicines, or find it difficult 
to take them as recommended, please do talk to your doctor about this.
R em em ber we are here to help you
